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Abstract 
 
The thesis that this dissertation aims to defend is: 
Certain self-management behaviours in End Stage Renal Disease are predicted by self-
efficacy, patient activation, and psychological distress, and in turn predict clinical status. 
However, self-management is often oversimplified and poorly operationalised, in both the 
literature and in clinical practice, to adherence and ‘good/bad’ distinctions that may impede 
future investigations and interventions. 
 
End Stage Renal Disease (ESRD) is a chronic condition associated with significant morbidity 
and increased risk of death. It is commonly treated with haemodialysis, a life sustaining treatment 
that last approximately four hours, repeated in a healthcare centre or at home, at least three times a 
week. ESRD also necessitates adherence to a complex set of dietary and fluid intake guidelines, in 
addition to a complex medication regimen, if the person is to avoid a further increase in the risk of 
severe symptoms and death. 
Chronic illness self-management is more than just adherence to prescribed medical 
treatments however, and requires an individual to preserve their emotional wellbeing, maintain 
social support networks, and continue to function in a variety of social roles and situations. While 
this has long been recognised in the theoretical literature about self-management, these concepts 
are often not well translated into clinical practice or empirical investigations of self-management 
behaviour in ESRD. When operationalising self-management, some investigations treat the 
‘behaviour’ element of self-management as being limited to dialysis, medication, and fluid 
adherence, or are ignored in favour of psychological correlates such as self-efficacy. A frequent 
criticism of the self-management literature is that self-efficacy is often treated as an outcome, rather 
than a psychological component of changes in behaviour, wellbeing, or clinical outcomes. 
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The investigations presented in this dissertation seek to investigate self-management in 
terms of specific behaviours that go beyond adherence. In doing so, they explore two different types 
of self-management behaviour, here termed ‘cooperative’ and ‘defensive’ self-management. These 
behaviours can then be examined in relation to adherence and self-efficacy, as well as other 
theoretically related factors including patient activation, psychological distress, and illness 
perceptions.  
The first three chapters set out the background to the empirical investigations reported in 
this dissertation. Chapter one covers the background on ESRD and its treatment. Chapter two 
describes the current state of the conceptual and empirical literature concerning self-management. 
Chapter three combines a narrative review of empirical investigations into self-management in 
ESRD, and a review of publically available resources concerning self-management in ESRD. Chapter 
four describes the methods used in the following empirical chapters. Chapters five, six, seven and 
eight report original empirical investigations on self-management in ESRD. Chapter nine is a 
discussion of the combined findings, and their implications in the wider clinical and academic 
context. 
Chapter 5 presents the results of a series of focus groups conducted with people on in-
centre haemodialysis for ESRD, and the healthcare professionals involved in their care. These 
explored what each group understood by ‘self-management’, the behaviours and tasks that were 
important, and the practical, social, and emotional facilitators and barriers. A series of interviews 
conducted with patients eighteen months later revisited these concepts, focusing on motivations for 
engaging in self-management behaviours. The combined findings revealed that patient and HCP 
concepts around self-management overlap, but have a different focus, with HCPs seeing self-
management as being about adherence, and patients seeing it as a complex balancing act to 
maintain their health, emotional wellbeing, and social roles. HCPs identified some patients as ‘good’ 
and others as ‘bad’. 
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Chapter 6 presents the results of a cross-sectional investigation of self-management 
behaviour and theoretically related psychological factors, including self-efficacy and psychological 
distress. Self-management was operationalised using an available scale that covered a variety of the 
behaviours patients and HCPs identified as important in chapter 5, which included both ‘cooperative’ 
and ‘defensive’ subscales. Self-efficacy, patient activation, and psychological distress were related to 
‘defensive’ behaviours, with higher levels of psychological distress being related to the performance 
of more defensive behaviours. Higher self-efficacy was related to less frequent performance of 
defensive behaviours. A novel finding was that psychological distress mediated the relationship 
between self-efficacy and self-management behaviours. The implication that some proactive self-
management behaviours may be associated with poorer emotional wellbeing is discussed. 
Chapter 7 presents the results of an 18 month longitudinal study of self-management 
behaviour and clinical markers of adherence. It also reports a survival analysis in the same cohort 
followed up to 30 months. Higher frequency of cooperative self-management behaviours were 
associated with lower levels of adherence as indicated by clinical markers. This may be due to the 
dialysis units in which the study took place, and may in fact reflect how self-management support 
was conducted in the units at the time of the study. Higher self-efficacy was found to be associated 
with lower mortality over 30 months after controlling for factors such as age and residual kidney 
function, an original and potentially important finding. 
The findings in chapters 6 and 7 raised additional questions about how self-management 
behaviours are measured and what those measurements indicate. To further investigate, and lay the 
groundwork for a new scale and general guidelines on the operationalisation of self-management in 
ESRD, a series of cognitive interviews were conducted. These are reported in chapter 8. They were 
conducted with people on home haemodialysis, a population whose engagement in a whole range 
of self-management behaviours is likely to be high. The role of social and emotional factors in the 
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scale and behaviours discussed was also explored. The chapter concludes with a series of 
suggestions for measuring self-management behaviour in ESRD. 
 This dissertation will explore the concept of self-management for people on haemodialysis, 
the behaviours involved, and their relationship with psychosocial and clinical status. 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
List of tables 
 
Table 2.1: Stages of change and approximately equivalent 
 Patient Activation Measure categories …………………………………………………………. 32 
Table 3.1: Self-management interventions in CKD ............................................ 51 
Table 3.2: Self-management resources available to people with ESRD ……….. 67 
Table 4.1: Self-management questionnaire subscales ………………………………….. 93 
Table 5.1: Patient and staff focus group participants ……………………………………. 115 
Table 5.2: Themes emerging from focus groups ……………………………………………. 119  
Table 5.3: Themes emerging from interviews ……………………………………………….. 136 
Table 6.1: Descriptive statistics for participants …………………………………………….. 154 
Table 6.2: Zero order correlations between psychological variables, 
 self-management behaviours, and symptoms …………………………………………….. 156 
Table 6.3: Zero order correlations between depression and 
 self-management behaviour subscales ………………………………………………………… 157 
Table 6.4: Zero order correlations between psychological 
 variables and defensive self-management …………………………………………………… 158 
Table 6.5: Regression model predicting variation in 
 self-management behaviours ………………………………………………………………………... 159 
Table 6.6: Hierarchical regression with self-efficacy and depression 
vii 
 
 predicting defensive self-management …………………………………………………………… 160 
Table 7.1 Descriptive statistics for clinical, behavioural and 
 psychosocial variables over time ………………………………………………………………………. 177 
Table 7.2: Proportion of patients in each stage of patient activation 
 at baseline and 18-month follow-up ………………………………………………………………… 179 
Table 7.3 Zero order correlations for clinical, behavioural, 
 and psychosocial variables ………………………………………………………………………………… 181 
Table 7.4 Steps for building an MLM predicting IDWG as a 
 proportion of dry weight ………………………………………………………………………………….. 184 
Table 7.5: Steps for building an MLM predicting phosphate………………………………. 189 
Table 7.6: Multivariate Cox Hazard regression predicting 
 survival using self-efficacy and covariates ………………………………………………………. 191 
Table 8.1: Summary of themes emerging from cognitive 
 interviews, and frequency of themes ……………………………………………………………… 225 
  
List of figures 
 
Figure 1.1: Stages of kidney disease by Glomerular Filtration Rate (GFR). Reproduced from the UK 
Department of Health’s Renal Services Framework Part 2: Chronic Kidney Disease and Acute Renal 
Failure (2005) ……………………………………………………………………………………………… 4 
viii 
 
Figure 1.2: RRT modality at 90 days (incident cohort 01/10/2011 to 30/09/2012).  
Reproduced from the UK Renal Registry report 2013. ……………………………………… 14 
Figure 1.3: Treatment modality in prevalent RRT patients on 31/12/2012. 
 Reproduced from the UK Renal Registry report 2013……………………………………….. 14 
Figure 2.1: The self-management triangle from the Health Foundation ………….. 28 
Figure 7.1: Kaplan-Meier survival curve stratified by self-efficacy …………………… 191 
 
 
 
 
 
 
 
 
 
 
ix 
 
List of abbreviations 
 
BHDS: Behaviours in Haemodialysis Scale 
CI: Confidence Interval 
CHD: Coronary Heart Disease 
CKD: Chronic Kidney Disease 
COPD: Chronic Obstructive Pulmonary Disorder 
CSM: Common Sense Model of Illness Representations 
ESRD: End Stage Renal Disease 
GAD-7: General Anxiety Disorder 7-item scale 
GFR: Glomerular Filtration Rate 
HCP: Healthcare Professional 
HD: Haemodialysis 
HRQoL: Health Related Quality of Life 
ICC: Intraclass Correlation 
IDWG: Interdialytic Weight Gain 
IPQ: Illness Perceptions Questionnaire 
KRU: Residual Renal Function 
LL: Log Likelihood 
MAR: Missing At Random 
x 
 
MCAR: Missing Completely At Random 
MI: Multiple Imputation 
MLM: Multilevel Model 
MNAR: Missing Not At Random 
PAM: Patient Activation Measure 
PD: Peritoneal Dialysis 
PHQ-9: Patient Health Questionnaire 9-item scale 
QoL: Quality of Life 
RA: Renal Association 
REC: Research Ethics Committee 
SCT: Social Cognitive Theory 
 
 
 
 
 
 
 
xi 
 
Table of contents 
 
Chapter 1: Kidney disease and its treatment .......................................................................................... 1 
1.1 Introduction .................................................................................................................................. 1 
1.2 The healthy kidney ........................................................................................................................ 2 
1.2.1 What is Chronic Kidney Disease? ........................................................................................... 3 
1.3 Classification and progression ...................................................................................................... 4 
1.3.1 Prevalence, symptoms, and risk factors ................................................................................ 6 
1.3.2 Comorbidity ........................................................................................................................... 7 
1.4 Treatment of End Stage Renal Disease: Dialysis, transplantation and conservative management
 .......................................................................................................................................................... 10 
1.5 The organisation of a typical in-centre haemodialysis service ................................................... 15 
1.6 Beyond dialysis: The daily self-management challenges of a person living with ESRD .............. 17 
1.6.1 Medical ................................................................................................................................. 17 
1.6.2 Social .................................................................................................................................... 20 
1.6.3 Emotional ............................................................................................................................. 21 
1.7 Summary ..................................................................................................................................... 23 
Chapter 2: Review of Self-Management in chronic disease ................................................................. 24 
2.1 Introduction ................................................................................................................................ 24 
2.2 Shifting burden of disease and need for self-management ....................................................... 25 
2.3 Evolution of ‘self-management’ as a concept ............................................................................. 26 
2.4 Working definition of self-management ..................................................................................... 29 
2.5 Self-management and self-efficacy ............................................................................................. 30 
2.6 Self-management and Patient Activation ................................................................................... 31 
2.7 Measuring self-management ...................................................................................................... 33 
2.8 Self-management and associated psychological variables ......................................................... 37 
2.9 Self-management behaviour and relationship with clinical variables and outcomes ................ 39 
2.10 Self-management in models of health psychology ................................................................... 42 
2.11 Summary ................................................................................................................................... 45 
Chapter 3: Self-management in End Stage Renal Disease .................................................................... 46 
3.1 Introduction ................................................................................................................................ 46 
3.2 Thematic review of previous work on self-management in ESRD .............................................. 47 
3.2.1 Search strategy..................................................................................................................... 47 
3.3 Results ......................................................................................................................................... 49 
xii 
 
3.3.1 Prior reviews – interventions ............................................................................................... 49 
3.3.2 Prior reviews – observational .............................................................................................. 55 
3.4 Question 1 – What aspects of self-management have previous studies looked at? .................. 55 
3.5 Question 2 – What has been found on psychological factors associated with self-management?
 .......................................................................................................................................................... 56 
3.5.1 Social Cognitive Theory ........................................................................................................ 57 
3.5.2 Common sense model of illness representations ................................................................ 58 
3.5.3 Transtheoretical model of stages of change ........................................................................ 58 
3.6 Question 3 – What tools exist for measuring concepts related to self-management in ESRD? . 59 
3.7 Scoping review of self-management materials available to the public ...................................... 64 
3.7.1 Search strategy..................................................................................................................... 65 
3.7.2 Findings ................................................................................................................................ 66 
3.8 Summary ..................................................................................................................................... 74 
Chapter 4: Methods .............................................................................................................................. 76 
4.1 Introduction ................................................................................................................................ 77 
4.2 Background ................................................................................................................................. 77 
4.3 Research questions ..................................................................................................................... 78 
4.4 The SELFMADE study .................................................................................................................. 78 
4.4.1 Distinctions between SELFMADE and this thesis ................................................................. 80 
4.5 Ethics and governance approvals ............................................................................................... 81 
4.6 Participants ................................................................................................................................. 81 
4.6.1 Chapters 5, 6, and 7 ............................................................................................................. 82 
4.6.2 Chapter 8 .............................................................................................................................. 82 
4.7 Settings ........................................................................................................................................ 82 
4.7.1 In-centre dialysis .................................................................................................................. 82 
4.7.2 Home haemodialysis ............................................................................................................ 84 
4.8 Qualitative methods ................................................................................................................... 84 
4.8.1 Focus groups ........................................................................................................................ 85 
4.8.2 Interviews ............................................................................................................................. 86 
4.8.3 Cognitive interviews ............................................................................................................. 86 
4.8.4 Inter-rater reliability ............................................................................................................ 88 
4.8.5 Questionnaire development ................................................................................................ 88 
4.9 Quantitative methods ............................................................................................................. 89 
4.9.1 Self-report and clinical data ................................................................................................. 89 
xiii 
 
4.9.2 Questionnaires used (see appendices A to E) ...................................................................... 90 
4.9.3 Behaviours on Haemodialysis Scale (BHDS) ......................................................................... 91 
4.9.4 Patient activation ................................................................................................................. 94 
4.9.5 Anxiety and depression (appendices C and D) ..................................................................... 95 
4.9.6 Illness perceptions ............................................................................................................... 97 
4.9.7 Self-efficacy (appendix B) ..................................................................................................... 98 
4.9.8 Health related quality of life ................................................................................................ 99 
4.9.9 Social support ..................................................................................................................... 100 
4.9.10 Data collection - questionnaire administration ............................................................... 100 
4.9.11 Data collection - clinical variables .................................................................................... 101 
4.10 Statistical analyses .................................................................................................................. 101 
4.10.1 Hierarchical linear regression .......................................................................................... 102 
4.10.2 Mediation and bootstrapping .......................................................................................... 103 
4.10.3 Survival analysis ............................................................................................................... 104 
4.10.4 Multilevel modelling (MLM) ............................................................................................ 105 
4.10.5 Multiple imputation ......................................................................................................... 107 
4.11 Summary ................................................................................................................................. 108 
Chapter 5: What does “self-management” mean to dialysis patients and staff that care for them? 109 
5.1 Introduction .............................................................................................................................. 110 
5.1.1 Aims.................................................................................................................................... 110 
5.1.2 Self-management concepts among patients and staff ...................................................... 111 
5.1.3 Beliefs about facilitators and barriers ................................................................................ 112 
5.2 Methods .................................................................................................................................... 113 
5.2.1 Overview ............................................................................................................................ 113 
5.2.2 Participants ........................................................................................................................ 114 
5.2.3 Setting ................................................................................................................................ 116 
5.2.4 Personnel ........................................................................................................................... 116 
5.2.5 Procedure ........................................................................................................................... 116 
5.2.6 Analysis .............................................................................................................................. 117 
5.3 Results 1: Focus groups ............................................................................................................. 118 
5.3.1 Good patient/Bad patient .................................................................................................. 119 
5.3.2 Challenges .......................................................................................................................... 121 
5.3.3 Complex balancing acts and trade offs .............................................................................. 124 
5.3.4 What helps? ....................................................................................................................... 126 
xiv 
 
5.3.5 Unit as family ..................................................................................................................... 129 
5.4 Discussion 1 (focus groups): ...................................................................................................... 130 
5.5 Results 2: Interviews ................................................................................................................. 135 
5.5.1 Preventing or reducing unpleasant symptoms .................................................................. 137 
5.5.2 Coping by forgetting .......................................................................................................... 138 
5.5.3 Relieving boredom and reducing waiting times ................................................................ 139 
5.5.4 Getting on with life ............................................................................................................ 141 
5.6 Discussion 2: Interviews ............................................................................................................ 142 
5.6.1 Motivations for self-management behaviours .................................................................. 142 
5.6.2 Self-management behaviour categories ............................................................................ 144 
5.7 Combined summary .................................................................................................................. 145 
5.8 Conclusion ................................................................................................................................. 146 
Chapter 6: Psychosocial determinants of self-management behaviours in people on haemodialysis
 ............................................................................................................................................................ 147 
6.1 Introduction .............................................................................................................................. 147 
6.2 Methods .................................................................................................................................... 149 
6.2.1 Design and procedure ........................................................................................................ 149 
6.2.2 Setting ................................................................................................................................ 149 
6.2.3 Participants ........................................................................................................................ 150 
6.2.4 Materials ............................................................................................................................ 150 
6.2.5 Statistical analysis .............................................................................................................. 152 
6.3 Results ....................................................................................................................................... 153 
6.3.1 Descriptive statistics .......................................................................................................... 153 
6.3.2 Correlations between psychological variables ................................................................... 155 
6.3.3 Regressing psychological variables on self-management behaviours ............................... 158 
6.3.4 Mediation analysis ............................................................................................................. 161 
6.4 Discussion .................................................................................................................................. 162 
6.4.1 Depression, anxiety, and psychological distress ................................................................ 162 
6.4.2 Relationships between psychological variables ................................................................. 162 
6.4.3 Relationship between psychological variables and self-management .............................. 162 
6.4.4 Relationship between bothersome symptoms and self-management ............................. 164 
6.4.5 Strengths and limitations ................................................................................................... 165 
6.4.6 Conclusion .......................................................................................................................... 166 
Chapter 7: Longitudinal study of self-management behaviour and clinical status over time ............ 167 
xv 
 
7.1 Introduction .............................................................................................................................. 167 
7.1.1 Background ........................................................................................................................ 168 
7.1.2 Changes in patient activation, self-efficacy, and self-management behaviour over time 168 
7.1.3 Relationship between self-management behaviour and clinical status or adherence ..... 170 
7.1.4 Self-management and survival .......................................................................................... 171 
7.1.5 Hypotheses......................................................................................................................... 172 
7.2 Methods .................................................................................................................................... 173 
7.2.1 Participants ........................................................................................................................ 173 
7.2.2 Questionnaires ................................................................................................................... 174 
7.2.3 Clinical status ..................................................................................................................... 174 
7.2.4 Statistical methods ............................................................................................................. 175 
7.3. Results ...................................................................................................................................... 176 
7.3.1 Univariate change over time .............................................................................................. 176 
7.3.2 Attrition for self-management observations ..................................................................... 177 
7.3.3 Multilevel models and the effect of research site ............................................................. 180 
7.3.4 Correlations between IDWG and self-management variables .......................................... 180 
7.3.5 The relationship between IDWG and self-management ................................................... 182 
7.3.6 Correlations between phosphate and self-management variables ................................... 186 
7.3.7 The relationship between phosphate and self-management............................................ 186 
7.3.8 Survival analysis ................................................................................................................. 190 
7.4 Discussion .................................................................................................................................. 192 
7.5 Concluding remarks .................................................................................................................. 196 
Chapter 8: Refinement of a self-management behaviour questionnaire for people on haemodialysis
 ............................................................................................................................................................ 197 
8.1 Introduction .............................................................................................................................. 198 
8.2 Methods .................................................................................................................................... 202 
8.2.1 Overview ............................................................................................................................ 202 
8.2.2 Participants ........................................................................................................................ 202 
8.2.3 Approval ............................................................................................................................. 203 
8.2.4 Procedure ........................................................................................................................... 203 
8.2.5 Cognitive interviewing & analysis ...................................................................................... 203 
8.3 Results of structural analysis .................................................................................................... 205 
8.3.1 Frequency or duration ....................................................................................................... 205 
8.3.2 Limited applicability ........................................................................................................... 208 
xvi 
 
8.3.3 Unclear reference, wording, or misunderstanding ............................................................ 211 
8.3.4 Difficulty producing an example ........................................................................................ 213 
8.3.5 Conflicting clauses .............................................................................................................. 213 
8.3.6 Incongruous answers ......................................................................................................... 215 
8.3.7 Wording or tone ................................................................................................................. 217 
8.3.8 Specific items ..................................................................................................................... 218 
8.3.9 General comments on acceptability .................................................................................. 219 
8.4 Results from social and emotional analysis .............................................................................. 219 
8.4.1 Emotional ........................................................................................................................... 219 
8.4.2 Social .................................................................................................................................. 223 
8.5 Summary ................................................................................................................................... 224 
8.5.1 Structural............................................................................................................................ 227 
8.5.2 Social and emotional .......................................................................................................... 228 
8.6 Discussion of findings ................................................................................................................ 229 
8.6.1 Structural............................................................................................................................ 229 
8.6.2 Social and emotional factors .............................................................................................. 232 
8.7 Suggestions for measuring self-management .......................................................................... 233 
8.7.1 Lessons learned .................................................................................................................. 233 
8.7.2 General suggestions ........................................................................................................... 235 
8.7.3 Alterations specific to the BHDS ........................................................................................ 236 
8.8 Conclusion ................................................................................................................................. 240 
Chapter 9: General discussion ............................................................................................................ 241 
9.1 Introduction .............................................................................................................................. 241 
9.2 Conceptualising self-management in ESRD .............................................................................. 242 
9.3 Predicting performance of self-management behaviours ........................................................ 244 
9.4 Self-management behaviours as predictors of clinical status .................................................. 246 
9.5 Measuring self-management .................................................................................................... 248 
9.6 General remarks ........................................................................................................................ 249 
9.7 Limitations ................................................................................................................................. 251 
9.8 Practical implications and directions for future research ......................................................... 254 
References .......................................................................................................................................... 256 
xvii 
 
 
List of appendices 
 
A. Behaviour in Haemodialysis Scale (BHDS) 
B. Self-efficacy in chronic disease 6-item scale 
C. PHQ-9 
D. GAD-7 
E. Brief Dialysis Symptoms Inventory 
F. National Research Ethics Service (NRES) approvals 
G. Focus group schedules 
H. Interview schedules 
I. References to study outputs 
 
 
 
 
 
 
 
1 
 
Chapter 1: Kidney disease and its treatment 
 
 
1.1 Introduction .................................................................................................................................. 1 
1.2 The healthy kidney ........................................................................................................................ 2 
1.2.1 What is Chronic Kidney Disease? ........................................................................................... 3 
1.3 Classification and progression ...................................................................................................... 4 
1.3.1 Prevalence, symptoms, and risk factors ................................................................................ 6 
1.3.2 Comorbidity ........................................................................................................................... 7 
1.4 Treatment of End Stage Renal Disease: Dialysis, transplantation and conservative management
 .......................................................................................................................................................... 10 
1.5 The organisation of a typical in-centre haemodialysis service ................................................... 15 
1.6 Beyond dialysis: The daily self-management challenges of a person living with ESRD .............. 17 
1.6.1 Medical ................................................................................................................................. 17 
1.6.2 Social .................................................................................................................................... 20 
1.6.3 Emotional ............................................................................................................................. 21 
1.7 Summary ..................................................................................................................................... 23 
 
 
 
1.1 Introduction 
 
This introductory chapter provides the clinical background to self-management in Chronic 
Kidney Disease (CKD). Some background on the physiology of the kidneys, kidney disease and its 
progression, and how the disease is treated, will lay the foundation for understanding the roles of 
the health service and the patient in living with advanced CKD, or End Stage Renal Disease (ESRD). 
Understanding the factors that contribute to the development of ESRD, its prevalence, and common 
comorbidities will help demonstrate the scope of the problem. The chapter will go on to set out the 
practical self-management tasks faced by patients with ESRD, as well as the typical picture of 
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routinely undergoing dialysis in a hospital haemodialysis setting. Combined, this information will set 
out the clinical context that will make clear the self-management challenges faced by people with 
ESRD on haemodialysis. 
 
1.2 The healthy kidney 
 
The kidneys are situated behind the peritoneum (lining of the abdominal cavity), on either side 
of the spinal column. They extend roughly from the twelfth thoracic vertebra to the third lumbar 
vertebra. Each kidney is typically about 12cm long and weighs about 150g (Lote, 2012). 
Blood is usually supplied to each kidney by a single renal artery arising from the abdominal 
aorta. The kidney is made up of a dark outer area called the cortex, and a lighter inner area called 
the medulla. The kidneys are connected to the bladder by ureters, muscular tubes approximately 
30cm in length. 
The basic functional unit of the kidney is called the nephron. A nephron is a tube that starts in a 
Bowman’s Capsule, around a knot of capillaries called the glomerulus.  From Bowman’s Capsule the 
nephron extends into a complex tubular system extending from the proximal tubule, through the 
loop of Henle and into the distal tubule and collecting duct which connects to the ureter.  
The purpose of the glomerulus is to produce an ultrafiltrate of plasma. ‘Ultrafiltrate’ refers to 
the fact that the filtering processes take place on a molecular level.  Glomerular filtration is a key 
process of the kidneys. An almost protein-free ultrafiltrate passes into the Bowman’s capsule from 
the glomerular capillaries. Molecular weight is the main determinant of whether a substance will be 
filtered, or will remain in the capillaries. In the average human male, the glomerular filtration rate 
(GFR ) is approximately 180 L/day, or 125mL/min. As the filtrate is derived from plasma, and the 
average person has approximately 3L of plasma, the same plasma is filtered many times a day. The 
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ultrafiltrate passes from the glomerulus into Bowman’s Capsule and into the renal tubular system 
described above. Here it is further modified by selective reabsorption and secretory processes  
before eventual excretion as urine. During this process, 180L/day of filtrate is converted to around 2 
L of daily urine output.  The kidneys have a high blood flow. Between them they receive over 20% of 
cardiac output. This is required since many tubular processes are highly energy dependent.  
The primary functions of the kidneys include excretion of waste products – many of which are 
toxic . Without kidneys,  waste products would accumulate and kill the average person within a 
week or so. Kidneys also have a major role in maintaining fluid, electrolyte and acid-base balance. 
Additionally, the kidneys are responsible for the production of some hormones including renin, 
erythropoietin, and calcitriol. Renin has a role in the control of blood pressure.  Erythropoietin 
controls erythropoiesis (red blood cell production). As a result, anaemia is common in people with 
advanced kidney disease, and erythropoietin and iron supplementation is often required to correct 
this.  Calcitriol has a major role in calcium balance and in maintaining bone health, and is also 
commonly substituted in people with advanced kidney disease. 
1.2.1 What is Chronic Kidney Disease? 
 
Chronic Kidney Disease (CKD) is a long term, often progressive, condition. It involves damage or 
abnormality in both kidneys. There are a number of accepted terms, including Chronic Kidney 
Disease, Chronic Renal Failure, Chronic Kidney Failure and Chronic Renal Insufficiency. 
  CKD is usually diagnosed by finding evidence of retained waste products (urea and creatinine) 
in blood tests, often accompanied by the finding of excess protein in the urine (a sign of glomerular 
damage) and abnormal kidney imaging usually by ultrasound.  In its early stages, CKD is usually 
asymptomatic. Additionally, many people will have early stage CKD by the end of their lives, but will 
die of other causes before it becomes problematic in terms of symptoms or other health 
consequences (Department of Health, 2005).  In its later stages symptoms are often non-specific e.g.  
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tiredness, poor appetite, nausea and shortness of breath. However, when kidney failure is severe, it 
is fatal if not treated by a kidney transplant or regular sessions of dialysis. 
 
1.3 Classification and progression 
 
In the past two decades, renal services in many countries have adopted a common 
classification system for CKD. Primarily developed by the US National Kidney Federation in their 
Kidney Disease Outcomes Quality Initiative (K/DOQI), a five stage system based on estimated GFR is 
now used in UK’s National Health Service (NHS). The five stages are shown in figure 1.1. 
 
 
Figure 1.1: Stages of kidney disease by Glomerular Filtration Rate (GFR). Reproduced from the UK 
Department of Health’s Renal Services Framework Part 2: Chronic Kidney Disease and Acute Renal 
Failure (2005) 
 
 Stages of kidney disease are measured as estimated glomerular filtration rate (eGFR). This is 
derived from equations based on a measurement of serum creatinine, age, sex and ethnicity. There 
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are a number of such equations , the most commonly used being the MDRD-4 and CKD-EPI (Levey et 
al., 2007; Rule, 2010). Certain circumstances may require a 24 hour urine test, (e.g. for people with 
exceptional diets). For most purposes, eGFR can be thought of as a proxy measure for overall kidney 
function. An eGFR of between 90 and 60 ml/min/1.73m2 does not necessarily mean that an 
individual has progressive CKD; only a minority of people who fall into stages 1 and 2 of the above 
categories will go on to stages 4 and 5. The formal definition of CKD proposed by the K/DQOI group 
takes this into account. They define CKD as occurring when one of the following two criteria is met: 
1. Kidney damage is present for ≥ 3 months, as defined by structural or functional 
abnormalities of the kidney, with or without decreased GFR, manifest by either 
a. Pathological abnormalities, or 
b. Markers of kidney damage, including abnormalities in the composition of the blood 
or urine, or abnormalities in imaging tests 
2. An eGFR < 60mL/min/1.73m2 for ≥ 3 months, with or without kidney damage. 
 Stage 5 may be referred to as Established Renal Failure (ERF). ERF is currently defined by a 
GFR of less than 15 mL/min/1.73m2. Creatinine is a waste product generated by muscle activity. As 
kidney function declines, serum creatinine levels rise, and elevated serum creatinine is another 
indicator of the progression of kidney disease. End Stage Kidney Disease (ESKD), or End Stage Renal 
Disease (ESRD) are when Renal Replacement Therapy (RRT) is indicated by way of symptoms 
(described below); ESRD is the term that shall be used throughout this dissertation. People with 
ESRD require either a transplant or dialysis to stay alive. This dissertation describes work conducted 
with people with ESRD on either in-centre or home haemodialysis. 
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1.3.1 Prevalence, symptoms, and risk factors 
 
Due to the lack of symptoms in earlier stages of CKD, accurately assessing the number of 
people affected can be difficult.  In 2000/2001, the prevalence of diagnosed moderate to severe CKD 
in the South East of England was 5,554 patients per million population (pmp) (John, Webb, Young, & 
Stevens, 2004). In this case, moderate to severe CKD was defined as a serum creatinine of ≥ 180 
μmol/L in men and ≥ 135 µmol/L in women. More recently, the UK Renal Registry estimated that the 
incidence rate for starting Renal Replacement Therapy in 2011 was 108 pmp. This was an increase 
from 95 pmp in 2001 (Renal Association, 2012). This meant a total of 6,835 people started some 
form of RRT in 2011 in the UK. The prevalence (total number of people receiving RRT) in 2011 was 
53,207, or 842 pmp. In 2000, the prevalence was 523 pmp. The number of people receiving RRT in 
the UK is increasing, as it is in many countries worldwide, including the US (Collins et al., 2013). 
CKD does not typically exhibit symptoms until GFR starts to reach approximately 
30mL/min/1.73m2, or CKD stage 4. By the time stage 5 is reached and GFR is below 
15mL/min/1.73m2, the physiological consequences include the inability to excrete certain waste 
products, excess water and salts, and control the body’s acidity. Haemoglobin production, blood 
pressure regulation, and bone formation also become dysregulated. 
By stage 5, symptoms can include tiredness, nausea, and loss of appetite.  Clinically, fluid 
retention (oedema), particularly around the ankles, is common, as is breathlessness, discolouration 
of the skin and raised blood pressure. 
Risk factors for CKD and subsequent ESRD are most evident in demographic and clinical 
status, rather than direct results of lifestyle. The most pronounced risk factors are diabetes, age, 
hypertension, and South Asian, African or African Caribbean ethnicity. Male sex, being a smoker, and 
heavy alcohol use are also predictors of CKD. 
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Age is highly predictive of decreased kidney function. In 2001 in the UK, nearly half of all 
patients starting RRT were over the age of 65, despite this age group making up a quarter of the 
total population (Department of Health, 2005). In the NHANES III study conducted in the USA, 0.2% 
of individuals aged 20 to 39 had moderately or severely decreased kidney function (stage 3 CKD or 
greater). In individuals aged 70 and over, the rate was around 25% (Coresh, Astor, Greene, Eknoyan, 
& Levey, 2003) 
Diabetes is the most common cause of ESRD. Estimated in 2006 from USRDS data, diabetes 
accounted for approximately 44% of all new cases of treated ESRD in the USA (Burrows, Li, & Geiss, 
2010). As with many risk factors, this figure varies substantially between countries. In the DOPPS 
study, the percentage of patients with ESRD caused by diabetes varied from 10.4% in France, to 
40.9% in the USA (Young et al., 2000). For the UK, the most recent Renal Registry report states that 
diabetic renal disease was the primary cause in 26% of people starting renal replacement therapy 
(Renal Association, 2013). Hypertension is the second most common cause of ESRD, estimated to be 
responsible for approximately 27% of all cases in the USA. This figure rises to 33.4% for African 
Americans (Lea & Nicholas, 2002). Male sex is associated with a greater risk of ESRD, and more rapid 
progression of the disease (Neugarten, Acharya, & Silbiger, 2000). 
 
1.3.2 Comorbidity 
 
Later stage CKD is frequently accompanied by other health conditions. This is particularly 
true of ESRD. After the initiation of dialysis, median survival is approximately 4-5 years, and the 
majority of patient deaths will be attributable to one of these comorbid conditions (Prichard, 2000). 
Cardiovascular conditions, abnormal blood pressure, diabetes, and related vascular conditions are 
common in people with ESRD, and some of these can be causes of ESRD, consequences, or both. Due 
to ESRD being more common with increasing age, cancer is also present in some patients. HIV/AIDS 
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creates additional treatment challenges where present. Comorbidities increase mortality, and 
produce additional treatment and self-management challenges for individuals living with those 
conditions. 
The most common cardiovascular comorbidities include ischemic heart disease and left 
ventricular hypertrophy, which are common in pre-dialysis populations (people who are approaching 
the threshold for, but not yet on, dialysis).  Congestive heart failure is common after dialysis 
commences. Diabetes has a strong negative impact on survival and is associated with the presence 
of vascular disease (Morioka et al., 2001). Poor nutrition, which can be indicated by low serum 
albumin or subjective global assessment, is a strong predictor of mortality. The course of conditions 
such as diabetes is to some extent modifiable, which makes effective management an important 
element of care. 
Hypertension is predictive of mortality in the general population, and is associated with CKD. 
Seemingly paradoxically, hypotension predicts mortality in people with ESRD (Hemmelgarn, Manns, 
Quan, & Ghali, 2003). This may be due to cardiovascular complications of advanced kidney disease, 
and the additional strain that dialysis causes. Between dialysis sessions, blood pressure rises as 
anywhere up to several litres of fluid is retained. The removal of this fluid over a 3-4 hour period can 
cause a rapid drop in blood pressure, producing strain on the cardiovascular system. 
One of the most common tools for measuring the presence of comorbidities across different 
primary conditions is the Charlson Comorbidity Index (CCI). Developed in a sample of hospital 
inpatients, this list of 19 conditions provides weighted values that are prognostic of survival, and has 
been tested in populations with breast cancer, rheumatoid arthritis and congestive heart failure. It 
also takes age into account. This means that the CCI is more useful in clinical situations, but can 
complicate statistical analysis where age is already accounted for as a covariate. Due to the complex 
nature of ESRD, an adapted version with modified weights was developed (Hemmelgarn et al., 
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2003). In this study, the most common comorbidities for people dialysing for ESRD were (from most 
to least prevalent): 
 Diabetes with complications: 43.5% 
 Myocardial infarction: 27.9% 
 Chronic lung disease: 27.4% 
 Congestive heart failure: 26.2% 
 Peripheral vascular disease: 18.6% 
 Cerebral vascular disease: 13.9% 
The conditions that were found to require higher weighting in ESRD (indicating an increase 
relative impact on survival) were: Myocardial infarction, congestive heart failure, cerebral vascular 
disease, diabetes without complications, metastatic disease, and lymphoma. 
Age has been discussed as a risk factor for CKD/ESRD and poor outcomes above. Diabetes, 
cardiovascular disease, malnutrition and inflammation (these latter two factors are associated with 
hypoalbuminuria) are the conditions most closely associated with poor outcomes. 
Comorbidities do more than complicate the clinical picture in terms of mortality. They also 
represent additional challenges to the person living with those conditions. The self-management 
challenges faced by people with ESRD (medications, fluid allowances, dietary modification, dialysis) 
rarely exist in isolation. This means that people will often have to attend additional clinics, make 
further dietary modifications and take additional medications on top of this already huge ESRD 
treatment burden. Additionally, for some there can be conflicts between dietary advice for the 
general population, CKD, and conditions such as diabetes. 
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1.4 Treatment of End Stage Renal Disease: Dialysis, transplantation and 
conservative management 
 
As an individual with CKD approaches stage 5, or ESRD, options regarding Renal Replacement 
Therapy (RRT) should be considered. There are a range of options, and the decision is based on a 
combination of clinical considerations and patient preference. Most broadly, for most patients the 
options are dialysis, or kidney transplantation. A small number of people with, or approaching, ESRD 
opt not to have RRT in favour of a supportive approach – this is called conservative management. 
These are often older, frailer patients with other comorbidities, for whom the benefits of dialysis 
may be outweighed by the burdens (Jassal & Watson, 2009). In general, transplantation is the most 
effective form of RRT but is usually not suitable treatment for patients with a high comorbidity 
burden.  Dialysis can take the form of either centre-based haemodialysis or home treatment by 
haemodialysis or peritoneal dialysis.  Centre-based treatment is the dominant modality in Europe 
and the USA.  Even when patients are being treated by dialysis, other interventions are necessary to 
keep patients as well as possible; these include dietary modification, limiting fluid intake and taking a 
number of medications. 
Dialysis is a treatment that involves using a membrane to filter toxins from a person’s 
bloodstream (a synthetic membrane in the case of haemodialysis, and the patient’s own peritoneal 
membrane for peritoneal dialysis). The process also involves removing excess fluid, which is normally 
retained due to the inability to excrete urine.  
Haemodialysis (HD) is where this process takes place in a machine external to the person’s body. 
Blood is carried away from the person by tubes connected to an access site. This access site may be 
either a central venous catheter, or a fistula. If using a central venous catheter, this is usually located 
in the jugular vein in the neck. A fistula is a surgically joined artery and vein, usually located in the 
forearm. Blood is then passed through the dialyser, against a membrane with dialysis fluid on the 
other side. Through diffusion (down a concentration gradient across the selectively permeable 
11 
 
membrane), and convection (down a trans-membrane hydrostatic pressure gradient), small and 
middle-sized molecules (molecular weight up to around 15Kd) move across the membrane into the 
dialysis fluid. Thus the blood is cleaned and then returned to the person’s body via the access site. 
During each session, blood will make many ‘passes’ through the dialyser, each time removing more 
toxins. Fluid balance is maintained by ultrafiltration – convective removal of fluid by applying a 
negative pressure across the membrane. During a dialysis session, excess fluid is gradually removed 
in a controlled fashion, allowing the correction of fluid based weight gain since the last dialysis 
session.  
There are a number of variations on the basic principle of HD. It can be carried out either in-
centre or at home. In-centre, it may be carried out at a hospital, but it is common for each hospital 
providing dialysis treatment to have a number of ‘satellite’ units. This cuts down travel time for 
many patients, but may not be not suitable for anyone likely to require urgent inpatient care. Home 
HD uses similar technology, installed in the person’s home. Dialysis can take the form of a standard 
3-4 hour session, or overnight; termed ‘nocturnal HD’. Home HD means that the individual and their 
partner or carer will set up, conduct, and clean up after each dialysis session. This requires training in 
the technical aspects, but can carry a huge benefit in terms of eliminating the time taken travelling 
to and from dialysis, arranging transport, and allowing the individual to dialyse at a time convenient 
for them.  
Access, whether via a fistula or a catheter, is an important element of HD treatment. The 
preferred route of access is via a fistula, where an artery and a vein are surgically joined together 
and allowed to mature. This site can then be accessed via a needle inserted either by a healthcare 
professional, carer, or the patient themselves. The use of a fistula is associated with lower 
complication rates and increased survival compared to a catheter (Rose, Sonaike, & Hughes, 2013). A 
fistula can last many years, but it requires ongoing self-care. Some fail early, and some fail to ever 
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mature. Developing a better understanding of how to create and preserve fistulae is considered a 
key challenge in ensuring good quality HD (Riella & Roy-Chaudhury, 2013). 
Peritoneal dialysis (PD) utilises the person’s own peritoneal membrane. Dialysate is fed into the 
abdominal cavity via a ‘Tenckhoff Catheter’. The peritoneal membrane forms the filter between the 
small blood vessels running within the membrane and dialysis fluid. Through diffusion and osmosis, 
waste products are filtered from the blood into the fluid. As with haemodialysis, the dialysis fluid 
needs to be frequently changed in order to ensure that an optimal concentration gradient is 
maintained. PD can take the form of Continuous Ambulatory Peritoneal Dialysis (CAPD), where 
exchanges take place manually 3 – 4 times per day. In Automated Peritoneal Dialysis (APD) the 
exchanges are performed by a machine overnight. PD is usually conducted at home, and is often a 
preferable option for people who wish to continue to work. The greatest risk in PD is infection, 
which commonly necessitates a change to HD. PD may be contraindicated by the presence of 
abdominal scarring, hernias, morbid obesity, colostomy or polycystic kidney disease. However, it 
may be that surmountable barriers such as impaired vision or hearing, or psychological anxiety, are 
responsible for the comparatively low uptake of PD (Oliver & Quinn, 2008). Physician attitudes may 
also present barriers. 
Kidney transplants are considered to be the most preferable option for people with ESRD. They 
have a good chance of success relative to other types of transplant, and if successful, mean that 
dialysis will not be required. The main risk is infection and rejection. Even if the transplant is 
successful, the individual will need to keep taking immunosuppressant drugs for the rest of their life. 
Immunosuppressant drugs also have side effects, such as an increased susceptibility to infection and 
increased risk of diabetes. It is a major procedure so not everyone is suitable. Additionally, a 
sufficient number of living or cadaver donors are required. People who have received a transplant 
usually have more energy, feel better, and are more able to lead a ‘normal’ life. 
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RRT may not be for everyone. ‘Conservative management’ is when a person with ESRD and their 
care team attempt to manage the symptoms of the disease and its complications without initiating 
RRT. There are many reasons why someone may choose conservative management, but it is most 
commonly preferred by people who are older with many comorbidities, where the survival 
advantage of dialysis is smallest. While dialysis probably offers a survival advantage to this 
population, this benefit almost completely disappears when only considering hospital-free days (Da 
Silva-Gane et al., 2012; Carson, Juszczak, Davenport, & Burns, 2009). In the latter study, survival for 
older patients with comorbidities was 37.8 months for those opting for RRT, and 13.9 months for 
those choosing ‘maximum conservative management’ though much of the difference in time was 
spent in dialysing in the dialysis centre or as a hospital inpatient. 
Deciding which treatment is right for the individual is important, and this will frequently depend 
on more than just clinical considerations. Many consider a transplant to be the ideal treatment, but 
transplants are often not available immediately, or many be clinically contraindicated. PD and home 
HD offer more freedom to the individual, but require training and confidence to carry out the 
dialysis procedure.  In-centre treatment means that trained staff will be on hand should anything go 
wrong, but requires travel time, arranging or waiting for transport, and potentially waiting for a 
machine to become available when delays occur. ‘Shared decision making’, between the person, 
their carers or those close to them, and the clinician should take into account all these factors 
(Durand et al., 2014). 
In the UK, the NHS offers all of the above treatments to those clinically suitable for them. Figures 
2 and 3 show the proportion of patients receiving each type of treatment (other than conservative 
management), split by incident and prevalent cases UK Renal Registry 2013). These figures did not 
include the proportion of people choosing conservative management. 
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Figure 1.2: RRT modality at 90 days (incident cohort 01/10/2011 to 30/09/2012). Reproduced from 
the UK Renal Registry report 2013. 
 
 
Figure 1.3: Treatment modality in prevalent RRT patients on 31/12/2012. Reproduced from the UK 
Renal Registry report 2013. 
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Figures 1.2 and 1.3 show that most patients do not receive a transplant until they have spent 
some time on dialysis. The average waiting time for a transplant for eligible individuals is 
approximately 2 years. Haemodialysis is the most common RRT in incident patients (71%), and the 
most common form of dialysis in prevalent patients (42.7% of all RRT patients). Only a very small 
number of patients use haemodialysis at home (0.2% incident, 2.0% prevalent), although home HD 
appears to be on the increase (Mitra, Brady, & O’Donoghue, 2011). Despite this, most prior work on 
self-management has focused on those undertaking home therapies, which constitute a minority of 
patients. While highly important, the majority undergoing in-centre HD should not be neglected. 
 
1.5 The organisation of a typical in-centre haemodialysis service 
 
 In-centre haemodialysis tends to occur in either a hospital or a satellite setting. 
Typically, a given area of service provision will see nephrology services centred at a hospital site, 
where patients who are more ill will be treated. Satellite services will be mostly run by nursing staff 
and Clinical Support Workers (CSWs). Often, the choice of dialysis location for a patient in a given 
service is based on the distance of the unit from home. There is a move towards introducing more 
‘minimal care’ units, where patients can perform most of their own dialysis. This may benefit people 
who wish to have more agency in their dialysis, but may be unable to dialyse at home (for example, 
available space or being worried about dialysing alone). These are rare in the NHS at present. 
 In-centre HD units normally comprises a number of ‘bays’, each with a bed or chair, and 
a HD machine. There may be as many as 20 bays in a single large room, with isolated ‘side rooms’ 
with a single bay each for patients with infectious diseases. In the main unit, patients are close 
enough to be able to talk, but often not very conveniently. As a typical session lasts 4 hours, 
entertainment is often provided in the form of radio, TV, or Wi-Fi, but these vary by unit.  
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 The unit will have a number of ‘shifts’ throughout the day as machines are reused for 
different patients. For example, there may be a morning shift and an afternoon shift. The Renal 
Association recommends that a bay should be booked for no more than two shifts per day to allow 
patient choice of dialysis times, but this is often not practical due to the patient/machine ratio in a 
given service (Mactier, Hoenich, & Breen, 2011). Thus there may be two to three shifts throughout 
the day, and a ‘twilight’ evening shift, often used by people who continue to work during the day. 
 Getting to and from the unit can often be a challenge. Patients may choose to drive 
themselves to their session. However, they are encouraged not to drive home after, at least for the 
first few weeks after initiation of dialysis, as the dialysis process can leave people feeling tired, 
lightheaded, dizzy or faint – although many do still drive (Mactier et al., 2011). Friends, family or 
carers may drive the patient, or they may take public transport. If these are not options, the local 
NHS Trust will provide transport. Renal Association guidelines suggest that a person should be 
picked up no more than 30 minutes prior to their treatment, and no more than 30 minutes after 
their treatment ends, with a travelling time of less than 30 minutes in one direction. In practice, 
approximately 68% of patients have a travelling time under 30 minutes, and 66% of patients using 
hospital transport wait 30 minutes or less to be picked up for the return journey (National Kidney 
Care, 2010). 
 Clinic appointments with a nephrologist occur separately to dialysis sessions, but 
efforts are usually made to co-ordinate so that the two occur on the same day, if convenient for the 
patient. 
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1.6 Beyond dialysis: The daily self-management challenges of a person living 
with ESRD 
 
 The self-management challenges associated with ESRD will be split into medical, social, 
and emotional challenges, based on conceptual models of self-management described in chapter 2. 
It should be noted that there is a debate in the person-centred care literature about whether 
‘patient’ is an appropriate term for someone living with a long term condition, as they are much 
more than that, and that it connotes an imbalance of power in favour of healthcare providers 
(Neuberger & Tallis, 1999). Alternatives such as ‘service user’, ‘client’, or ‘consumer’ have been 
suggested. However, previous work directly asking 1,037 people with various health conditions 
(including cancer, fracture, and HIV) for their preference has found that the term ‘patient’ to be 
preferable to the more market-focused alternatives presented above (Deber, Kraetschmer, Urowitz, 
& Sharpe, 2005). This preference has also been found in the psychiatric literature (Simmons, Hawley, 
Gale, & Sivakumaran, 2010). For this reason, the term ‘patient’ will continue to be used, with the 
caveat that all people living with long term conditions are more than that, regardless of the current 
parlance of the self-management literature. 
1.6.1 Medical 
 
 Completing 4 hours of dialysis, three times a week, is only part of the treatment burden 
of ESRD. Treatment includes limiting fluid intake, dietary modification, taking medications, and 
managing comorbid conditions. 
 Once a person’s renal function reaches end-stage, the amount of urine they produce 
falls. Urine output can eventually reach zero. As only a small quantity of imbibed fluid is lost through 
remaining renal function, sweat, and in stools, much of it is retained. Dialysis can remove this 
additional fluid through ultrafiltration. Weight gained from fluid in between dialysis sessions is called 
interdialytic weight gain (IDWG). High IDWG can increase the risk of oedema (swelling), 
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hypertension, left ventricular hypertrophy and cardiac failure. Higher IDWG is also associated with 
cramps, dizziness and low blood pressure during dialysis due to the requirement to remove large 
amounts of fluid over relatively short periods. Patients are therefore advised to limit the amount of 
fluid they intake on a daily basis. For people with minimal residual renal function, this can be as little 
as 500ml per day. Fluid is also contained in many foods, which makes calculating fluid intake more 
complicated than counting glasses of water. 
 A key consideration when attempting to limit fluid intake is also limiting dietary sodium 
(most commonly sodium chloride, or salt). Sodium increases thirst, and causes extracelluar fluid 
retention. Optimal clinical management of ESRD requires sodium intake be significantly limited. This 
means that many processed foods are advised against. The relationship between sodium and fluid is 
such that it may not be worth advising a person with ESRD to limit their fluid intake if they are not 
also advised on a low-sodium diet (Tomson, 2001). Whilst urine output is maintained diuretics may 
be prescribed for fluid retention. 
 Whilst salt and fluid restriction, diuretics and ultrafiltration during dialysis form the 
basis of managing blood pressure, most patients on modern dialysis programmes are also prescribed 
anti-hypertensive medications. Many take a number of these agents. 
 Phosphorus is difficult to filter out during dialysis, meaning that preventing too much 
from entering the bloodstream in the first place is a priority. Dietary modification to avoid foods high 
in phosphorus is recommended. Additionally, tablets called phosphate binders are prescribed to be 
taken with every meal. Phosphate binders will bind dietary phosphorus in the digestive system 
before it enters the bloodstream, which is why they need to be taken in close proximity to meals. 
Phosphate retention is associated with bone disease and calcification of blood vessels, so control is 
important. 
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 Potassium can be filtered by dialysis, but can build up quickly between sessions. Too 
much can result in muscle weakness and cardiac dysrhythmias which can be fatal. Many fruits, 
vegetables and dairy products are high in potassium, meaning many foods recommended as 
‘healthy’ to the general population are recommended against for people with ESRD. 
 Polypharmacy, or being prescribed a number of medications, is common in ESRD. These 
medications are primarily to manage the physiological consequences of the disease. In addition to 
diuretics, antihypertensive drugs and phosphate binders, patients may also require to take many 
other medications.  Anaemia is a common consequence of ESRD and may be treated using 
supplements of the hormone erythropoietin, iron, or both. Additionally, Calcium and vitamin D 
supplements may also be prescribed for people with ESRD. Many patients take statins to reduce 
cardiovascular risk. Pain medication is also required by many. Drug treatment for comorbidities adds 
to the pill burden. In a cross sectional study of 233 maintenance dialysis patients in the United 
States, the median daily number of prescribed pills per person was 19. For one quarter of patients, 
this exceeded 25 pills per day. 
 The presence of comorbidities increases the burden still further.  Managing diabetes, 
the single biggest cause of ESRD, includes its own dietary requirements, blood glucose monitoring, 
and insulin administration, on top of the medical self-management tasks listed here. 
 Self-management behaviours relating to physical health go beyond adherence. For 
example, they may include the way the person communicates with their healthcare professionals, 
seeking information about kidney disease and its treatment, and making decisions about symptom 
reporting. Some of these behaviours may involve a person working cooperatively with their 
healthcare team. Others, such as not speaking up about symptoms and trying to handle them alone, 
may be more proactive or ‘defensive’. See chapters 2 and 3 for more detail.  
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1.6.2 Social 
 
 The disruption to normal functioning that people on dialysis for ESRD face is not limited 
to the burden of clinical tasks. The disease, its consequences, and treatment demands also create 
barriers to continuing to function socially, and to continue in employment. This is also sometimes 
referred to as ‘role management’ (Lorig & Holman, 2003). 
 Dialysis is a time consuming process, and as such affects almost all domains of life. For 
those undergoing in-centre dialysis, 4 hours of treatment 3 times a week, plus travel and recovery 
time, means that those days may be ‘written off’ as dedicated only to dialysis. This makes fitting in a 
job, family life, friends, and other interests difficult. 
 Cognitive impairment may be common in ESRD, with estimates varying from 16% 
(Tamura et al., 2010), up to 70% of maintenance dialysis patients over 55 experiencing moderate to 
severe impairment (Murray, 2008).  There are a number of potential causes; including “uraemia” 
itself and cerebrovascular disease (stroke risk is greatly elevated in people with CKD and ESRD). HD 
itself may also be associated with cognitive impairment (Pereira, Weiner, Scott, & Sarnak, 2005). 
Cognitive impairment can create difficulties in every day social functioning. In more mild cases it may 
make continuing to work in a complex and mentally demanding job more difficult. In more severe 
cases it may make even basic self-care and daily functions such as going to the shops or keeping 
social engagements difficult, even where physical impairment is absent. 
 The combination of time consuming treatment and cognitive impairment make 
continued employment difficult. In the US Comprehensive Dialysis Study (CDS), out of 585 people 
starting long term dialysis (including HD and PD) who were in paid employment the previous year, 
only 191 (32.6%) remained in employment 4 months after dialysis initiation. Depression also 
appeared to play a role in this relationship. Patients were screened for depression using the PHQ-2. 
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Of those still working, 12.1% were screened as depressed, compared to 32.8% of those no longer 
working. Whether this is a cause, effect, or reciprocal relationship is unclear. 
 The ‘renal diet’, with its myriad restrictions, makes cooking, being cooked for, and going 
out for a meal difficult. The ‘to avoid’ list for ESRD is complex and strict adherence requires 
knowledge of the exact ingredients of a meal. There is no simple ‘rule of thumb’ for foods to avoid, 
and many foods that are normally considered healthy are advised against, such as fruits, salads, 
pasta and wholemeal bread. This makes eating out a complex and difficult process, especially if 
some degree of cognitive impairment is present. 
 Reduced fluid allowances mean that social drinking is advised against for many people 
with ESRD. While people with ESRD can go to a bar with their friends or a wedding reception (for 
example), drinking alcohol is an important ‘social lubricant’ for many people (Park, 2004). The 
physiological costs of drinking alcohol typically include high interdialytic weight gains with all the 
attendant risks described earlier. 
 
1.6.3 Emotional 
 
 Emotional adjustment to chronic disease can be a difficult process. Depression, anxiety, 
and a disrupted sense of self are common (Bury, 1982). More detail on depression and anxiety as 
they relate to ESRD and self-management can be found in chapter 3. The following is a brief 
consideration of the basic characteristics of the issues presented to a person living with ESRD. 
 Adjustment to ESRD means adapting to the burden of the disease, symptoms, 
treatment, loss of primary roles, loss of function, and an uncertain future. One way of measuring the 
impact ESRD has on emotional health is too look at the presence of depression and anxiety. 
22 
 
 According the Diagnostic and Statistical Manual (DSM) of mental health conditions IV-
TR, depression is the loss of pleasure or depressed mood, for 2 or more weeks, accompanied by 
other symptoms such as sleep or appetite disturbance, guilt and suicidal thoughts (American 
Psychological Association, 1994). Depression is likely the most common psychopathology in ESRD, 
with prevalence estimates typically ranging between 20-30% (Chilcot, Wellsted, & Farrington, 2009). 
It appears to be more common among people on HD compared to those on PD. It is associated with 
lower residual renal function, and higher depression appears to be associated with higher levels of 
inflammation. 
 Perceptions of loss appear to be important in the development of depression among 
those with ESRD (Kimmel, 2002). In a study of 191 people on HD, perceptions of loss were the 
strongest predictors of depression, which in turn predicted quality of life (Chan, Brooks, Erlich, 
Chow, & Suranyi, 2009). ‘Loss’ refers to loss of function, and to loss of primary roles such as family, 
social and work roles. 
 Treatment options for patients with depression are typically similar to those for the 
general population. Cognitive Behavioural Therapy and antidepressants are favoured by the UK’s 
National Institute for health and Clinical Excellence (NICE). There are additional barriers to treatment 
in this population however, including a desire to avoid additional appointments on top of dialysis 
and clinics in the case of CBT, and the potential for drug-drug interactions in the case of 
antidepressants. 
 Anxiety disorders include generalised anxiety disorder (GAD), obsessive compulsive 
disorder (OCD) and post-traumatic stress disorder (PTSD). Depending on severity and nature, they 
can range from unpleasant to completely impairing a person’s ability to function. Estimates of 
prevalence in ESRD vary substantially, between 0 and 45.7% when using formal diagnostic 
interviews. One study estimated the most common forms of anxiety disorder in HD patients were 
specific phobias (26.6%) and panic disorder (21.0%) (Cukor et al., 2007). 
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 Depression and anxiety are unpleasant conditions associated with lower perceived 
quality of life, and also related to mortality (Chilcot et al., 2009) (Chan et al., 2009). Furthermore, 
they can also impact social functioning, and may negatively impact medical self-care behaviours such 
as adherence to medication (DiMatteo, Lepper, & Croghan, 2000). 
 
1.7 Summary 
 
Chronic kidney disease has many causes, and can occur suddenly, but usually progresses 
slowly in later life. The disease is classified into five stages, with the disease being considered 
‘established’ in stages 3 and 4. Stage 5 is also known as End Stage Renal Disease (ESRD), and is when 
renal replacement therapies such as haemodialysis are required to maintain life. ESRD is usually 
accompanied by comorbidities, with diabetes and vascular diseases being the most common. 
Without a kidney transplant, renal replacement therapy and lifestyle modification are time and 
energy consuming. Most people with ESRD will not receive a transplant, and instead rely on dialysis. 
Forgoing renal replacement therapy, referred to as conservative management, is also an option for a 
small proportion of older, frailer people. People with ESRD face a number of clinical, social and 
emotional self-management challenges. Depression and anxiety are present in at least 20-30% of 
prevalent ESRD patients, and may complicate an individual’s ability to effectively manage other 
areas of their treatment and life. 
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Chapter 2: Review of Self-Management in chronic disease 
 
Gregory Bateson once said, “one cannot not communicate”. The same is true for health behaviour 
and disease management. One cannot not manage. If one decides not to engage in a healthful 
behaviour or not to be active in managing a disease, this decision reflects a management style. (Lorig 
& Holman, 2003) 
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2.1 Introduction 
 
Self-management is a term used to describe the actions people with any illness take in order 
to manage their condition and its treatment. The self-management literature has emerged in light of 
a changing landscape of health threats, which over the last 200 years has shifted from primarily 
acute, physician managed conditions, to chronic, long term conditions that require substantial 
management by the person living with the condition. There are many related terms, some used 
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synonymously, some with subtle distinctions. This chapter aims to introduce the reader to the 
evolution of self-management as a sociological and psychological concept in a range of chronic 
diseases, where there is a rich literature to draw upon (for example, in diabetes). Chapter 3 will then 
consider the comparatively sparse literature on self-management in ESRD and the issues research in 
this area faces. As such, the present chapter will not consider self-management in ESRD in more than 
passing. 
 
2.2 Shifting burden of disease and need for self-management 
 
Two hundred years ago, life expectancy was largely determined by communicable, acute 
diseases such as tuberculosis or malaria. With the advent of effective vaccinations and antibiotics, 
many of these diseases have ceased to be significant threats to the populations in developed 
countries such as the United Kingdom (Horton, 2012). 
As many life-threatening communicable diseases have been eradicated or cured, along with 
our greater understanding of how to prevent the spread of communicable disease, people are living 
longer. With an aging population has emerged an increase in the prevalence of so called, ‘diseases of 
old age’ such as Coronary Heart Disease (CHD) and End Stage Renal Disease (ESRD). In addition, 
other chronic conditions are increasing in prevalence due to population wide changes in lifestyle, 
such as diabetes (Cooper et al., 2013). Diabetes is, in turn, one of the major causes of organ failure, 
and is the main cause of ESRD (USRDS, 2012). 
Here we define a chronic disease as one that cannot currently be cured, and that will 
therefore affect the individual for the rest of their life. The World Health Organisation’s list of non-
communicable diseases (which with the exception of HIV, are largely synonymous with chronic 
diseases) includes such conditions as CHD, ESRD, diabetes, gastrointestinal conditions such as 
Crohn’s Disease and ulcerative colitis, respiratory diseases such as Chronic Obstructive Pulmonary 
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Disease (COPD) and asthma, and anaemia (WHO, 2010). While many mental health conditions such 
as depression and schizophrenia are lifelong, this review will focus only on chronic physical 
conditions, as the self-management issues in mental health conditions have their own set of 
complicating factors. 
Chronic physical conditions tend to share a common factor compared to many acute 
illnesses; they cannot be treated by a physician alone. They require a substantial investment of time 
and effort from the individual to undertake the management of their own condition. For example, 
an individual with diabetes is advised to regulate their sugar intake, and self-administer insulin, 
throughout the day. Unless the person is being looked after as an in-patient, these kinds of tasks 
must be carried out by the individual. 
 
2.3 Evolution of ‘self-management’ as a concept 
 
Self-management as it is conceptualised today can be understood as arising from the 
biomedical tradition, and the tradition of cognitive psychology (Greenhalgh, 2009). This can be 
mapped onto the rise of the biopsychosocial model of understanding health and illness (Smith, 
2002). As a concept, it competes and overlaps with ideas such as empowerment, self-care, whole 
systems approaches and critical public health. Modern conceptions of self-management can be seen 
in highly visible campaigns and initiatives such as the UK’s Expert Patient Programme (Plews, 2005) 
and the Health Foundation’s Co-Creating Health (The Health Foundation, 2011). 
 Regarding the term ‘self-care’, it should be noted that the term ‘self-care haemodialysis’ and 
‘shared haemodialysis care’ appear at certain points in this dissertation. In this case, these are used 
as specific terms to denote patient engagement in the process of haemodialysis itself (Dainton & 
Wilkie, 2013). Examples of tasks involved in self-care haemodialysis include inserting the needle into 
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the fistula (self-cannulation), setting up the dialysis machine itself, and cleaning the machine after 
use. 
The Health Foundation conceptualises self-management in a tripartite model based on 
biological, social and emotional challenges (see figure 1.1). This model can be traced back to 
sociological work by Corbin & Strauss (1985). The ‘three lines of work’ referred to in this seminal 
paper are illness work (biological), everyday life work (social), and biographical work (emotional). 
Illness work includes tasks such as adhering to prescribed medical regimen, such as taking 
medication. Everyday life work includes a broad range of tasks, such as cooking, cleaning, 
employment, and fulfilling roles such as being a parent. Biographical work includes working through 
the emotions and the changes in self-concept that may arise in response to illness. 
Corbin & Strauss (1985) conceptualise these tasks as part of an ‘illness trajectory’, which 
includes illness work; tasks to be undertaken in response to changing situations (‘structure in 
process’), which in turn reciprocally interact with changing biographical factors. In essence, an 
individual’s illness trajectory is in part determined by their broader life circumstances. Further, ideas 
about what one is capable of, and one’s very sense of self, will change in response to changes in 
illness and changes in life circumstances.  
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Figure 2.1: The self-management triangle from the Health Foundation 
 
Importantly, this enduring sociological take on managing chronic illness looks at a picture 
beyond tasks directly related to the biological management of illness. It acknowledges that chronic 
illness is normally accompanied by changes in one’s self-concept, appraisal of capabilities, ability to 
work, to maintain social roles and relationships and so on. While tasks such as taking insulin or 
modifying one’s diet may be vital to maintaining health, successfully managing the illness may 
require that an individual adjust to going from a position of high earnings and fulfilling work, to 
taking a more backseat role, if they can even continue to work at all. Similarly, it may mean being 
unable to fulfil their normal role in a spousal relationship, moving from a position of equilibrium to 
one of dependency upon their significant other. 
 This model of self-management has famously been built upon by Kate Lorig and colleagues 
at Stanford in the Chronic Disease Self-Management Programme (CDSMP). These programmes can 
be either generic or tailored to a specific disease group, can be delivered either by Health Care 
Professionals (HCPs) or lay people, and can be delivered to a group or individuals. These 
programmes hinge upon the premise that the key to effective self-management is self-efficacy. Self-
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efficacy is a core component of Albert Bandura’s Social Cognitive Theory (SCT). In essence, self-
efficacy is one’s confidence in one’s ability to bring about a given outcome by successfully 
performing a given behaviour (Bandura, 1977). Self-efficacy and operationally similar constructs are 
still considered highly important in the initiation, continuation of and outcomes achieved through 
self-management, and so will be focused on later in this chapter. 
 The CDSMP has been adapted to the UK’s needs as part of the Expert Patient Programme 
(EPP, Choices, 2013). There has been some controversy about how well the EPP has been 
implemented, and indeed whether it truly represents the patients it seeks to empower (Wilson, 
Kendall, & Brooks, 2007). Furthermore, there is debate over the extent to which the CDSMP itself 
has been proven efficacious (Greenhalgh, 2009). This debate hinges on what one considers the 
outcome of interest to be; CDSMP interventions frequently succeed in improving self-rated self-
efficacy, but often fail to demonstrate improvements in clinical outcomes (Sobel, Lorig, & Hobbs, 
2002). It may be that changes in clinical outcomes are not required for a self-management 
programme to be considered ‘effective’. For example, it may succeed in producing changes in quality 
of life, due to changing how the actions people living with chronic illness take to cope emotionally, 
maintain social roles, or finding ways to fit their treatment into their everyday life in a way that is 
less intrusive. The debate about ‘what to measure’ is ultimately a question of perspective, one that 
will be addressed empirically in chapters 5 and 8 through focus groups and interviews. 
 
2.4 Working definition of self-management 
 
 Part of the thesis that this dissertation seeks to defend is that self-management is often 
poorly operationalized, particularly in ESRD, and therefore the empirical chapters will seek to 
address this. However, it is necessary to set out with a working definition to build upon. Drawing on 
the work of Corbin & Strauss, and Lorig & Holman, this definition shall be formulated thus: 
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 Self-management is the term given to the tasks undertaken by an individual living with a 
chronic disease and its treatment. Self-management tasks incorporate not only adherence to 
medically prescribed treatment, but also tasks relating to continued social functioning, and tasks of 
adapting emotionally to living with the condition and its treatments. 
 This definition clearly does not refer to one single dimension, but would logically appear to 
fit a three factor structure. One thing this definition makes clear is that when studying self-
management, it is important to measure what people do to look after themselves. 
 Previous work on self-management would suggest that these three factors do not 
necessarily correlate, and that while they can be mutually reinforcing, they instead often require 
balancing by the individual living with the condition (Kralik, Koch, Price, & Howard, 2004). Kralik and 
colleagues used in depth interviews with nine people living with arthritis, and pointed to the 
possibility that people living with arthritis may see self-management as something very different to 
the healthcare professionals who care for them. In this dissertation, the terms, ‘medical’, ‘social’ and 
‘emotional’ will be used to refer to the three domains. Medical is synonymous with illness work and 
biological self-management, as described above. ‘Social’ is broadly analogous to ‘everyday life work’, 
and ‘emotional’ to ‘biographical work’. 
 
2.5 Self-management and self-efficacy 
 
 If self-management is a term for what people do, then self-efficacy could be considered a 
closely related psychological variable that is often regarded as moderating one’s capability to 
perform those actions. Self-efficacy as a concept was widely popularised by Albert Bandura and his 
work on Social Cognitive Theory (SCT). Broadly, it is one’s confidence in one’s ability to successfully 
perform a behaviour in a given situation (Bandura, 1994).  
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An important distinction should be made between personal efficacy or efficacy expectations, 
and response-outcome expectancies or outcome expectations. Personal efficacy is the extent to 
which one is confident that one can perform a given behaviour in a given set of circumstances. 
Outcome expectations describe what a person expects to happen should that behaviour be 
successfully performed. In other words, a person with diabetes may have a great deal of confidence 
in their ability to remember their morning dose of insulin, but they may not believe that consistently 
delivering this dose will control their blood glucose, or stave off organ failure or death. Conversely, 
they may have a great deal of confidence in the effectiveness of their medication, but lack 
confidence in their ability to remember to take their dose as prescribed. 
 A sense of personal efficacy can be derived from a number of sources. The focus of much 
empirical work has been on performance accomplishments, vicarious experiences, verbal persuasion, 
and emotional arousal. These are, in theory, modifiable factors that influence behaviour, making 
self-efficacy a natural target for self-management interventions (Clark & Dodge, 1999). Much of the 
existing literature on self-management hinges on the notion that  improving personal efficacy will 
increase the extent to which individuals undertake self-management oriented actions, such as taking 
medications, attending clinics, and actively trying to continue their social routines and maintain a 
sense of self in light of their illness (Marks, 2005). 
 
2.6 Self-management and Patient Activation 
 
“Activation” is a term that has been used for decades to describe the extent to which 
patients are active and involved in their care (Snell, 2011). The idea that there are stages of 
activation is best exemplified theoretically by the transtheoretical stages of health behaviour change 
model (Prochaska & Velicer, 1997). This model posits that there are five stages of change, described 
in table 2.1 – pre-contemplation, contemplation, preparation, action, and maintenance. According to 
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Prochaska & Velicer, people not only have different levels of ‘activation’, but that people are 
constantly moving from one stage to another. Thus according to the model it is possible for 
individuals to move from contemplation, to preparation, and to begin to take action. Similarly, it is 
possible that individuals may move ‘backwards’ or relapse, and after a period of maintaining a health 
behaviour such as dietary modification, may end up back in the contemplation stage, or even back in 
pre-contemplation where they no longer recognise the need for the health behaviour.  
 
Table 2.1: Stages of change and approximately equivalent Patient Activation Measure equivalents 
 
Stage of change Description PAM equivalent 
Pre-
contemplation 
Individual not planning to take 
action within the next 6 months 
Believing patient role is important 
Contemplation Individual intending to take action in 
next 6 months. Aware of pros of 
behaviour change, but also acutely 
aware of cons 
 
Preparation Individual is intending to take action 
within the next month. Some actions 
have been undertaken, or plans 
made 
Having the confidence and 
knowledge to take necessary action 
Action Individual has made specific overt 
modifications to their lifestyle in the 
last 6 months. Must be a sufficient 
level of action to realistically achieve 
goals (e.g. weight loss) 
Taking action to improve one’s 
health 
Maintenance  Individual is working to prevent 
relapse, but not applying change 
processes as frequently as 
individuals in the action stage 
Staying the course even under stress 
Relapse Individual has reverted to previous 
behaviour 
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 Testing this model was made difficult by a lack of well developed instruments. The Patient 
Activation Measure (PAM) was developed by Hibbard and colleagues to address what they viewed as 
a promising model, but with some flaws (Hibbard, Stockard, Mahoney, & Tusler, 2004). The PAM is a 
22-item scale that measures ‘activation’ by asking individuals about their beliefs around their role in 
their care, assessing confidence, actions, and ability to cope under stress. A 13 item short form 
version was developed for clinical use, and use in research alongside other instruments (Hibbard, 
Mahoney, Stockard, & Tusler, 2005). 
 The PAM ultimately yields an ‘activation score’, which can be coded into a ‘stage’ of 
activation. In contrast to the six stages of the transtheoretical model, the PAM has four stages: 
‘Believes active role is important’, ‘Confidence and knowledge to take action’, ‘Taking action’ and, 
‘Staying the course under stress’. Thus the PAM measures some elements of general disease related 
self-efficacy, but also actions, coping and attitudes. Thus, despite its purported unidimensional 
structure, it contains many elements that are useful for examining psychological theories of 
behaviour change. 
  
 2.7 Measuring self-management 
 
 As above, self-efficacy is sometimes used as a psychological proxy for self-management. In 
these instances, self-efficacy can be measured by a number of scales, some of which are very 
general, and some of which are specific to the disease and the challenges presented by that disease. 
General self-efficacy in chronic disease is often measured by the Self-Efficacy for Managing Chronic 
Disease scale from Lorig and colleagues, which takes the form of a 33 item scale that assesses 10 
dimensions including exercise and diet self-efficacy, or a brief 6 item version (Lorig et al., 1996). 
There are various disease-specific versions available for diabetes, arthritis and other chronic 
conditions. A 2009 systematic review identified 25 instruments designed specifically for evaluating 
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self-efficacy in a given chronic disease: 13 for diabetes, 5 for asthma, 4 for arthritis, 3 for COPD and 
none for CHD (Frei, Svarin, Steurer-Stey, & Puhan, 2009). They found many of these to be poorly 
described in the papers detailing their development, notably failing to state the purpose they were 
being developed for and lacking a description of how they were validated. Nonetheless, there is a 
debate about whether it is adequate to measure self-efficacy as a general construct, or whether it is 
important to measure self-efficacy with regards to behaviours specific to the disease in question, for 
example self-monitoring of HbA1c in people with diabetes. 
 The conflation of self-management behaviours and self-efficacy can be problematic 
however, especially if we hold that the purpose of improving self-rated self-efficacy is to moderate a 
change in self-management behaviour. If we take this view, then self-management should be 
measured in terms of behaviour. Many studies have taken the approach where self-management is 
synonymous with adherence to healthcare professional (HCP) prescribed behaviours such as dietary 
modifications, taking prescribed medications and exercise. These adherence behaviours certainly 
form at least part of the category of ‘medical management’, although it is important that these are 
based on goals mutually agreed between the patient and HCPs (Allen, Wainwright, & Hutchinson, 
2011). When measuring adherence, there are a number of approaches possible; the appropriate 
methods will vary by disease and setting. 
 One method of measuring adherence is the use of routinely collected biomarkers. In 
diabetes, HbA1C (glycated haemoglobin) is commonly used as a combined measure of dietary 
control and appropriate insulin usage (Glasgow, Boles, McKay, Feil, & Barrera Jr., 2003). This can be 
measured during clinic visits, and is regarded as a reliable reflection of an individual’s health 
behaviours. One drawback of this method is that in other diseases, arthritis for example, the 
relationship between medication adherence and disease activity can be so tenuous or unpredictable 
as to render the biomarker a poor reflection of adherence. This means that the measures used need 
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to be carefully selected with expert clinical input, to ensure the validity of concluding that a 
biomarker really does measure adherence and not other unrelated factors. 
 For medications, another method of measuring adherence is pill counting. This is where 
leftover medication is recorded each time a new prescription is given. This method is less reliant on 
memory than self-report (Lee et al., 2007). However, this method still requires study participants to 
be honest about the amount of leftover medication, which may be influenced by demand 
characteristics; for example, the idea that it is bad to have leftover medication (Grymonpre, Didur, 
Montgomery, & Sitar, 1998). 
 Another commonly employed method is self-report. Compared to measuring bio-markers 
and medication counting, this method can be used to assess a much wider range of behaviours, such 
as exercise, diet, medication adherence, and other lifestyle factors including drinking and smoking. 
This allows researchers to capture a much broader range of medically related self-management 
behaviours. The drawbacks here are the same as found in self-report measures elsewhere; they 
require the participants to correctly interpret the question, which requires a certain level of 
language skill and comprehension in the language used. They are also subject to various memory 
biases, and may also be subject to demand characteristics (Prince et al., 2007). Some of these 
problems can be overcome to varying extents through good questionnaire design informed by 
cognitive interviewing, appropriate piloting, and validation against other methods mentioned above 
such as medication counts and biomarkers (Beatty & Willis, 2007). 
Two commonly used examples of self-report questionnaires in diabetes are the Diabetes 
Self-Management Questionnaire (DSMQ, Schmitt et al., 2013) and the Summary of Diabetes Self-
Care Activities (SDSCA, Toobert, Hampson, & Glasgow, 2000). The SDSCA contains 25 items, although 
a revised 11 item version has been suggested due to moderate to poor internal consistency (α = 
0.47) and test-retest reliability (mean r across subscales = 0.40). The revised scale measures 6 
dimensions: diet, exercise, blood sugar testing, foot care, smoking, and activities recommended by 
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the individual’s health care team. The SDSCA is intended for both clinical and research use, and 
measures only the ‘medical management’ component of the self-management triangle. 
 The DSMQ was developed specifically in response to what has been seen as a 
weakness of the SDSCA; the scores on the latter scale do not correlate with observed glycaemic 
control. The argument is that if structural relationships between self-care behaviours, psychological 
factors such as depression and anxiety, and outcomes such as death are to be explored, the 
measurement of self-care behaviours must be able to explain variance in factors that drive the 
clinical outcome of interest; in this case HbA1c. The DMSQ has a total of 16 items, which break down 
into four areas of self-management (termed self-care in this paper): glucose management, dietary 
control, physical activity, and health-care use. There are further self-management scales in diabetes, 
but these two are representative in that they are focused on medical management, but. They also 
demonstrate that it is important that medical aspects of self-management can be seen to explain 
some of the variance in clinical variables of interest. However, even within the medical domain, they 
do not cover broader behaviours such as information seeking and communication with healthcare 
professionals. 
According to theory, self-management is broader than just medical behaviours. However, 
social and emotion related behaviours often remain undefined and unmeasured in studies of self-
management. The literature on coping provides some potentially useful groundwork for defining 
how people with chronic illnesses attempt to manage their emotions, and is described below. 
Socially proactive behaviours tend to be considered far less frequently, and where social support is 
assessed, it is usually via measuring an individual’s perceived social support. Additionally, some 
interventions have been aimed at modifying social support, for example by implementing elements 
offering opportunities to reduce social isolation. These elements are rare, or rarely explicitly stated 
to be components of self-management interventions. In COPD, Kaptein and colleagues identified 
only two studies focusing on social support from the last 50 years (Kaptein, Fischer, & Scharloo, 
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2014). Both used social support as integrated elements of a wider intervention (Chavannes et al., 
2009; Moullec & Ninot, 2010). In both cases, the aim was to improve quality of life. 
 
2.8 Self-management and associated psychological variables 
 
 Self-efficacy is often held to be an important variable in predicting self-management 
behaviours. Theoretically, one would expect other variables such as depression and anxiety, to be 
related to self-management. Depression is a more common focus of research, but both depression 
and anxiety are overlapping constructs of what might be termed ‘psychological distress’ (Norton, 
Cosco, Doyle, Done, & Sacker, 2013). Studies into self-management among many chronic disease 
populations reveals that self-management is often adversely affected by the presence of depression 
and anxiety. For example, in CHD depression and anxiety are two of the most reliable predictors of 
poor self-management (Riegel, Lee, & Dickson, 2011). 
 Depression and anxiety appear to be the most commonly measured indicators of emotional 
management in self-management studies (Kaptein et al., 2014). For example, in COPD, a recent 
meta-analysis found 29 studies looking at psychological and lifestyle interventions to reduce anxiety 
and depression (Coventry & Gellatly, 2008). In these studies, the emotional component is treated as 
an emotional state, rather than actions taken to manage one’s emotions. 
 In CHD, one study addressed the relationship between self-management skills, and 
wellbeing and depression, in 296 older adults (>65 years old) in the Netherlands (Cramm et al., 
2012). Self-management was assessed using the Self-Management Ability Scale, which includes six 
dimensions: taking initiative, investing in resources for long term benefits, taking care of a variety of 
resources, taking care of resource multifunctionality, being self-efficacious, and having a positive 
frame of mind. Note that this scale contains elements of both practical management skills, an 
emotional component, and includes social components in its assessment of ‘resources’. Wellbeing 
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was measured using the Social Production Function instrument and Cantril’s ladder. Depression was 
assessed using the Geriatric Depression Scale. Regression analyses showed that initiative taking, 
investment behaviour and a positive frame of mind were all predictive of lower depression scores.  
As predicted, the higher self-efficacy, the lower depression scores. 
These putative relationships between self-management behaviours and depression are 
particularly important in people suffering with a chronic disease with a high self-management 
burden like diabetes, ESRD, or CHD. It is important to establish the extent to which life-sustaining 
self-management behaviours such as adherence to insulin regimes or statins, dietary changes, and 
exercise are impacted. Depression predicts survival in many diseases, including ESRD (Chilcot, 2012). 
There are theorised biological mechanisms specific to different diseases that may be responsible, 
e.g. cytokine function in cancer (Sephton, Sapolsky, Kraemer, & Spiegel, 2000). However, it is likely 
that self-management behaviours play an important role in survival. For example, in a type 2 
diabetes population in the US, negative correlational relationships between self-management (as 
measured by the SCDSA, above), and depression as measured by the PHQ-9 (Lin et al., 2004) were 
observed. Major depression was associated with less physical activity, an unhealthy diet, and lower 
adherence to oral hypoglyemic, antihypertensive and lipid-lowering medications. However, 
performance of a variety of proactive preventative care activities was similar for those with, and 
those without, depression. 
Measures of distress and self-care in these studies are predominantly cross-sectional, and 
cannot be used to infer causality. It is not clear whether depression drives self-management 
behaviour, or whether poor general self-care results in conditions that cause depression. It is likely 
that there is a reciprocal relationship, but this needs to be empirically established longitudinally. 
Whichever direction the relationship turns out to run in, or if it is reciprocal, an important question is 
whether modifying the driving factor can in turn ameliorate the dependent factor. For example, if 
certain patterns of self-management results in depression, it will be important to establish whether 
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altering self-management activities through education, training, and goal-oriented enhancement of 
self-efficacy can ameliorate depressive symptoms. 
 
2.9 Self-management behaviour and relationship with clinical variables and 
outcomes 
 
 The ultimate aim of self-managing chronic illness may depend on who is asked. Clinicians 
may have very different goals to patients (DeJesus, Vickers, Stroebel, & Cha, 2010). Trying to 
improve clinical outcomes will usually be on the agenda of HCPs, patients, and managers and health 
services as a whole, although the focus may vary. The clinical outcomes of interest will vary 
depending on the disease. For example, in diabetes HbA1c may be the chief outcome measured; in a 
large CHD study it may be the occurrence of a future cardiovascular event. Alternatively, health 
related quality of life (HRQoL) may be the outcome of interest (Zwerink et al., 2014). 
 It is important to note the difference between an actual outcome of interest and surrogate 
outcomes. Returning to CHD, controlling lipid levels is known to be important in preventing the risk 
of a heart attack. However, a person generally would not care about their lipid levels if they did not 
translate from a biomarker of cardiovascular risk into an actual cardiovascular event. The real 
outcome of interest is the cardiovascular event. Lipid levels are a surrogate outcome. This works well 
when the outcome of interest is known to be highly reliably related to the surrogate outcome. 
HbA1c and risk of retinopathy is a good example. One must be careful about claiming an outcome is 
important to the person with the condition when the link is less clear. 
 Some of the work examining the relationship between self-management and clinical 
outcomes has taken the form of interventional research.  The evidence for the efficacy of self-
management programmes has been explored in hundreds of trials of various kinds, with greatly 
mixed levels of methodological rigour (Warsi, Wang, LaValley, Avorn, & Solomon, 2004). In some 
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conditions, there is a sufficient number of randomised trials, using similar enough outcome 
measures to conduct a meta-analysis. For example, in rheumatoid arthritis it has been found in 
multiple meta-analyses that self-management interventions produce a statistically robust, but 
clinically small improvement in pain and disability (Chodosh et al., 2005; Warsi, LaValley, Wang, 
Avorn, & Solomon, 2003). Other reviews have found that arthritis outcomes do not even reach 
statistical significant thresholds (Warsi et al., 2004). This may in part be due to the duration of the 
average study, which may not have been able to capture changes in outcomes such as functional 
disability, or may have been measuring the wrong outcomes. 
 In diabetes, meta-analyses have generally produced statistically and clinically significant 
reductions in HbA1c, representing greater glycaemic control (Norris, Engelgau, & Venkat Narayan, 
2001). Importantly, it appears that this effect is apparent when measurements are taken in the short 
term (<6 months), and that longer term benefits tend to only persist if follow up procedures are 
employed. No improvement was found for mortality between self-management and control groups 
in two studies, one over 5 years, the other over 13 months (Malone et al., 1989; Hanefeld et al., 
1991). 
 Hypertension typically uses blood pressure as the main clinical outcome, and self-
management interventions have been found to result in a statistically and clinically significant 
reduction in both systolic and diastolic blood pressure (Chodosh et al., 2005). 
 In Chronic Obstructive Pulmonary Disease (COPD), attempts at meta-analysis have been 
hampered by heterogeneous outcomes variables, which would render statistically compiling 
outcomes theoretically problematic. However, a Cochrane review on the subject, looking at 14 trials, 
found that it is likely that self-management education programmes reduce hospital admissions 
(Effing et al., 1996), although no clear recommendations are made due to heterogeneity in 
interventions, study populations, follow-up times and outcome measures. 
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 There are several common messages in each of these reviews. One of the main criticisms 
each makes is that the nature of the self-management intervention being employed is poorly 
described in the majority of articles considered for inclusion. Even the quality of the description of 
the intervention in those included in the reviews is often not especially high. This is problematic for 
obvious reasons; if substantially different interventions are being employed, they should not be 
entered into a single meta-analysis together, as meta-analysis relies upon an assumption of 
homogeneity of subject matter. Further, if we wish to conduct either exact or conceptual 
replications of successful interventions, being able to replicate the intervention itself is obviously a 
key component. Lastly, it is impossible to translate a trial-intervention formulated in a research 
setting into clinical practice if the contents of the intervention are unknown. The message here is 
clear; self-management interventions need to be better described in published literature or related 
protocols. 
 When considering the success or otherwise of self-management interventions, it is 
important to be clear about what the training aims to help people to self-manage (Newman, 2008). 
If the main aim is to improve psychological wellbeing or quality of life, then success should be 
measured by clinical diagnosis of depression or screening tools that allow some assessment of 
wellbeing. If the goal is to improve clinical control of blood pressure or HbA1c, this is what should be 
measured. The meta-analyses above are hampered by the fact that not only are the interventions 
poorly described, but they also may not have all been setting out with the same goals in mind. In 
light of this, overly broad phrases such as, ‘improving self-management’ or ‘increasing self-
management’ seem next to meaningless. 
 Methodological issues above notwithstanding, there does appear to be promising evidence 
from accumulated randomised controlled trials that self-management interventions aimed at 
providing more than just education may be able to produce reliable and clinically significant 
improvements in key clinical outcomes for diseases such as diabetes and hypertension. 
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2.10 Self-management in models of health psychology 
 
Many theoretical models in health psychology seek to explain some, if not all, aspects of 
self-management, resulting in overlap between models. Most commonly, models address the 
‘medical’ aspect of the condition, and say less about predicting social or emotional outcomes – 
although both have a place in the predictive pathways of some models. Most commonly, health 
psychology models attempt to describe adherence, part of the medical aspect of self-management, 
as well as care-seeking behaviours. Other theoretical models not specific to health psychology have 
to date, for the most part, been used to describe adherence and care seeking behaviours. The 
following is a brief overview of salient models, and comparisons between them; for a more general 
review of the models in question, see Armitage & Connors (2000). 
The active element of self-management is a set of behaviours that are more easily 
embedded into other existing theories – most commonly social cognitive theory (SCT), and the 
stages of change model (more commonly operationalised today as patient activation). Therefore, 
when examining the properties and utility of measuring medical, social and emotional variables 
associated with self-management, SCT and patient activation are often used as the theories guiding 
hypotheses. 
As previously discussed, much of the self-management literature has been built upon Social 
Cognitive Theory, and self-efficacy in particular. Perceived self-efficacy, “… is defined as people's 
beliefs about their capabilities to produce designated levels of performance that exercise influence 
over events that affect their lives” (Bandura, 1994). Part of the reason for this focus is that empirical 
work looking at SCT’s descriptive, and predictive power as a model of behaviour change does not 
improve beyond what can be explained by self-efficacy (Armitage & Conner, 2000). Indeed, Armitage 
and Connor conclude that due to its central role in many theories, and the lack of empirical support 
for other elements of SCT, self-efficacy is therefore likely more important than SCT per se. 
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Patient activation largely emerged from the transtheoretical model of stages of health 
behaviour change  (Prochaska & Velicer, 1997). Initially, the Patient Activation Measure was 
developed as tool to measure how important an individual believed their role in their care to be, 
their perceived knowledge about their treatment and condition, and their confidence to take action 
and stay the course under stress. This final component maps onto self-efficacy, while perceived 
knowledge and role are more distinct. Empirical work has been undertaken more recently in an 
attempt to develop patient activation from a single measure into a more comprehensive theory 
useful for generating hypotheses. For example, Hibbard and Mahoney (2010) attempted to 
incorporate the role of emotions and self-concept into patient activation theory. In a sample of 843 
participants, 93.6% of which had one or more chronic conditions, higher patient activation level was 
found to be correlated with higher positive affect measured by a shortened version of the Positive 
Affect Negative Affect Scale (PANAS). They concluded that the PAM may be tapping into not just 
attitudes towards behaviour, but also affect and self-worth. 
 Despite this, patient activation remains largely underdeveloped as a theory, and 
remains largely untested in the ESRD population – which will be explored further in chapter 3. 
Despite their overlaps, SCT and patient activation are to some extent distinct, with patient activation 
being marketed as a clinically useful tool. Patient activation has recently received a lot of attention 
among healthcare policymakers in the UK (NHS England, 2013), and is being increasingly used as a 
routine clinical measure. Therefore, there are both theoretical and practical reasons to measure 
both self-efficacy and patient activation, and comparing their utility in predicting self-management 
behaviours and illness outcomes. 
A third theory often guiding the self-management literature is the Common Sense Model 
(CSM) of Illness Representations (Leventhal, Leventhal, & Contrada, 1998). Leventhal’s Common 
Sense Model of Illness Representations (CSM) posits that the coping behaviours undertaken by an 
individual in response to illness are driven by a dual-pathway system of illness representations. 
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These cognitive representations govern cognitive coping strategies, and emotional coping strategies, 
the results of which feed back into the illness representations. A strength of this model is that it 
attempts to explain more than adherence to a single health behaviour; it also seeks to predict 
whether people will seek social support, their psychological outcomes (depression, anxiety, general 
psychological distress), and whether they will engage in problem focused or emotionally focused 
coping. The core dimensions of illness representations are: timeline, control/cure, illness identity, 
cause, and consequences. Timeline is further subdivided into perceptions of whether the illness is 
acute or chronic, and whether the symptoms are continuous or cyclical. Control/cure can to a certain 
extent be thought of as analogous to Bandura’s notion of self-efficacy; it is subdivided into 
treatment control (can the treatment help the illness – similar to outcome expectancies) and 
personal control (can the person maintain behaviours that will ameliorate symptoms – similar to 
perceived self-efficacy). 
These illness representations are operationalised in the various forms of the Illness 
Perception Questionnaire (IPQ). The original IPQ did not include a cyclical/continuous dimension, 
nor did it differentiate between treatment and personal control (Weinman, Petrie, Moss-morris, & 
Horne, 1996). These additions were included in the revised illness perception questionnaire (IPQ-R, 
Moss-Morris et al., 2002). Finally, due to the expansive nature of these questionnaires (the IPQ-R 
contains 38 main items, plus a checklist of symptoms, possible causes, and open ended questions on 
causes, resulting in over 70 items), a brief version was devised (Broadbent, Petrie, Main, & 
Weinman, 2006). The brief version contains eight likert style items, plus a question asking the 
respondent to rank the three most important causes of their illness. 
There has been a great deal of empirical investigation into the CSM (Hagger & Orbell, 2003). 
Illness representations of control and illness identity have been found to be a greater predictor of 
illness-related functioning and emotional outcomes than coping style, for example in chronic fatigue 
syndrome, even though illness perceptions still drive coping styles (Moss-Morris, Petrie, & Weinman, 
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1996). Theoretically, illness perceptions should be a good predictor of the steps that people take to 
self-manage, medically (adherence, presentation to healthcare services), socially (socially-oriented 
coping) and emotionally (emotion-focused coping, emotional outcomes). 
 Illness perceptions are useful to measure alongside self-efficacy, particularly the 
control/cure, timeline, and consequences dimensions, as this can give a good approximation of an 
individual’s outcome expectancies, allowing investigation of cognitive representations that may 
interact with self-efficacy to better predict self-management behaviour. 
 
2.11 Summary 
 
Self-management is described in the psychological and sociological literature as having three 
dimensions; medical, social, and emotional. Self-management is a term for behaviours aimed at 
promoting health, often in light of serious illness. It is commonly incorporated into social cognitive 
theory, patient activation theory, and the common sense model of illness representations, all of 
which overlap to some degree. Self-management as a set of behaviours is often conflated with self-
efficacy and patient activation, which are also held to be variables that predict or moderate self-
management behaviours. Chapter 3 will examine how theories surrounding self-management have 
been applied to people with Chronic Kidney Disease (CKD), how these theories can be better tested, 
and why self-management behaviour needs to be better operationalised in this condition. 
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3.1 Introduction 
 
The previous chapter explored the concept of self-management from a general standpoint, 
across all chronic conditions. The social and emotional challenges faced by people living with ESRD 
are unique, as are the tasks required for optimal clinical outcomes. Therefore the following chapter 
concerns self-management specifically in ESRD. An overview of the daily self-management 
challenges faced by those with ESRD is provided in chapter 1. Briefly, people on dialysis for ESRD are 
faced with polypharmacy, performance of dialysis at least three times a week, narrow dietary and 
47 
 
fluid restrictions, fatigue, mild cognitive impairment, and often reduced physical capabilities. The 
present chapter initially focuses on reviewing the literature concerning self-management and the 
role of psychosocial variables. 
The second half of the chapter presents the results of a scoping review of materials that are 
available to the public via the internet, whether aimed at patients or healthcare professionals. This 
provides context for the work presented in chapter 5, which examines patient and healthcare 
professionals’ perceptions of self-management. The aim is to explore what publically available 
materials say about self-management, and compare this with the views that patients and healthcare 
professionals actually hold. 
 
3.2 Thematic review of previous work on self-management in ESRD 
 
This literature review is guided by several key questions, to allow further exploration in the 
empirical chapters that follow. 
Question 1: What aspects of self-management have previous studies looked at? 
Question 2: What has been found on psychological factors associated with self-management? 
Question 3: What tools exist for measuring concepts related to self-management in ESRD? 
 
3.2.1 Search strategy 
 
To obtain literature classified as focusing on self-management, a systematic search was 
conducted on PubMed and PsychNET. Further citations were then obtained from the reference 
sections of papers deemed relevant to the present review based on the following inclusion/exclusion 
criteria. 
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The initial search was conducted using the following criteria: 
PubMed: (self management OR self care) AND (esrd OR dialysis) 
PsychNET: self management AND dialysis 
Abstracts were reviewed for inclusion using the following criteria: 
Inclusion:  
 Topic of the paper is self-management in ESRD, or late stage CKD focusing on preparing for 
dialysis 
 Original research or review paper (including questionnaire development) 
 Is about ‘self-management’, or self-management related topics, specifically adherence, 
decision making, or social/emotional adjustment 
 Is focused on adults 
 Originally in or officially translated into English 
Exclusion: 
 On children only 
 Individual case study or opinion piece 
 Not in English 
 Focus is solely on comparing dialysis modalities, e.g. outcomes in home haemodialysis versus 
in-centre haemodialysis, or other aspects of medical management such as drug comparison 
studies 
 
Paediatric renal papers were excluded as there are different issues, such as transitional care, 
that are beyond the scope of this dissertation. Case studies and opinion pieces were not included.  
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Late stage CKD was included as certain issues, such as dietary management and blood pressure 
control, or decision making regarding dialysis modality, are relevant to subsequent treatment as the 
disease progresses to ESRD. Studies in languages other than English were excluded due to 
translation being logistically beyond the scope of this dissertation. 
 
3.3 Results 
 
3.3.1 Prior reviews – interventions 
 
A recent review presents one of the most comprehensive overviews of self-management for 
a renal audience (Novak, Costantini, Schneider, & Beanlands, 2013). However, much of the article is 
focused on presenting the concept of self-management, and only briefly touches on previous studies 
in ESRD. The review argues for ‘whole-person’ care, and that self-management support can be useful 
in helping people with ESRD, while not defining what should be measured when defining the success 
of such interventions. 
A number of reviews attempt to summarize the literature on more focused questions, such 
as how self-management support interventions can improve adherence. For example, Welch & 
Thomas-Hawkins (2005) reviewed prior studies of psychoeducational interventions to promote 
adherence to fluid restrictions. They found nine studies of educational or Cognitive Behavioural 
Therapy (CBT) based interventions, which had mixed outcomes. The studies described included a 
theoretical component, although the application of theory to the intervention was often lacklustre. 
Theories used included the transtheoretical model of stages of change (Prochaska & Velicer, 1997), 
self-regulation theory (Leventhal et al., 1998), the health belief model (Rosenstock, 1974), and social 
cognitive theory (Bandura, 1985). The two studies that used social cognitive theory  (Tsay, 2003; 
Tucker, 1989) proved effective at reducing Interdialytic Weight Gain (IDWG) with a self-efficacy 
training programme used by Tsay proving particularly effective. Self-monitoring was found to be one 
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of the most promising components, producing significant effects in the five studies in which it was 
used. However, the performance of a theory driven intervention does not necessarily reflect the 
veracity of the theory it is based on. For this, hypothesis driven attempts to falsify individual 
mechanisms described by a theory are required. 
 A recent review of studies in the teaching of self-care behaviours for arteriovenous fistulae 
(AVF) documented practices of nurses as reported in the literature (Sousa, Apóstolo, Figueiredo, 
Martins, & Dias, 2014). No summary of evidence of efficacy was presented. Instead it was 
documented that most nurse led education on fistula care is delivered post-construction of the AVF, 
and is often a one off session, rather than ongoing or routinely supported. This is a common finding 
with self-management education in ESRD, despite the fact that all self-care behaviours associated 
with the disease, including AVF care, will likely be important for the rest of the individual’s life 
(Blomqvist, Theander, Mowide, & Larsson, 2010). 
 Burke et al. (2005) reported on two pilot studies for self-monitoring dietary intake in HD 
patients, one using pencil and paper, and one use electronic Personal Data Assistants (PDAs). Due to 
the pilot nature of the studies, no conclusions could be drawn about efficacy. However, the report 
does illustrate the potential role that technology can play in helping people to manage their diet. 
 Self-management interventions in a broad range of chronic conditions typically use either 
adherence or self-efficacy as outcome measures (Foster, Taylor, Eldridge, Ramsay, & Griffiths, 2007). 
This appears to be largely true for interventions in the renal context as well. As noted in chapter 2, it 
is often a psychological outcome (such as self-efficacy) that is successfully modified, not adherence 
(Greenhalgh, 2009). It is therefore interesting that many of the renal self-management interventions 
described above appear to have success with both psychological outcomes and clinical markers of 
adherence such as IDWG. It may be that this is the result of publication bias, or possibly something 
specific about self-management in ESRD that is responsible for this.
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Table 3.1: Self-management interventions in CKD 
Study Theoretical model Aim Intervention Methods Results Conclusions 
(Afrasiabifar, Karimi, 
& Hassani, 2013) 
Roy’s adaptation 
model (RAM) 
Improve 
adjustment 
Eight one hour 
education 
sessions over 
eight weeks 
Single blind RCT, 59 
patients (31 active, 
28 control). Two 
month follow-up. 
Physiological and 
self-concept, and 
role function scores 
improved in active 
v control 
Education based on 
RAM could be 
effective 
(Aliasgharpour, 
Shomali, 
Moghaddam, & 
Faghihzadeh, 2012) 
Social cognitive 
theory/self-efficacy 
Reduce IDWG Six session self-
efficacy training 
programme 
Single blind RCT, 63 
patients. Two 
month follow-up. 
SE increased, IDWG 
decreased in active 
group compared to 
control group 
SE training effective 
at reducing IDWG 
for people on HD 
(Christensen, Moran, 
Wiebe, Ehlers, & 
Lawton, 2002) 
Self-regulation 
(Kanfer & Gaelick-
Buys, 1991) 
Reduce IDWG  Single blind RCT, 40 
patients (20 active, 
20 control). Eight 
week follow-up. 
Adherence 
improved in active 
group, worsened in 
control group. 
Significant 
difference at 
follow-up. 
Self-regulation 
based intervention 
appeared effective 
at reducing IDWG 
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(Karamanidou, 
Weinman, & Horne, 
2008) 
Self-regulatory 
theory (Leventhal et 
al., 1998) 
Change illness 
and medication 
perceptions 
 Single blind RCT 
intervention (N 
=19) v control (N = 
20). Four month 
follow-up. 
Illness 
understanding 
improved over 
time, even after 
cessation of 
intervention 
 
(Lin, Tsai, Lin, Hwang, 
& Chen, 2013) 
Self-regulation 
(Barlow, Wright, 
Sheasby, Turner, & 
Hainsworth, 2002) 
Improve self-
management, 
self-efficacy, 
and slow CKD 
progression 
Five week self-
management 
based education 
programme 
Single group pre-
post design. Twelve 
month follow-up 
Self-efficacy 
improved but self-
management did 
not. Serum 
creatinine 
decreased. 
Self-management 
education may slow 
CKD progression, 
despite not 
improving self-
management 
behaviour 
(Moattari, Ebrahimi, 
Sharifi, & Rouzbeh, 
2012) 
Self-efficacy, 
empowerment 
Self-efficacy, 
QoL, clinical 
markers 
Four individual 
and two group 
empowerment 
counselling 
sessions 
Single blind RCT, 
intervention (N = 
25) v control (N = 
25). Twelve week 
follow-up. 
Self-efficacy, QoL, 
BP, IDWG 
significantly 
improved in 
intervention v 
control 
Empowerment 
counselling effective 
(Moonaghi, 
Hasanzadeh, 
Shamsoddini, 
Orem’s self-care 
model 
Attitudes to 
dietary and 
fluid adherence 
Face to face or 
video based 
education, over 
Randomised trial, 
no control group. 
75 participants, 
‘Improvement’ in 
attitudes towards 
restrictions in both 
Both face to face 
and video based 
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Emamimoghadam, & 
Ebrahimzadeh, 2012) 
two sessions in 
one week 
four week follow-
up 
groups pre-post. No 
difference between 
groups 
education can 
change attitudes 
(Nozaki, Oka, & 
Chaboyer, 2005) 
Self-efficacy, CBT Reduce IDWG CBT versus 
standard patient 
education 
Randomised, 
intervention (N = 
11) v control (N 
=11). Follow-up at 
12 weeks. 
Both programmes 
significantly 
reduced IDWG. 
Effect lasted for 8 
weeks in standard 
education, v 12 
weeks in CBT 
CBT based on self-
efficacy theory may 
prolong the effects 
of self-management 
education on IDWG 
(Royani, Rayyani, 
Behnampour, Arab, & 
Goleij, 2013) 
Self-efficacy Improve 
empowerment 
and self-care 
self-efficacy 
Empowerment 
education, two 
sessions a week, 
for one month 
Randomised trial, 
intervention (N = 
40) v control (N = 
40).  
Improvement in 
self-efficacy and 
empowerment v 
control group 
Self-efficacy and 
empowerment are 
modifiable in this 
population 
(Sharp et al., 2005) Health beliefs Reduce IDWG Four week CBT 
with some focus 
on health beliefs 
Intervention (N = 
29) v wait list 
control (N = 27), 
over four weeks, 
plus 18 week 
follow-up 
Reduced pre-post 
IDWG when both 
groups were 
combined for 
longitudinal 
analysis 
Intervention may be 
effective, but 
methods 
questionable 
(Su, Lu, Chen, & 
Wang, 2009) 
Social cognitive 
theory/self-efficacy 
Improve clinical 
status and QoL 
Self-management 
promotion based 
Pre-post design, 30 
patients on PD, 
Volume status, QoL 
and rehabilitation 
Multidisciplinary 
self-management 
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on self-efficacy 
theory. In PD 
patients. 
followed up for 6 
months 
status improved. 
Kt/V and KRU did 
not change. 
promotion can be 
effective 
(Tsay & Hung, 2004) Self-efficacy Empowerment, 
Strategies Used 
to Promote 
Health, 
depression 
Self-efficacy based 
self-management 
counselling, three 
times a week for 
four weeks 
RCT, intervention 
(N = 25) v control 
(N = 25), measures 
taken baseline and 
6 weeks post 
intervention 
Significantly greater 
improvement in 
empowerment, 
self-care self-
efficacy and 
depression in 
intervention group 
Self-efficacy based 
training can be 
effective 
(Welch et al., 2013) Social cognitive 
theory 
Feasibility of 
intervention 
Six week use of 
mobile app to aid 
self-monitoring 
Intervention (N 
=24) v controls (N = 
20) 
App was found to 
be feasible and 
acceptable 
Further studies 
required regarding 
efficacy 
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3.3.2 Prior reviews – observational 
  
 Observational research on self-management more frequently examines the psychological 
factors involved in self-management, although often as predictors of adherence to treatment. This 
relationship is potentially extremely important from a clinical perspective. Reviewing this 
relationship in depth, Clark, Farrington & Chilcot (2014) found that a number of psychosocial factors 
can predict non-adherence in ESRD, including mood, self-efficacy, social support, and illness and 
treatment perceptions. This work will be considered in more depth below, along with any relevant 
interventional studies. 
 
3.4 Question 1 – What aspects of self-management have previous studies 
looked at? 
 
 Self-management is theorised to comprise of three domains: medical, social, and emotional 
management. This model has not been consistently applied to studies of self-management in ESRD, 
however. Questions of whether a division between these three domains are useful remains, as they 
are likely interlinked and overlapping. Further, while these three domains are frequently discussed, 
there is no accepted model for how they interact in self-management. Indeed, self-management 
itself is not so much a theory as a combination of other theories. 
However, when using these three domains, unsurprisingly the majority of studies focus on 
medical management. Of these, most focus on adherence to prescribed treatment, be it fluid (Welch 
& Thomas-Hawkins, 2005), medication (Browne & Merighi, 2010), dietary adherence (Burke et al., 
2005) or dialysis attendance (Kim, Evangelista, Phillips, Pavlish, & Kopple, 2010). 
 Where emotional and/or cognitive variables are studied, they are usually studied as 
predictors of adherence rather than as outcomes, moderators, or mediators. For example, 
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depression has been found to be a predictor of adherence in a number of studies, and this is 
theorised to be linked to increased mortality in people with depression on dialysis (Taskapan et al., 
2005). The impact of depression on quality of life has also been studied, with the predictable 
outcome that higher depression results in lower self-reported quality of life (Drayer et al., 2006). The 
impact of medical management on quality of life has also been assessed, including the impact of 
various biomarkers on QoL outcomes. While factors such as Kt/V were found to have a small effect 
on QoL, nutritional status and haematocrit demonstrated a moderate to large impact on QoL as 
measured by the SF36 (Spiegel, Melmed, Robbins, & Esrailian, 2008). The relationship between 
psychological variables and medical and social factors is likely to be complex, and future analyses 
should take this into account by including these factors as moderators or mediators. 
Intervention studies included in this review were coded for whether they included medical, 
emotional, and/or social aspects of self-management. Out of 43 studies, 40 (93%) included a focus 
on medical management, either as a predictor or an outcome. Twenty-one (49%) included a 
significant focus on psychological factors, either as predictors or outcomes. Only two studies (5%) 
included social factors, such as perceived social support, or role functioning, as substantial elements 
of interest. 
 
3.5 Question 2 – What has been found on psychological factors associated 
with self-management?  
 
 This section will focus on what has been found in ESRD self-management intervention 
studies that have a theoretical basis. However, it is important to restate that the success of an 
intervention based on a theory only provides support for that intervention, not necessarily the 
theory itself (though it may be suggestive of its veracity). 
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3.5.1 Social Cognitive Theory 
 
 As described in chapter 2, self-management is most often discussed in light of Bandura’s 
Social Cognitive Theory (SCT). Other models include the Transtheoretical Model of Behaviour 
change, and Leventhal’s self-regulation theory/common sense model of illness representation. 
While many studies into psychological factors and self-management are not theoretically driven 
(Welch & Thomas-Hawkins, 2005), these models have all been applied to ESRD with varying degrees 
of fidelity. These studies will now be considered. 
 As anticipated from SCT and previous self-management work in other chronic illness, self-
efficacy and self-care ability appear to be correlated in ESRD (Bağ & Mollaoğlu, 2010). This study 
looked at a cross sectional sample of 125 people receiving haemodialysis in Turkey, and found that 
people in the highest self-care ability category scored significantly higher on the general self-efficacy 
scale (GES; Rimm & Jerusalem, 1999). Similar correlations have been found for clinical markers of 
adherence in a number of other studies in different countries. For example, in a Portuguese study of 
113 people on haemodialysis, patients with an IDWG of less than 3.5% of total bodyweight had 
scored significantly higher on self-efficacy (Lindberg, Fernandes, Lindberg, & Fernandes, 2010). 
 Self-efficacy has also been used to predict quality of life in dialysis patients. In Taiwan, a 
study found that self-efficacy predicted a huge portion of the variance in quality of life scores (r2 = 
0.475, p < 0.001), while adding depression to the model increased the explained variance by a 
further 5.5%. The relationship between self-efficacy and QoL may be partially due to these 
constructs being partially overlapping. However, these studies only look at self-efficacy which is only 
part of SCT. In the USA, Patterson et al. (2014) tested self-efficacy, in addition to outcome 
expectancies and self-regulation (self-monitoring, goal setting, feedback), as predictors of physical 
activity among people on dialysis. While each component of SCT was related to physical activity 
individually, outcome expectancies were found not to contribute to final model, and was removed as 
a factor. 
58 
 
3.5.2 Common sense model of illness representations 
 
 The Common Sense Model (CSM) posits that health related behaviours are related to the 
cognitive and emotional representations people hold of their illness (schema). In ESRD, illness 
representations have been shown to be related both to depression (Chilcot, 2012b) and fluid non-
adherence (Chilcot, Wellsted, & Farrington, 2010). While some argue that illness perceptions can be 
combined into a summary score, each dimension of illness perceptions relates to a distinct aspect of 
cognitive or emotional illness representations. In the previous example for fluid, perceptions of a 
shorter disease timeline are related to non-adherence. Another study again found that perceptions 
of a shorter illness timeline predicted phosphate binder non-adherence, as did greater emotional 
representations of ESRD (O’Connor, Jardine, & Millar, 2008). However, they did not find these 
relationships when it came to fluid adherence. Illness perceptions are a promising area to explore in 
future intervention studies. Illness perceptions have proven to be modifiable, and can result in 
changes to knowledge and understanding of ESRD (Karamanidou, Weinman, et al., 2008). Further 
studies are required to identify whether these changes translate into adherence, clinical outcomes, 
and quality of life (Kaptein et al., 2010; Clark et al., 2014). 
 
3.5.3 Transtheoretical model of stages of change 
 
 The transtheoretical model purports that the success or failure of attempts to modify 
behaviour will depend, at least in part, on a person’s “readiness to change”. While many studies 
have examined the role of stages of change in dietary modification, few have examined the TTM in 
the context of self-management and ESRD. Molaison & Yadrick (2003) staged an intervention in 316 
people on HD (216 intervention, 100 controls). The 12-week intervention was designed to move 
people from pre-contemplation to readiness to change, using techniques similar to motivational 
interviewing (Miller & Rollnick, 1992). Readiness to change was assessed using a 6-item 
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questionnaire and placing them into one of five readiness categories. While the intervention 
succeeded in changing participants’ ‘readiness to change’, as well as improved treatment related 
knowledge scores, fluid adherence did not improve over the course of the intervention. In fact, fluid 
adherence worsened between the beginning and the end of the study. 
 
Other models 
 The health belief model (Rosenstock, 1974) has been used to explore dietary sodium intake 
in people on HD. In a study of 79 people, adherence to dietary sodium restrictions were associated 
with greater perceived benefits, and fewer perceived barriers to adherence to those restrictions 
(Walsh & Lehane, 2011). Perceived benefits are roughly analogous to treatment beliefs, often 
studied in concert with illness perceptions (Horne, Weinman, & Hankins, 1999). 
 
3.6 Question 3 – What tools exist for measuring concepts related to self-
management in ESRD? 
 
 General issues relating to measuring self-management are discussed in chapter 2. In most 
conditions, the purported tripartite structure of self-management has not been translated into 
specific scales for measuring self-management as a whole concept, but rather as individual 
components. 
 In ESRD, most self-management studies have used clinical measures of adherence as a proxy 
measure for assessing medical self-management behaviours. These most commonly include 
interdialytic weight gain (IDWG) to assess adherence to fluid allowances, serum phosphate to 
measure adherence to dietary recommendations and phosphate binder medication, and sodium, 
again as a measure of dietary adherence. Self-report is sometimes used, although there is a wider 
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debate about whether this method is ever sufficiently reliable when assessing adherence 
(Grymonpre et al., 1998). An instrument has recently been developed that assesses a wide range of 
adherence behaviours, from shortening/skipping dialysis, to medication and dietary adherence (Kim 
et al., 2010). It also assesses a variety of attitudes to treatment, and is potentially useful for 
exploring the relationship between the two. However, with 46 items it may be unfeasible for use 
alongside other instruments. 
 Assessment of emotional aspects of self-management has typically involved the use of tools 
developed to screen for mood disorders. These typically include depression and anxiety 
questionnaires, such as the Beck Depression Inventory II (Beck, 1996), the PHQ-9 (Kroenke, Spitzer, 
& Williams, 2001), and the HADS (Bjelland, Dahl, Haug, & Neckelmann, 2002). Mental health 
components of quality of life measures have also been used, most commonly the mental health 
component subscale of the SF-36 (Wight et al., 1998). These measures are screening tools, and are 
not to be used to conclusively diagnose psychopathology (Chilcot, Wellsted, Da Silva-Gane, & 
Farrington, 2008). Rather, they are used to assess mood. However, they may miss some 
psychological details important to adjustment in chronic illness. Furthermore, they often do not 
address what people do to protect or promote their emotionally wellbeing. 
 Most published studies on self-management included in this review did not address the 
issue of social functioning (95%). Perceived social support was assessed in one study, using the Social 
Support from Healthcare Providers scale (Neri et al., 2011). Other scales exist for assessing social 
support in chronically ill populations, such as the Duke Functional Social Support questionnaire 
(Broadhead, Gehlbach, de Gruy, & Kaplan, 1988). While it is useful to measure perceived social 
support, these scales alone do not capture behaviour, such as the seeking of social support, or 
participation in social activities. 
 Variables relating to self-management behaviour such as self-efficacy, illness perceptions, 
and readiness to change, have all been used in ESRD and appear to be valid and useful measures. 
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Self-efficacy can be measured using generic scales for self-efficacy in chronic disease (Lorig et al., 
1996). It can also be assessed using ESRD specific scales, although these often relate to one specific 
adherence related behaviour, such as fluid adherence (Winters, Lindberg, & Sol, 2013). Illness 
perceptions can be assessed using tools developed in other chronic illnesses, but that have been 
validated for use in ESRD (Chilcot, Norton, Wellsted, & Farrington, 2012). “Readiness to change”, as 
per the transtheoretical model, can be assessed using the Patient Activation Measure (PAM), 
although this does not appear to have been extensively tested in ESRD populations. 
 Some tools have been developed or adapted for ESRD that may provide useful insight 
beyond the simple measures listed above. For example, Thomas-Hawkins developed a tool for use 
with people on HD, that examines role functioning (Thomas-Hawkins, 2005). Rather than look at 
physical functional status in terms of what people are able to do, it asks what they actually do. It 
breaks these role activities into three categories; personal care activities such as bathing and 
dressing; household activities, such as housework and shopping; and social and community 
activities, such as going out with family and friends or participating in social clubs. By measuring the 
extent to which people undertake these roles, they are providing a good measure of the ‘social’ side 
of self-management. 
 Two other questionnaires have tried to tackle the concept of self-management, one in early 
stage CKD, the other in people on HD. Curtin et al. (2004) developed a scale assessing self-
management and knowledge with 372 patients on in-centre HD across 17 facilities. Based on prior 
self-management theories, and previous work by the authors, 60 items were developed and pre-
tested in a small convenience sample of 25 people. After dropping 6 items for lack of clarity, these 
questionnaires were given to 372 people on HD. After item reduction and rotation using exploratory 
factor analysis, 8 domains, with a total of 37 items, remained. The domains were: 
1. Suggestions to providers 
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a. Example: Asked for a change in treatment based on information you learned on your 
own? 
2. Self-care during haemodialysis 
a. Example: Cleaned/prepared your access site for needle placement? 
3. Information seeking 
a. Example: Looked for additional kidney diet information? 
4. Use of alternative therapies 
a. Example: Tried an alternative treatment (such as yoga, acupuncture, magnets or 
hypnosis?) 
5. Selective symptom management 
a. Example: Kept problems or symptoms to yourself so as not to bother staff or your 
doctor? 
6. Assertive self-advocacy 
a. Example: Spoke up to a caregiver because you thought they were doing something 
wrong? 
7. Impression management 
a. Example: Tried to get staff or your doctor to think well of you, in order to get better 
care? 
8. Shared responsibility in care 
a. Talked regarding a treatment or medicine you learned about, hoping the 
information might work for you? 
The full questionnaire can be found in appendix A. 
 During development, the scale was concurrently administered with the physical component 
subscale 12 (PCS-12) and mental health subscale 12 (MCS-12) of the SF-12 quality of life 
questionnaire (Ware, Kosinski, & Keller, 1996). Cross sectional correlations revealed that self-care 
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during haemodialysis and shared responsibility in care were both associated with better physical 
functioning. However, selective symptom management, assertive self-advocacy and impression 
management, were all associated with both poorer physical functioning and poorer mental 
wellbeing. Only knowledge was associated with greater mental wellbeing. It is not clear from 
available data which causes which, or whether it is a self-reinforcing reciprocal relationship. 
 The authors posit that the mixed negative/positive correlations result from different ‘styles’ 
of self-management. Shared responsibility in care, for example, is an example of ‘cooperative’ or 
‘participatory’ self-management, where the patient works together with the care team. Selective 
symptom management, where a person withholds information from the care team and attempts to 
deal with the problem alone, is an example of ‘defensive’ or ‘protective/proactive’ self-
management, which may be associated with poorer psychological and physical functioning. This 
question of self-management styles has not been extensively studied in ESRD, but raises important 
questions about the nuances inherent to self-management, and whether cooperative self-
management or shared care may be more appropriate terms than self-management, which can 
imply the idea of health behaviours being undertaken in isolation. 
 The issue of cooperative and defensive self-management behaviours, covering a range of 
activities that go beyond adherence, warrants further investigation. For this reason, the scale was 
selected for use in the empirical chapters of this dissertation. As it did not have a specific title, the 
scale will be referred to as the Behaviours on Haemodialysis Scale (BHDS) for ease of reference. 
 One tool has been developed with the intention of reflecting the three domain background 
behind self-management in chronic illness. Lin and colleagues (2013) developed a 29-item 
multidimensional questionnaire for use with people with stage 2 and 3 CKD. As this tool focuses on 
pre-dialysis medical issues, it does not cover many of the medical challenges and life interruptions 
that are experienced in ESRD. For example, it does not cover the time, fatigue, and emotional issues 
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associated with dialysis itself, or medication or fluid adherence and the social and emotional 
implications of these complex regimens. 
 However, the instrument is a potentially useful template for future instruments in ESRD. The 
final 29 items were obtained from a pool of 59 items, derived from an expert consensus panel and 
reduced using exploratory factor analysis and a sample of 252 Taiwanese respondents. The final 
scale has four factors; self-integration, problem solving, seeking social support, and adherence to 
recommended regimen.  
This structure closely mirrors the three domain self-management model, and a similar scale 
in ESRD may allow for better assessment of ‘self-management’ as a behavioural predictor or 
outcome in studies that purport to examine this. Examples of items for each factor include: 
1. Self-integration 
a. Managing food portions and choices in social activity 
2. Problem solving 
a. Thinking over reasons about bad [sic] laboratory data 
3. Seeking social support 
a. Asking family or friends for help when helpless or frustrated 
4. Adherence to recommended regimen 
a. Don’t follow care providers’ suggestion to control weight 
 
3.7 Scoping review of self-management materials available to the public 
 
The previous section provided a review of the academic literature on self-management in 
ESRD. The following section describes a scoping review of web materials available on self-
management, as well as educational materials on ESRD. This will allow for a comparison of academic 
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and public-facing self-management materials, as well as providing additional context for the work in 
chapter 5 exploring self-management concepts among patients and healthcare professionals. 
 
3.7.1 Search strategy 
 
Online searches for publically available websites and materials were conducted using 
Google. These searches ranged from narrow to broad in scope, including as many synonyms as 
possible. Subsequent hits were recorded in a word file with the website’s title and front page link, 
followed by a brief summary of materials found, and any that could be locally stored (.PDFs etc) 
were downloaded and filed. 
As many websites that deal with education for chronic disease have their own links, a system 
was employed whereby all salient links from a website were followed up and listed in an indented 
fashion under the site from which they were found, before the results of the main search were 
returned to. This helped to identify the source of materials that were found for replicability and 
clarity. 
The first search concerned self-management education relating to dialysis patients, and the 
primary search parameters used were: 
(“self management” OR “self-management” OR “self-efficacy” OR “self efficacy”) AND (education OR 
resources) AND (haemodialysis OR hemodialysis OR dialysis) 
Self-efficacy was included, as it is frequently associated with self-management interventions 
(Lorig & Holman, 2003). The two are often used more or less interchangeably However it should be 
noted that they refer to two distinct concepts; self-efficacy to one’s sense of being able to achieve a 
desired outcome, self-management describing observable behaviour. 
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3.7.2 Findings 
 
A list of the resources found during this search can be seen in table 3.2. 
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Table 3.2: Self-management resources available to for people with ESRD 
 
Name Focus Description URL 
Self-management in renal 
resources, aimed at patients 
   
    
Kidney End-of-Life Coalition End of life care planning Has a section for patients that refers to some 
issues aligned with self-management, such as 
planning ahead and giving a sense of control 
http://www.kidneyeol.org/Home.aspx  
HealthLinkBC Self-monitoring A US site that has a programme with an 
emphasis on self-management 
http://www.healthlinkbc.ca/ 
Kidney Health Australia General self-management 
skills 
Has downloadable factsheets such as, 
“You’re in Charge – self-management health 
book” and, “Using the web to research 
kidney health information” 
http://www.kidney.org.au/ 
DaVita Diet, travelling, education Includes a useful diet helper and guide to 
cooking recipes suitable for people on 
dialysis. Includes videos and recipies. Has a 
GFR and Kt/V calculator. Information on 
travelling very useful for people on dialysis. 
http://www.davita.com/ 
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Kidney Patient Guide Emotional impact of renal 
disease, diet, finances, 
advice for carers, holidays 
Covers a broad range of issues, many of 
which relate to self-management. Diet, 
holidays and finances included. 
http://www.kidneypatientguide.org.uk/ 
    
National Kidney Foundation Charity with broad remit Includes a section on education on self-
management behaviour (Guideline 5). Also 
includes diet guidelines via KidneyKitchen, 
including, recipes, links to dialysis patient 
cookbooks, and tips on low salt seasoning 
http://www.kidney.org/ 
PatientsLikeMe Peer to peer 
communication 
Site designed to provide patients with the 
opportunity to share experiences 
http://www.patientslikeme.com/ 
The Renal Gourmet Diet Kidney diet website written by a patient who 
has been on dialysis for 10 years 
http://www.kidneycookbook.com/ 
 
American Association of 
Kidney Patients (AAKP) 
Education Non-profit US kidney charity. Extensive range 
of educational materials on diet, 
understanding clinical markers, treatment 
options, nutrition counting, and “Five way to 
be active in your care at the hospital” 
http://www.aakp.org/ 
Kidney Research UK Fact sheets Includes fact sheets, information on financial 
help, and interactive health checks. Has free 
downloadable recipe book, as well as a DVD, 
“Living with kidney disease” 
http://www.kidneyresearchuk.org/ 
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British Kidney Patient 
Association 
Factsheets Includes fact sheets on psychological 
strategies for depression, renal diets, and 
“Renal patients take charge” 
http://www.britishkidney-pa.co.uk/ 
    
Global Dialysis Travel Allows users to search for international 
dialysis centres for patients wishing to go on 
holiday. Includes phrase cards for travelling. 
http://www.globaldialysis.com/ 
DPC: Dialysis Patient Citizens Campaign for self-care 
education 
Discusses issues such as patients often 
knowing their dry weight better than 
clinicians 
http://www.dialysispatients.org/education-
portal 
Cleveland Clinic Foundation Diet Sells ‘Creative Cooking for Renal Diets’ and 
‘Creative Cooking for Renal Diabetic Diets’ 
http://www.patientsupport.net/ 
Culinary Kidney Cooks Diet Includes a nutrition pyramid for people on 
dialysis 
http://www.culinarykidneycooks.com/ 
Big D and Me Shared experiences A blog written by a long term dialysis patient. 
Includes a video of what it’s like to be on 
dialysis. 
 
 
 
https://bigdandme.wordpress.com/  
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Self-management in renal 
resources, aimed at clinicians 
   
    
Kidney Care Matters Online Promoting self-
management 
Emphasis on home dialysis modalities, aims 
to encourage self-management promotion 
and e.g. patient held kidney-care plans 
http://www.kidneycarematters.nhs.uk/ 
Home dialysis central Technical dialysis related 
self-management 
Includes manual for staff to help teach 
patients to self-cannulate 
http://www.homedialysis.org 
PEAK: Kidney Care Partner’s 
Performance and 
Accountability in Kidney Care 
Quality improvement A voluntary quality improvement programme 
based in the US. Includes guidelines for best-
practice, including sections on education and 
empowerment, and supporting self-
management 
http://www.kidneycarequality.com 
Fistula First Vascular access Supports system wide changes to encourage 
fistula access over catheter usage. Contains a 
number of resources on self-management, 
focused both on fistulae and general tasks 
http://www.fistulafirst.org/Default.aspx 
Life Options Self-management 
education, financial 
aspects of care 
A website from the Medical Education 
Institute Inc. Produces a newsletter called 
the Renal Rehabilitation Report. 
http://www.lifeoptions.org/ 
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Ontario Local Health 
Integration Network (LHIN) 
 Includes a document, “Chronic Kidney 
Disease Initiative: Practitioner’s Manual”, 
including a section on patient self-
management 
http://www.centraleastlhin.on.ca/ 
    
Edinburgh Renal Unit Both GP and patient 
information 
Mostly fact-related information about kidney 
disease rather than self-management tips, 
but does include a Diet in Renal Disease 
section. 
http://www.edren.org/ 
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There were no online resources devoted solely to patient self-management, though many 
charities and organisations included at least some educational materials devoted to educating 
individuals about self-management. Some explicitly used the term ‘self-management’, while others 
discussed the kinds of tasks under different terms; sometimes self-care, sometimes simply, ‘living 
with kidney disease’. 
The list provided is by no means exhaustive, and some results were excluded due to being of 
very low quality or relevance. For example, if the standard of English was insufficient, the website 
was nearly unreadable, or there was in fact no information about self-management. 
  One extremely strong theme that emerged was the frequent focus on diet. Renal cookbooks 
and dietary suggestions could be found in many places, including in one instance a cookbook for 
people with kidney disease and diabetes. As we have seen, these are common comorbidities, but 
finding complementary dietary advice for both can be difficult. As will be discussed in chapter 5, 
managing one’s diet is a substantial challenge for people with kidney disease, and the presence of 
these materials speaks to how much planning goes into self-management of diet in ESRD. 
 Several sites, such as DaVita, included calculators to allow patients to calculate their own 
GFR and Kt/V, as well as providing information to help people interpret their lab results, such as for 
phosphate. This encourages patient engagement, and also allows patients to modify their dietary 
behaviours based on informed reading of those results.  
 Some resources, such as the US National Kidney Federation, have information on travelling 
to other centres abroad for dialysis (http://www.kidney.org.uk/help-and-information/holidays/). 
This site includes feedback from patients who have been on holidays, and lists of centres that accept 
patients for treatment while on holiday. Global Dialysis is a site that specialises in helping people on 
dialysis find centres, with a search function allowing users to find dialysis units across the world. 
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 Very few of the resources identified had much information on dealing with the social or 
emotional consequences of ESRD, instead focusing on practical issues such as diet, fistula care, 
information seeking, and decision making around dialysis modalities. The Kidney Patient Guide, a UK 
based, Wellcome Trust funded resource, is a notable exception, with information about adjustment, 
stress, anxiety, depression, anger, sexual problems, and how counselling may help. 
 There appears to be little or mention of a contrast between cooperative and defensive self-
management, or analogous concepts. While information is provided about different dialysis 
modalities, there is little advice on how to go about shared decision making with healthcare 
professionals. 
 While there are many blogs on the subject of dialysis, Big D and Me was included as an 
example of a well written, long-running record of a patient’s experiences with dialysis and the self-
management challenges they face. This could be seen as an example of one-to-many peer support, 
as many patients feel overwhelmed when they first start dialysis without context or peer support. 
 The search also resulted in finding resources aimed at renal services and clinicians, with the 
goal of encouraging the promotion of self-management. This draws attention to the issue that while 
many patients will simply self-manage, the culture of the dialysis unit may influence this. This issue is 
explored further in chapters 5 and 8 of this dissertation. 
 There are a variety of resources for people living with kidney disease. There appears to be 
more readily available information on diet, holidays, choosing a dialysis modality, and financial 
support, than there is on the emotional or social impact and what a patient struggling with these 
might do. 
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3.8 Summary 
 
There is an increasing volume of self-management literature available for people with 
chronic illnesses. Much of this is not aimed at any one condition, although there has been a huge 
quantity made available for people with diabetes. Increasingly, there are materials for people with 
ESRD, although as with the academic literature, these materials tend to focus on medically related 
issues. It may be due to ESRD being a less common condition, but there are few readily available 
materials that talk about the emotional impact of ESRD in the same way as in, for example, cancer. 
 The Health Foundation bases its triangle of self-management (see chapter 2) closely on the 
work of Corbin & Strauss (Corbin & Strauss, 1985). It is interesting to note that the publically 
available resources promoting and supporting self-management in this case line up closely with 
some aspects of self-management research, but not others such as emotional and social aspects. 
Language barriers are an issue that is sometimes addressed in these materials, particularly for ESRD. 
As ESRD is overrepresented in people from South Asian populations, translation of both medical 
information, but also information on emotional and social issues, is of great importance. 
There is a growing academic literature on self-management in ESRD, with an increasing 
frequency of publications in the last few years. Much of this work still focuses on medical self-
management, with adherence to prescribed treatment being the most common outcome of interest. 
Tools exist for measuring some aspects of self-management in ESRD, as well as theorized drivers of 
behaviour such as self-efficacy and illness perceptions. 
A scoping review of publically facing materials relating to self-management identified a number 
of useful tools for people with ESRD in terms of education regarding the illness and its treatment. 
However, as with the academic literature, there is a dearth of information on social and emotional 
issues. There has been almost no work on different types of self-management behaviour, and 
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whether there is a distinction between defensive and cooperative style self-management 
behaviours. 
 The BHDS was selected as a haemodialysis specific self-management scale to use and 
investigate further in the following empirical chapters. Chapter 4 will give an overview of the 
methods that will be used to address the thesis: 
Certain self-management behaviours in End Stage Renal Disease are predicted by self-efficacy, 
patient activation, and psychological distress, and in turn predict clinical status. However, self-
management is often oversimplified and poorly operationalised, in both the literature and in 
clinical practice, to adherence and ‘good/bad’ distinctions that may impede future investigations 
and interventions. 
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4.1 Introduction 
 
 The present chapter will discuss the major methodological elements of the following 
empirical chapters. This will include the rationale for the methods used, and issues common to 
design, participants, settings, and analysis across chapters. Questionnaires will also be described in 
detail, along with methods for transforming raw scores into summary and subscale scores. Details of 
methods of qualitative and statistical analysis will also be covered. Some methodological issues 
specific to individual studies will be covered in the relevant chapters. 
 This thesis was developed in parallel with the SELFMADE study. This chapter shall begin with 
the background of each, and distinctions between the two will be set out. Ethical and governance 
considerations will be documented next. Then the research questions that the empirical chapters set 
out to answer will be presented, followed by the methods used to address each, divided into a 
qualitative section, and a quantitative section. 
 
4.2 Background 
 
 Some of the work detailed in this chapter also contributed to the Self-Management and 
Dialysis Evaluation (SELFMADE) study, described below. This 3 year project was funded by the 
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National Institute for Health Research’s (NIHR) Research for Patient Benefit (RfPB) programme. The 
author co-authored the grant application, was the day to day lead on the study, and was involved in 
all empirical work described in this dissertation. The aim of the SELFMADE study was to develop the 
role of a self-management facilitator and measure changes in a number of variables, such as 
adherence and self-efficacy, over time. 
 The methods described in this chapter were chosen to address the research questions 
described below in section 4.3. These questions follow directly on from the background literature 
and issues explored in the introductory chapters.   
 
4.3 Research questions 
 
The broad research questions being addressed in this dissertation are as follows: 
1. How is self-management conceptualised by people on dialysis and the staff involved in their 
care? (chapter 5) 
2. Are self-efficacy, activation, psychological distress, and illness perceptions related to self-
management behaviours? (chapter 6) 
3. Does self-management behaviour predict clinical markers of adherence? (chapter 7) 
4. How can measurement of self-management behaviour in people with ESRD be improved? 
(chapter 8) 
Some of these questions are addressed in multiple chapters. 
 
4.4 The SELFMADE study 
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The SELFMADE study was a three year mixed methods project, funded by the NIHR and 
conducted in Hertfordshire, England. The purpose of the project was to develop a self-management 
‘facilitator’ role. In order to inform this, a number of empirical steps were taken. Broadly, the project 
involved: 
1. An academic review of the literature on self-management in ESRD 
2. A scoping review of self-management and educational tools available to ESRD 
patients and the staff involved in their care 
3. Focus groups held with both patients and staff, to assess their views on what 
constitutes, ‘self-management’, what is important, and what could be done to 
facilitate these behaviours 
4. The implementation of a ‘self-management facilitator’ role using action research. 
5. A collection of psychological and clinical measures to examine whether the 
facilitator role resulted in simple change over time 
6. Interviews to assess changes in patient perceptions regarding self-management, and 
the efficacy of the facilitator’s actions 
Data from the study relating to patient and staff conceptualisations of self-management, as 
well as quantitative data on relationships between variables, will be used in this dissertation. The 
author of this dissertation was the day to day lead on the study, and was involved in drafting focus 
group/interview schedules, conducting focus groups and interviews and analysing results, selecting 
and administering questionnaires, and conducting the analyses. 
Work that was part of the SELFMADE study that is not included by this dissertation includes 
the development and implementation of the self-management facilitator role using action research 
methods (Reason & Bradbury, 2000). This included the facilitator working directly with patients and 
setting up a number of services at the research sites. These services included peer support, 
introducing exercise bikes for use while on dialysis, a holiday information service, and setting up 
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dialysis bays to allow interested patients to do more of their own dialysis in-centre. As is common in 
action research, the facilitator kept detailed notes of their experiences for later analysis. The 
SELFMADE study was primarily focused on this development process. 
 
4.4.1 Distinctions between SELFMADE and this thesis 
 
The author was the day to day lead of the SELFMADE study, and was involved in writing the 
grant application, wrote the study protocol, selected questionnaires to employ, obtained NHS ethics 
and R&D approval for the study, and was directly involved in all elements of data collection, analysis, 
and write up. 
The SELFMADE project aimed to introduce a nurse facilitator role and assess its 
implementation using a variety of qualitative and quantitative methods. The focus of the project was 
on facilitators and barriers to self-management, and documenting the experiences of the process of 
introducing such a role. Quantitative data were collected in an attempt to establish whether there 
were changes in adherence or psychological variables over time.  
The initial qualitative work on conceptualisation of self-management served a similar role for 
SELFMADE and this dissertation, however the analysis presented in chapter 5 is greatly expanded 
from the analysis the author conducted for the SELFMADE study. However, a broad range of data 
were collected by the author as part of this project in an attempt to investigate self-management in 
greater, more theoretically driven detail. This is the author’s own work (chapters 6 and 7). 
Additionally, during the data collection process, difficulties participants faced in answering self-
management related questions led to investigating the cognitive process used in responding to the 
self-management questionnaire. This is also unique to this dissertation and separate to the 
SELFMADE study entirely (chapter 8). 
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The application of theory, methods of analysis, and interpretation using the available data 
were all the author’s own work. From this point on, all investigations will be presented in terms of 
their role in this dissertation, rather than the SELFMADE study. The only exception is chapter 5, 
which draws upon initial team coding for focus groups. 
 
4.5 Ethics and governance approvals 
 
The work described in chapters 5, 6 and 7 was approved by Cambridge South NHS Research 
Ethics Committee, REC reference 11/EE/0417. East & North Hertfordshire NHS trust acted as the 
study sponsor, and local Research & Development approval was obtained from Hertfordshire 
Hospitals R&D Consortium, reference RD2011-108. 
The work described in chapter 8 was approved by NRES Committee North West – Greater 
Manchester East, REC reference 14/NW/0272. The work was sponsored by the University of 
Hertfordshire, reference LMS/PG/NHS/00154. Local Research & Development approval was 
obtained from Central Manchester University Hospitals NHS Trust, reference R03623. The author 
was the chief investigator, with Dr Sandip Mitra acting as the local collaborator for participant 
identification, recruitment and governance purposes. Consent was obtained from all participants in 
all studies. 
 
4.6 Participants 
 
Participants consisted of people on in-centre haemodialysis, home haemodialysis, and renal 
staff. Specific inclusion and exclusion criteria can be found in the relevant empirical chapters, but 
common factors are described here. 
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4.6.1 Chapters 5, 6, and 7 
 
Staff participants were drawn from East & North Hertfordshire NHS Trust, as were patient 
participants for the SELFMADE study. This included three sites; Lister Hospital, Stevenage (site 1), 
Luton & Dunstable University Hospital (site 2), and St Albans City Hospital (site 3). 
Specific inclusion/exclusion criteria will be described in each section. Common inclusion 
criteria for patient participants included: 
 Presence of End Stage Renal Disease 
 On haemodialysis for >  3 months 
 Able to speak sufficient English to comprehend and respond to relevant questions in focus 
groups, interviews, or questionnaires 
Exclusion: 
 Under 18 
 Unable to consent for any reason 
 
4.6.2 Chapter 8 
 
Patient participants described in chapter 8 were drawn from Central Manchester University 
Hospitals NHS Foundation Trust, including Manchester Royal Infirmary and its satellite units. Specific 
details of participant characteristics can be found in chapter 8. 
 
4.7 Settings 
 
4.7.1 In-centre dialysis  
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The work described in chapter 5, 6 and 7 took place in East & North Hertfordshire NHS Trust 
in the South East of England. The sites were, Lister Hospital in Stevenage, St Albans City Hospital, and 
Luton & Dunstable University Hospital. Of these, Lister Hospital is the primary centre where Trust 
nephrology services are based, including, for example, the consultant nephrologists. 
 The work described in chapter 8 was conducted in Central Manchester University Hospitals 
NHS Foundation Trust. 
These centres share a number of characteristics. For example, all centres have a number of 
haemodialysis ‘bays’ located in a single room. Additionally, all have a number of ‘side rooms’ each 
containing a single haemodialysis bay, for patients with highly communicable blood borne diseases 
such as hepatitis B. Each unit has a mixture of chairs and beds, for use depending on preference and 
need. Most centres run three ‘shifts’ of patients, allowing each bay to be used three times per day. 
On some days, some centres run a fourth late shift (colloquially known as the ‘twilight shift’). All 
centres operate Monday to Saturday. 
Lister hospital is based in Stevenage, Hertfordshire. Nephrology services for E&N 
Hertfordshire NHS Trust are based there, including the consultant nephrologists for the area. In the 
unit itself, there are a total of 20 haemodialysis bays present in a single room, separable by curtains 
if necessary, with a further five side rooms, for a total of 25 bays. 
St Albans City Hospital (SACH) has a total of 16 bays and two side rooms. Specific 
demographic characteristics will be explored by chapter, but the patient population tends to be 
older in this unit. Luton & Dunstable University Hospital (L&D) has a total of 20 bays in the main unit 
and three side rooms. 
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4.7.2 Home haemodialysis 
 
 Interviews with patients on home haemodialysis described in chapter 8 were conducted in 
participants’ homes, one to one, in a quiet room. Different households will have different home 
haemodialysis setups. Current haemodialysis machines have sophisticated safety features that make 
it possible for people living alone to conduct their own dialysis. 
What follows is a description of the methods used throughout this dissertation. Methods will 
be broken down into qualitative and quantitative methods, along with the research questions that 
they address. 
 
4.8 Qualitative methods 
 
 A combination of focus groups, standard interviews, and cognitive interviews were used to 
address two of the above research questions: 
1. How is self-management conceptualised by people on dialysis and the staff involved in their 
care? 
4. How can measurement of self-management behaviour in people with ESRD be improved? 
 
 Question 1 is addressed in chapter 5 using focus groups and interviews. Question 4 is 
addressed in chapter 8 using cognitive interviews. A description of these methods follows here. 
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4.8.1 Focus groups 
 
 Focus groups were chosen as the most suitable method to investigate the concepts that 
people on dialysis and renal staff associate with self-management. Groups proceeded in accordance 
with a semi-structured format designed to elicit participants’ views on what ‘self-management’ is, 
who it is for, how it can be achieved, and the facilitators and barriers to achieving it. This rich level of 
data, seeking a view of self-management driven by participants rather than pre-constructed ideas of 
the researchers, would not be possible using quantitative methods. Focus groups were chosen over 
individual interviews, as they are useful for reaching a consensus between participants (Hughes & 
DuMont, 1993). They come with their own set of drawbacks, such as the views of quieter 
participants not emerging next to more vocal participants, and consensus emerging due to perceived 
social pressure rather than genuine agreement (Kitzinger, 1995). These are important considerations 
that will be dealt with in the analysis in chapter 5. 
 Participants were recruited using purposive sampling (MacDougall & Fudge, 2001). Selection 
of staff participants was based on aiming for a range of roles and seniority, for example including 
doctors, nurses, and clinical support workers. Selection of patient participants was based on aiming 
for a range of number of years on dialysis (vintage), age, sex, and ethnicity. 
 All focus groups were conducted by two facilitators, including the author and one of two 
experienced qualitative researchers. All focus groups were conducted in a suitable on-site setting, 
such as a quiet meeting room. Audio recordings were made with all participants’ informed consent, 
and sent to an external service for transcription. The author checked all transcriptions against the 
original audio for accuracy, especially regarding esoteric terms that may have been incorrectly 
transcribed (medication names, for example). 
 The analysis of focus groups was conducted by four members of the research team, made up 
of two senior qualitative health researchers, the author, and a nurse researcher. A thematic 
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approach was employed (Fereday & Muir-Cochrane, 2008). Transcripts were entered into NVivo 
software (QSR International, 2006). A combination of a priori and emerging themes were used. 
Codes were generated independently by each of the four researchers using the first transcript. The 
team then met to discuss these independent codes and reach a consensus and develop a codebook. 
The team then independently coded the remaining transcripts, and met once again to reach a final 
consensus for each transcript. Codes were then organised into coherent themes. These results were 
then fed back to participants (both staff and patients) for validation. This final step was largely 
informal, with the intention of flagging up any findings that were objected to or considered 
inaccurate. As there were no significant disagreements, the validation process was not carried on 
any further. 
 
4.8.2 Interviews 
 
 At 18 months follow-up, interviews with patients were employed to try to obtain a richer, 
qualitative picture to give context to the quantitative data that was being collected. Interviews were 
chosen over focus groups as there was an evaluative element to some of the questions. This made it 
important to try and gather individual experiences of the implementation of the self-management 
facilitator.  
 Interviews were conducted by either the author or another member of the SELFMADE team. 
As with focus groups, interviews were audio recorded, transcribed, and thematically analysed. 
Coding and analysis was conducted by the author. 
 
4.8.3 Cognitive interviews 
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Cognitive interviewing is a technique that generally uses a questionnaire, or proposed items 
from a questionnaire, as a template for an interview (Willis, 2005). This type of cognitive interview is 
distinct from the term ‘cognitive interview’ used in forensic psychology to describe interviews with 
eyewitnesses, which are designed to minimise responder bias via the use of mnemonic procedures 
(Geiselman, 1984). 
In cognitive interviews used to enhance questionnaire design, the interviewer may ask the 
respondent to either think-aloud as they complete the questions, or have the respondent fill in the 
questionnaire first, then ask a series of probe questions after. The aim is to obtain an understanding 
of the cognitive processes involved in arriving at an answer, rather than a simple score on a scale 
without context. Examples of previous use include developing the US National Cancer Institute’s 
Patient Reported Outcomes Common Terminology Criteria for Adverse events (Hay et al., 2013) and 
the PROMIS Pediatric Peer Relationships Scale (DeWalt et al., 2013). 
It has been observed in previous research that the process of conducting and reporting 
cognitive interviews is highly heterogenous, difficult to replicate, and raises questions about the 
validity of their findings (Beatty & Willis 2007). In order to address these concerns, the interviews 
were conducted with the Cognitive Interviewing Research Framework (CIRF) proposed by Boeije & 
Willis (2013) in mind. This framework was developed by adapting four existing qualitative reporting 
frameworks (e.g. the British Medical Journal Qualitative research checklist) and confirming adequate 
coverage using eight further frameworks (e.g. Consolidated criteria for reporting qualitative 
research, COREQ). 
In order to construct meaningful categories from the transcripts, coding followed an item-
by-item approach to flag up the issues encountered per participant per question. A thematic 
approach was then taken, with participants responses to each question placed into coded 
categories. Categories were generated using a priori and emerging themes. A priori themes were 
generated from the existing literature on cognitive interviewing, as a number of common cognitive 
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issues in questionnaire response are well documented (Knafl et al., 2007). Coding of themes 
wasundertaken by the author. 
 
4.8.4 Inter-rater reliability 
 
 Coding of focus groups and interviews in chapter 5 involved the use of multiple researchers, 
each coding and organising those codes into themes before analysis by the author. After each coding 
a single transcript, coders came together and compared transcripts, resolving any disagreements by 
discussion for coding subsequent transcripts. After all transcripts had been coded, researchers came 
back together to compare and discuss specific codes for each transcript, and their organisation into 
themes, before interpretation and write-up by the author. 
 Cognitive interviews were conducted, coded, and analysed by the author alone. 
Triangulation between researchers to achieve inter-rater reliability tends to result in consistency of 
how themes are ‘packaged’, not in a change to their contents. An example of this was provided in 
the analysis of reports for independents coders of a series of focus groups on genetic screening for 
cystic fibrosis  (Armstrong, Gosling, Weinman, & Marteau, 1997). As the ‘packaging’ of primary 
themes was already rooted in standard cognitive interviewing procedure, secondary coders were not 
used. 
 
4.8.5 Questionnaire development 
 
 Research question 4 relates to improving an existing questionnaire, referred to in this 
dissertation as the Behaviours on Haemodialysis Scale or BHDS, which is described below in 4.9.3. 
Tools used for measuring behavioural elements of self-management in people with ESRD often 
either measure internal states (such as self-efficacy or patient activation), or focus only on medically 
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related behaviours. It was considered desirable to develop a scale that measures what people do, 
beyond adherence.  
 
4.9 Quantitative methods 
 
 Quantitative methods were used to address two research questions: 
2. Are self-efficacy, activation, mood, and illness perceptions related to self-management 
behaviours? 
3. Does self-management behaviour predict clinical markers of adherence? 
 
4.9.1 Self-report and clinical data 
 
 In order to investigate the relationships between self-management behaviour, psychological 
states, and clinical elements of self-management such as adherence, data were collected at three 
time points over the course of 18 months. Previous work on self-management in ESRD has mostly 
looked at cross-sectional data, with a dearth of work looking at the predictive value of self-reported 
self-management behaviour and associated psychological variables over time (Novak et al., 2013). 
Research question 2 is concerned with examining how psychological factors predict self-
management behaviour, and question 3 with how self-management behaviours may predict clinical 
status and survival over time. 
 Questionnaire data were obtained by the researchers on-site at the relevant dialysis units in 
E&N Hertfordshire NHS Trust. Potential participants were approached while dialysing, and given a 5 
minute explanation of the study along with a Participant Information Sheet (PIS).  Potential 
participants were given time to read the PIS, and were then asked if they would like to take part. 
Those agreeing were given a consent form and pack of questionnaires, which took most participants 
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approximately 20 minutes to complete, after which packs were collected by the researcher. Data 
collection was conducted by the author and members of the SELFMADE team.  
 Questionnaires were disseminated at 0 months, 9 months, and 18 months. Routinely 
collected clinical data were also obtained for each participant at the same time point. The initial 
sample consisted of 104 participants. 
 A breakdown of the questionnaires and clinical measures used follows. 
 
4.9.2 Questionnaires used (see appendices A to E) 
 
A wide range of self-reported cognitions and behaviours were considered relevant to the 
work conducted here. Additionally, much of this work is exploratory in nature. For these reasons, 
brief versions of questionnaires were generally used to minimise burden on participants, but only 
when the brief versions were considered to have adequately comparable psychometric properties to 
the original versions. 
Self-management behaviours were measured, as question 2 relates to predicting self-
management behaviours, and question 3 relates to using self-management behaviours to predict 
clinical outcomes. Self-efficacy and patient activation were measured as they are theorized to be key 
predictors of self-management behaviour in both Social Cognitive Theory and emerging Patient 
Activation theory, and overlap while measuring slightly different concepts. 
Depression and Anxiety were measured as proxies of emotional wellbeing, as part of the 
‘emotional’ domain of the self-management triangle. Perceived Social Support was measured to 
represent the ‘social’ domain of the self-management triangle. Illness perceptions were measured as 
cognitions relating to illness may have an important interacting role to play with self-efficacy, patient 
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activation, and self-management behaviour. For example, the control/cure subscale in illness 
perceptions provides a measure of outcome expectancies in Social Cognitive Theory. 
Quality of Life was measured as a secondary outcome. Symptoms were measured as they 
may be an important covariate when considering relationships between other variables listed above. 
Licenses for use were obtained where appropriate. Copies of each public domain 
questionnaire can be found in the appendices. 
 
4.9.3 Behaviours on Haemodialysis Scale (BHDS) 
 
 As stated in the introductory chapters, self-management is theorised to comprise of three 
factors; emotional, social, and medical. Descriptions of the tools used to measure social support and 
emotional wellbeing are described below. The medical aspect of self-management is often measured 
through self-reported adherence, or various clinical proxy measures such as serum phosphate 
(Cukor, Rosenthal, Jindal, Brown, & Kimmel, 2009; Karamanidou, Clatworthy, Weinman, & Horne, 
2008). However, medical self-management can be conceptualised as a broader set of behavioural 
tools that go beyond adherence. For example, these behaviours can include decision making, 
information seeking and appropriate resource use. 
 In order to measure these behaviours, a self-report scale developed by Roberta Curtin and 
colleagues was employed (Curtin et al., 2004). A copy of the scale can be found in appendix A. This 
scale was developed with a population of people on in-centre haemodialysis for ESRD. Made up of 
eight subscales, it purports to measure the frequency of various medical self-management domains. 
Items are rated on a Likert scale from “Never” to “All the time”. 
 There is no abbreviated or distinct name for the scale provided in the paper describing its 
development, or in papers that have referenced it since. For ease of identification and to avoid 
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confusion with other scales, it will be referred to throughout this dissertation as the Behaviours on 
Haemodialysis Scale (BHDS). It is important to note that this is for internal ease of reference, and is 
not a name provided by the original authors of the scale. 
 The scale initially consisted of 60 items split across 10 domains, with 6 items being 
eliminated by the original authors after debriefing interviews with a convenience sample of patients 
(n =25). Exploratory Factor Analysis (EFA) was used by the authors on data obtained from a sample 
of 372 people on in-centre haemodialysis in the United States. Three restrictions were used in the 
analysis; the number of iterations for convergence was constrained, and only items with a factor 
loading of > 0.5 and an Eigen value of > 1 were included. Questions were further reduced to 37 items 
across 8 domains. 
The authors of the scale hypothesised that the construct measured by each subscale would 
fall into one of two ‘styles’ of self-management; co-operative/participatory, or defensive-
proactive/protective. The eight subscales and associated internal reliability for each are listed in 
table 4.1 below, by self-management style: 
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Table 4.1: Self-management questionnaire subscales 
 
Self-management 
style 
Subscale Internal reliability (α) Example question 
Co-operative Suggestions to 
providers 
0.80 Asked for a change in 
treatment based on 
information you 
learned on your own? 
 Self-care during 
haemodialysis 
0.77 Cleaned/prepared 
your access site for 
needle placement? 
 Information seeking 0.78 Looked for additional 
kidney diet 
information? 
 Use of alternative 
therapies 
0.81 Experimented with 
treatments other than 
other prescribed by 
your doctor? 
 Shared responsibility 
in care 
0.77 Adjusted your 
phosphate binder dose 
to the size of your 
meal? 
    
Defensive Selective symptom 
management 
0.79 Kept problems or 
symptoms to yourself 
so as not to bother 
staff or your doctor? 
 Assertive self-
advocacy 
0.65 Confronted staff in 
order to get better 
care? 
 Impression 
management 
0.72 Tried to get staff or 
your doctor to think 
well of you, in order to 
get better care? 
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Participants also completed the SF-12 quality of life scale. From this, one can yield the Physical 
Component Summary-12 score (PCS-12) and the Mental Component Summary-12 score (MCS-12). 
Curtin and colleagues hypothesised that defensive self-management subscales would be negatively 
correlated with mental wellbeing measured on the MCS-12. This was borne out by the results. All 
three defensive subscales were negatively correlated with the MCS-12; selective symptom 
management (r = -0.274, p < 0.001), assertive self-advocacy (r = - 0.166, p < 0.01), and impression 
management (r = -0.206, p < 0.001). None of the cooperative subscales were associated with MCS-
12 scores in either direction. All three defensive subscales were negatively correlated with the PCS-
12; more defensive self-management behaviour resulted in poorer self-rated physical quality of life. 
Self-care during haemodialysis and shared responsibility in care were significantly positively 
correlated with the PCS-12. These findings lend weight to the idea that these different ‘styles’ are 
valid constructs, and that cooperative styles may be adaptive, while defensive styles may be 
maladaptive. This concept is explored further in chapter 6. 
 
4.9.4 Patient activation 
 
 The transtheoretical model of health behaviour change (Prochaska & Velicer, 1997) is briefly 
introduced in chapter 2. Patient activation is essentially an operationalization of this model. The first 
Patient Activation Measure (PAM) developed by Hibbard and colleagues resulted in 22 items 
pertaining to four different dimensions relating to four stages of change (2004). The four dimensions 
are: 
 Believes active role is important 
 Confidence and knowledge to take action 
 Taking action 
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 Staying the course under stress 
Developed with robust sample sizes over three stages, the final 22 item PAM was tested in a 
separate national (USA) probability sample of people 45 years and older (N = 1,515). Infit reliability 
ranged from 0.71 to 1.44, while all but one outfit value ranged from 0.80 to 1.34. Construct validity 
was determined using comparisons with the SF 8, as according to patient activation theory, more 
activated patients should report significantly better health. This was indeed the case (r = 0.38, p 
<0.001). 
 Using the data from same final sample of 1,515 people both with and without chronic 
illness, a shortened 13 item scale was developed (Hibbard et al., 2005). The psychometric properties 
of the PAM-13 were found to be comparable to the original PAM, with a slight loss of precision 
among some subgroups of respondents: those without chronic illness, 85 or older, with poor self-
rated health, and those with low income. The 13 items are split across the same four dimensions as 
the original PAM. 
 
4.9.5 Anxiety and depression (appendices C and D) 
 
 There are a number of tools available for measuring anxiety and depression, the two most 
common pathological aspects of negative affect (Singleton, Bumpstead, O’Brien, Lee, & Meltzer, 
2003). Examples include the Hospital Anxiety and Depression Scale (HADS) and the Beck Depression 
Inventory (BDI). These questionnaires provide a continuous numerical value related to self-reported 
symptoms, with higher scores representing greater presence of the relevant aspect of negative 
affect. While a cut-off score can be applied to categorise people displaying clinically significant levels 
of depressive symptoms, they should not be confused with a clinical diagnosis of psychopathology 
(Chilcot et al., 2009). Two scales are based directly on the DSM-IV-TR (American Psychological 
Association, 1994) criteria for the respective psychopathologies to which they pertain.  
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The Patient Health Questionnaire (PHQ-9) is a nine item questionnaire used to assess 
depression (Kroenke et al., 2001). Each DSM criterion for depression is rated as being present from 0 
(not at all) to 3 (nearly every day). A copy of the questionnaire can be found in appendix C. The tool 
was developed by being tested in 6000 primary care and obstetrics-genecology clinics, assessed for 
construct validity using the Short-Form General Health Survey, and criterion validity was established 
by comparing the tool with assessments made by an independent structured mental health 
professional interview with 580 patients. 
 Due to being short and directly based on the clinical criteria for Major Depressive Disorder, 
the PHQ-9 is used in clinical practice as well as research. For example, the Veterans Health 
Association in the USA uses the PHQ-2 as an initial screening tool, and the PHQ-9 if an individual 
screens positive for depression (Smarr & Keefer, 2011). In the UK, the PHQ-9 is endorsed by the 
National Institute for Health and Clinical Excellence (NICE) for routine use in primary care, and 
secondary care mental health services, to measure changes in depression status from baseline to 
post-treatment. The fact that it is a clinical tool, as well as a research tool, means that understanding 
how scores relate to other variables such as self-management behaviour could be more directly 
applied to clinical practice. 
 The factor structure of the PHQ-9 has been investigated specifically in palliative populations. 
Chilcot and colleagues applied Confirmatory Factor analysis to data obtained from 300 participants 
receiving palliative care for a range of conditions (Chilcot et al., 2013). A two-factor structure 
emerged, comprising a cognitive-affective factor, and a somatic factor. 
 The GAD-7 was derived from the DSM criteria for Generalized Anxiety Disorder (Spitzer & 
Kroenke, 2006). It consists of seven main items, asking how often an individual has been bothered by 
each symptom over the last two weeks (e.g. “Feeling nervous, anxious or on edge”). As with the 
PHQ-9, responses range from 0 (not at all) to 3 (nearly every day). A final question asks that if any 
problems are checked, then “how difficult have these problems made it for you to do your work, 
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take care of things at home, or get along with other people?” Four options range from, “Not difficult 
at all” to “Extremely difficult”.  A copy can be found in appendix D. 
 The GAD-7 was initially tested on a sample of 2739 primary care patients in the USA. The 
first phase (n = 2149) was used in item selection and selecting cut-off scores. The second phase (n = 
591) was undertaken to determine test-retest reliability. A telephone interview was conducted with 
965 of the first phase participants to validate the selected cut-off scores for GAD (ICC = 0.83). A cut-
point of 10 or greater showed both a sensitivity and specificity of greater than 0.80, but produced an 
inflated estimate of individuals with GAD in primary care of 23%. A cut-point of 15 produced a 
prevalence of 9%, more in line with epidemiological estimates, but sensitivity was low (48%). The 
authors recommend 10 as a screening cut-point, but that scores of 5, 10, and 15 may be taken as 
rough indicators of mild, moderate and severe levels of anxiety. Internal reliability for the scale was 
good (Cronbach α = 0.92), as was test-retest reliability (ICC = 0.83). Increases in GAD-7 scores from 
mild, to moderate, to severe, were found to be associated with a stepwise decline in SF-20 scores, in 
all 6 domains of functioning (mental, social, role, general, pain, and physical). 
 The PHQ-9 and GAD-7 are used in chapters 6 and 7.  
 
4.9.6 Illness perceptions 
 
 Illness perceptions and their relationship to Leventhal’s Common Sense Model of Illness 
Representations (CSM) are described in chapter 2. 
These illness representations are operationalised in the various forms of the Illness 
Perception Questionnaire (IPQ). The original IPQ did not include a cyclical/continuous dimension, 
nor did it differentiate between treatment and personal control (Weinman et al., 1996). These 
additions were included in the revised illness perception questionnaire (IPQ-R, Moss-Morris et al., 
2002). Finally, due to the expansive nature of these questionnaires (the IPQ-R contains 38 main 
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items, plus a checklist of symptoms, possible causes, and open ended questions on causes, resulting 
in over 70 items), a brief version was devised (Broadbent et al., 2006). The brief version contains 8 
likert style items, plus a question asking the respondent to rank the three most important causes of 
their illness. 
 The B-IPQ was used in the present work due to practical considerations about participant 
burden. It has been found to be highly comparable to the IPQ-R. It has been used to investigate the 
effects of illness perceptions on physical functioning and medication adherence in multi-morbid 
adults (Schüz, Wolff, Warner, Ziegelmann, & Wurm, 2014). 
 
4.9.7 Self-efficacy (appendix B) 
 
 Self-efficacy, and Social Cognitive Theory (from which self-efficacy derives), are discussed in 
chapter 2 (Bandura, 1977). Broadly speaking, self-efficacy is divided into specific and general 
elements. Specific self-efficacy relates to specific contexts and actions (Życińska, Kuciej, & Syska-
Sumińska, 2012). General self-efficacy is a person’s broader confidence across a whole domain of 
behaviours. Due to the broad range of self-management behaviours of interest in the work 
conducted here, general self-efficacy was measured. The brief version of the Stanford Self-Efficacy 
for Managing in Chronic Disease scale was used (Lorig et al., 1996). This scale has been translated 
into a number of languages, and validated in multiple studies (Ritter & Lorig, 2014). The brief scale 
involves six questions asking an individual to rate their confidence in managing their illness and 
related emotions and activities, from 1 (not at all confident) to 10 (totally confident). Scores for each 
question are then summed and divided by the total number of questions answered. In a study of 605 
people with various chronic diseases, the scale displayed a range of values from 1 to 10, with a mean 
of 5.17, a standard deviation of 2.22, and an internal reliability of 0.91 (Lorig, Sobel, Ritter, Laurent, 
& Hobbs, 2001). 
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4.9.8 Health related quality of life 
 
 Two of the most common scales used to measure health related quality of life (HRQoL) are 
the EQ5D, and the SF-36 and its variants (Mukuria & Brazier, 2013). 
 The EQ5D has five dimensions; mobility, self-care, usual activities, pain, anxiety and 
depression, and a global ‘health thermometer’, which asks respondents to rate their health on a 
Visual Analogue Scale (VAS) from 0 to 100 (Rabin & de Charro, 2001). It was developed by 
multidisciplinary group of researchers from seven centres across five countries, and has been 
validated in a random sample of over 3000 adults in the UK (Dolan, Gudex, Kind, & Williams, 1996). 
 Another commonly used health-related quality of life scale is the  SF-36. The SF36 is, in itself, 
a shortened version of a battery of 149 health status questions (Garratt, Ruta, Abdalla, Buckingham, 
& Russell, 1993). A shorter version still is available in the form of the SF-6D (Mukuria & Brazier, 
2013). This version is most closely comparable with the EQ5D. While the two appear similar, there 
are some differences in their distributions, sensitivity to change, and ceiling effects. They also do not 
closely agree. However, there is no clear indication that one scale is, “right”, or which is clinically 
superior. The EQ5D is more commonly used, and allows for more direct comparison with other 
studies (Stel & Buskens, 2006). 
 There are several different versions of the EQ5D; studies described here use the EQ5D-5L, a 
version that uses a 5 point Likert scale in which items are rated from, “I have no problems…” to “I am 
unable to…”. 
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4.9.9 Social support 
 
 Social support was measured using the Duke-UNC functional social support scale (Broadhead 
et al., 1988). The scale is a brief eight-item inventory composed of two factors; confidant support, 
and affective support. The final items of this scale were derived by testing 14 initial items with 401 
ambulatory participants from the Family Medical Center in Durham, North Carolina. As a self-report 
scale, it measures perceived social support, and not necessarily the actual availability of social 
support. 
 The “confidant support” includes questions about opportunities to talk about problems, 
availability of advice, and invitations to go out and do things with other people. Affective support is 
composed of questions about whether a person feels people care what happens to them, whether 
they experience love and affection, and whether help is available when they are sick in bed. 
 
4.9.10 Data collection - questionnaire administration 
 
 Questionnaires were administered to participants while they dialysed in-centre. Potential 
participants meeting the inclusion criteria were identified using hospital records, and potential 
participants were approached by the author or another researcher while they dialysed. The purpose 
of the study was explained, and a Participant Information Sheet was handed out. An opportunity to 
ask questions was provided. Those agreeing to participate were given a consent form and pack of 
questionnaires. The researcher would then leave the participants as much time as they needed, 
before collecting the questionnaire, usually before the end of their dialysis session. All questionnaire 
data were stored in a locked research office at the research site. Data were transferred to an Excel 
database on a secure on-site computer in the research office. Data were pseudoanonymised using 
participant IDs whenever it was transferred off-site for analysis. 
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4.9.11 Data collection - clinical variables 
 
 A range of clinical parameters were recorded. The two main variables were Interdialytic 
Weight Gain (IDWG) and phosphate. These were used as clinical markers of adherence, as both 
change in response to patient fluid and food intake. 
Clinical parameters included Interdialytic Weight Gain (IDWG), serum phosphate, Residual 
Kidney Function (KRU), and serum albumin. Time since initiation of dialysis (in days) and date of 
either death or censoring for other reasons (receipt of a transplant, moving away from the area) 
were also recorded. By examining clinical variables, an estimation of levels of patient adherence 
could be made (Kimmel et al., 2000).  
 All clinical parameters were taken from routinely collected information held on the Trust 
clinical database, RenalPlus. IDWG is the difference between an individual’s weight in KG as 
measured at the end of one dialysis session, and again at the start of the next. IDWG was recorded 
as both a latest score, and as a three month average. Serum albumin was measured as g/dL. KRU 
was recorded as ml/min primarily to be used as a controlling variable, as IDWG’s value as an 
indicator of adherence is heavily dependent on KRU (Kimmel et al., 2000). In short, the greater the 
remaining amount of kidney function an individual has (indicated by KRU), the more fluid a person 
will be able to excrete as urine. This has implications for the advised fluid intake for each individual, 
and closely their IDWG matches their actual fluid intake (Vilar, Wellsted, Chandna, Greenwood, & 
Farrington, 2009). 
 
4.10 Statistical analyses 
 
All statistical analyses were conducted in Intercooled STATA 11.2, unless otherwise noted 
(StataCorp, 2009). 
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 In chapter 6, statistical procedures were primarily cross-sectional in nature, to test for 
associations at baseline. Correlation matrices were used to investigate associations. Unless 
otherwise noted, significance in these matrices was calculated using Bonferroni correction for 
multiple comparisons. Multiple regression models were constructed based on both theoretically 
important variables, and relationships observed in correlational data, rather than via automatic 
selection process such as forward or backward stepwise regression (Harrell & Harrell, 2006). 
Variables known to be important confounds were included as controls in baseline models.  
Chapter 7 aimed to assess whether self-management behaviour and associated psychological factors 
predict clinical status, and primarily utilised longitudinal analyses. Where clinical outcomes were 
binary, logistic regression was used, with baseline psychological and behavioural measures used as 
predictors. Cox Hazard regression was used to analyse the relationship between baseline 
psychological and clinical parameters and survival. 
 
4.10.1 Hierarchical linear regression 
 
 The hierarchical regression methods used here involve entering predictors into a regression 
model in an order dictated by theory (Tabachnick & Fidell, 2006). In other words, rather than using 
automatic selection based on which variable adds the greatest predictive power (forward stepwise) 
or reduces R2 by the greatest amount (backwards stepwise), predictors were specifically entered to 
test their contribution based on their theoretical importance. This can help reduce the problems 
with automatic selection processes overlooking important variables and identifying ‘noise’ variables 
as important (Derksen & Keselman, 1992; Huberty, 1989).  
Hierarchical regression was conducted using the hireg command in STATA 11.2, with 
covariates entered in the first block, and other predictors added one by one in subsequent steps, 
selected on the basis of theory. R2 change was noted at each step. 
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4.10.2 Mediation and bootstrapping 
 
 Mediation analysis is used in chapter 6. The method used is that described by Preacher and 
Hayes (2004), which involves significance testing the indirect effect between a predictor and 
outcome, a step absent from some methods of mediation (Baron & Kenny, 1986). 
 Simple mediation analysis allows the testing of the hypothesis that the relationship between 
two variables, X and Y, is mediated by a third variable, M. There are three basic requirements for 
establishing mediation. First, X should be significantly related to Y (the direct effect, c). Second, X 
should significantly predict M (path a). Third, M should significantly predict Y after controlling for X 
(path b). The indirect effect of X on Y can be expressed as the product of a and b. The indirect effect 
of X on Y via M, c’, is therefore c’ = c – ab. The Sobel method advocated by Preacher and Hayes 
(2004, 2008) then involves computing the ratio of ab to its estimated standard error, and a p-value 
for this ratio is computed in reference to the standard normal distribution. 
One problem with this method of significance testing mediation effects is the assumption of 
normality. Additionally, the Sobel method alone tends to be inaccurate in all but large samples. 
Bootstrapping is a non-parametric method of resampling from an observed sample, allowing 
estimation that permits the use of tests that normally only work in larger samples, and does not 
depend upon an assumption of normality. As the indirect effect is estimated repeatedly over many 
resamples, confidence intervals can be estimated (Shrout & Bolger, 2002). 
 Sobel-Goodman mediation analysis was conducted in STATA 11.2 using the sgmediation 
command.  Confidence intervals were estimated using the bootstrap command in combination with 
sgmediation, using 1000 resamples. 
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4.10.3 Survival analysis 
 
 Survival analysis in chapter 7 was conducted using Kaplan-Meier survival curves and Cox 
hazard ratios. Kaplan-Meier curves allow a comparison of two survival functions split across two 
groups. Thus it only allows for simple between group comparisons. Cox hazard ratios function more 
like multiple regression, and allow the use of multiple predictors and controlling covariates. Cox 
hazard functions allow the estimation of how much more likely an event is (e.g. injury or death) for 
each point of change in various predictor variables. Survival analysis was employed in chapter 7. A 
combination of Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards modelling 
were used. 
Survival analysis is used to examine time to event data. In time to event data, the dependent 
variable is typically the number of days individuals remain in a study without experiencing the event 
of interest, for example death or the development of a certain disease. Due to such data rarely being 
normally distributed, and ‘censored’ data, specific statistical methods are required (Bewick, Cheek, & 
Ball, 2004). ‘Censored’ cases are where a follow-up time is known, but the event of interest has not 
yet occurred. For example, an individual is event free at the end of the study, or they drop out of the 
study early. In both cases the number of ‘event free days’ is known, and this period ended for 
reasons other than the occurrence of the event, i.e. the end of observation period or drop out. 
Kaplan-Meier survival curves can be used to graphically illustrate the probability of being 
alive at time t (Kaplan & Meier, 1958). Stratification by group membership allows a visual 
comparison of the occurrence of events. The differences between these groups can be tested for 
statistically significant difference using a log-rank test. Log-rank tests involve calculating the 
expected events for the groups, then summing the ratio of the observed minus expected events to 
expected events for each group. The log rank value can then be compared against critical chi2 values 
to assess statistical significance. Kaplan-Meier and log-rank tests are useful for simple group 
comparisons, but cannot take into account multiple, or continuous, explanatory variables. 
105 
 
To examine multiple continuous variables, Cox proportional hazard ratios were used (Cox & 
Oakes, 1984). Cox models are essentially multiple regression, where the dependent variable is the 
‘hazard’, or probability of experiencing the event of interest given that patients have survived up to 
that point (Bewick et al., 2004). The model makes no assumptions about distribution, but does 
assume that the risk of an event in one group relative to the other does not change over time. In 
chapter 7, Cox proportional hazard models are used to estimate the hazard (risk of death), based on 
a number of continuous predictors. 
 
4.10.4 Multilevel modelling (MLM) 
 
Multilevel modelling is a form of regression analysis that takes into account the fact that, in 
the real world, variables are often related to each other based on some kind of grouping or 
‘clustering’. For example, a study looking at pupil performance on an exam in a school, we might 
expect performance of children in the same class to be more closely correlated with each other than 
with the performance of the whole school. This is called intraclass correlation (ICC). Ignoring this 
data structure can result in misattributions regarding the sources of observed variance. 
 Multilevel models (MLMs) address this by allowing for multiple ‘levels’ of data, where level 1 
observations (e.g. exam score) are nested within level 2 variables (e.g. class), and further levels are 
possible (e.g. we could have multiple schools). This also allows for longitudinal analysis, as the 
individual can be treated as the level 2 variable, with different observations over time the level 1 
variable. As observations are nested within the individual, this overcomes the problem of correlated 
residuals for repeated measures. This ability to handle longitudinal data is the primary function of 
multilevel models used in chapter 7, although 3 level models where patients are also nested within 
study sites are also employed. 
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 MLMs have a number of advantages over other methods such as ANOVA, including the 
ability to handle different periods of time between observations for different participants, and the 
ability to handle missing data without listwise deletion of all cases where any data is missing (and 
the resulting loss of power this causes). For a more comprehensive discussion of the advantages of 
multilevel models for longitudinal data, see Kwok et al. (2008). 
 A key concept in multilevel modelling is that of fixed and random effects. A fixed effect is a 
parameter that is consistent across the entire sample, while a random parameter is one that is free 
to vary across groups defined by the level 2 variables. This applies to both the intercept and 
regression coefficients for each level 1 variable. In practice, when the intercept is fixed, we assume 
the mean score in the outcome variable does not vary across groups defined by the level 2 variable. 
When the intercept is random we can examine the variance of the group intercepts around the 
grand mean to see whether this is in fact the case. When the coefficient for a predictor variable is 
fixed we assume that the size and direction of the relationship between the predictor variable and 
the outcome variable is the same across level 2 groups. When this coefficient is random, one can 
look at the variance of the coefficients around the coefficient for all groups, for each level 2 group, 
to see if they significantly differ. For more detail on fixed and random effects see Hayes (2006). 
 Centring is an important concept for interpretation of certain parameters in MLMs. Centring 
involves modifying a variable so that, while relationships between variables remain the same 
(coefficients remain unchanged), the intercept will be more readily interpretable. Grand mean 
centring was used for most predictor variables, meaning that the intercept in the MLM can be 
interpreted as the mean value of the outcome variable when all predictor variables are at their 
respective means. This is intuitively more useful for interpretation than the intercept for 
untransformed variables, which would represent the mean outcome value when all predictors are 0. 
Grand mean centring simply means subtracting the mean for a given variable from each individual 
observation for that variable. 
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 The main exception to grand mean centring is time. As time was measured in months from 
baseline, measuring from 0 makes intuitive sense. However, time should be centred based on the 
focus of the analysis (Biesanz, Deeb-Sossa, Papadakis, Bollen, & Curran, 2004). As such, time was re-
centred for baseline, mid-point, and follow-up results in certain analyses. In combination with grand 
mean centring of other predictor variables, this means that the intercept in an MLM represents the 
mean of the outcome variable when the predictor variables are assumed to be at their respective 
means, apart from time, which is assumed to be at whatever value for time it was centred around.  
The specific centring for specific models will be discussed in chapter 7. 
 As MLMs were used primarily for their ability to handle longitudinal data in chapter 7, 
participants were typically the level 2 variable, with observations for variables such as self-
management behaviour score and 3 month average IDWG treated as level 1 variables nested within 
the participant. Time was included as a covariate in months. The specifics of each model will be 
discussed in chapter 7. 
 
4.10.5 Multiple imputation 
 
 Multiple imputation (MI) involves generating values where data are otherwise missing for 
individual responses (imputing), estimated based on observed data. This process is conducted over a 
pre-specified number of iterations (hence ‘multiple imputation’), and these imputed sets of data can 
then be used in parameter estimation in statistical analysis (Meng & Rubin, 1992). 
 MI is useful for handling missing data, when missing values would otherwise result in a loss 
of power. It should not be used as a method of ‘guessing’ missing values, but retaining as much of 
the observed data as possible. For example, many statistical packages will omit cases in a listwise 
fashion in multivariate models where a single observation for a single variable is missing. This would 
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result in a loss of statistical power, as a large quantity of observed data would not be included in the 
analysis. 
 MI is only a valid tool when data are either Missing At Random (MAR) or Missing Completely 
At Random (MCAR) (Little, 1988). If data is MCAR, then there is no pattern to the ‘missingness’ of 
observations. That is, whether a given observation for a given variable is missing or not cannot be 
modelled based on the observed data. In this case, MI is useful for retention of observations and 
power. If data are MAR, then missingness can be modelled based on observed data; there is a 
pattern. In this case, MI can be used to take this into account. Finally, if data is Missing Not At 
Random (MNAR), then MI cannot be used. Data is MNAR if there is a real-world pattern to whether 
an observation is missing or not, but the variable(s) predicting missingness were not observed. 
 In chapter 7, MI was used to retain power in longitudinal MLM. Details are given in the 
chapter of how data were tested for MAR v MCAR. 
 
4.11 Summary 
 
This chapter summarised the general methodologies applied throughout this thesis. The 
next chapter sets out the results of qualitative work employing focus groups and interviews to 
explore how staff and patients conceptualise self-management. 
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5.1 Introduction 
 
There is an extensive academic literature on self-management, that has been emerging over 
the past two decades, and dates back even further (Gibson, Britten, & Lynch, 2012). This literature is 
discussed in chapter 2. Furthermore, a number of practical initiatives have been launched by various 
healthcare organisations to promote better self-management. Despite this, there is often 
disagreement about what exactly ‘self-management’ entails, and how to promote it. 
 The medical challenges of ESRD are well documented, and general self-management tasks 
are considered to be well established in other conditions such as Heart Failure (HF) or diabetes 
(Glasgow et al., 2002). However, to date there has been little work exploring what people on dialysis 
for ESRD consider ‘self-management’, and what helps and hinders in an in-centre setting (Hutchison 
& Courthold, 2011).  
Even rarer is examination of the beliefs renal staff hold about what patient self-management 
entails, and the role that they as healthcare professionals may play in enabling or hindering such 
behaviour. It is unclear whether staff and patients have congruent or incongruent ideas about what 
patient self-management entails. 
 
5.1.1 Aims 
 
The purpose of the work described here is to explore what patients and staff perceive ‘self-
management’ to entail. The aim is also to establish facilitators and barriers to achieving these goals 
according to patients and staff. Comparing staff and patient views will also allow for the 
identification of any potential mismatch that could have implications for care.  
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Primary aims: 
 Explore staff and patient perceptions of what effective self-management entails 
 Establish facilitators and barriers to self-management in order to identify both systemic 
barriers, and those which could be overcome by individual behaviour or support 
 Establish what motivates patients to engage in different types of self-management 
behaviour 
Secondary aim: 
 Compare staff and patient perceptions of facilitators and barriers to self-management 
 
5.1.2 Self-management concepts among patients and staff 
 
While there is an increasingly well developed academic literature on self-management, it is 
not always clear whether this concept transfers to those, ‘on the ground’. This means people with 
long term conditions, their carers and families, and also healthcare professionals (HCPs) involved in 
their care.  While a valid psychological or sociological phenomenon does not require understanding 
from the perspective of individuals in question to remain ‘true’, self-management is often presented 
as being about empowering patients, rather than achieving top-down goals set by institutions 
(Gibson et al., 2012). Understanding individuals’ beliefs about self-management is an important part 
of documenting the concept, and reasons for different styles of management. Furthermore, should 
staff hold conflicting views to the patients they care for regarding the individual’s role in managing 
their condition, this could have important implications for both cognitions and behaviours relating to 
self-management. 
There has been work outside of the renal context into which perceptions about self-
management in patients have been assessed (Novak et al., 2013), but less on the perceptions of 
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staff. Self-management can be thought of as engaging in the behaviours necessary to problem solve 
the barriers to ‘looking after oneself’. Whether patients and staff view the desired outcomes of this 
set of behaviours to be purely clinical (e.g. living as long as possible), or whether this includes a good 
quality of life and continued social functioning is an important question. 
It is possible that a reciprocal model, where social and psychological factors feed into 
medical management, medical and psychological factors feed into social management, and medical 
and social factors feed into psychological management would be relevant. Each side of the self-
management triangle may be both a process and an outcome. 
 
5.1.3 Beliefs about facilitators and barriers 
 
Some of the most telling work analysing patients’ views on self-management has been 
qualitative work around facilitators and barriers. Such studies typically employ semi-structured 
interviews or focus groups to uncover what patients believe stops them from self-managing, and 
what helps. This discussion often involves identifying the kinds of behaviour they are trying to 
engage in. In many ways, engaging in behaviours that overcome these barriers can be thought of as 
the activities that comprise successful, active, self-management behaviour. This includes 
psychosocial factors that patients believe are relevant to their ability or otherwise to self-manage. 
 Jerant et al. (2005) conducted 10 focus groups with 54 individuals, 85% of whom were living 
with multiple chronic conditions. They were interested in what patients viewed as the barriers to 
‘active’ self-management (see chapter 2), and barriers to self-management resources. They found 
that barriers to active self-management included: depression, problems controlling weight, difficulty 
exercising regularly, fatigue, poor communication with physicians, lack of support from family, pain, 
and financial problems. The study was conducted in the USA, and financial problems frequently 
related to health insurance. The questions posed to participants were open ended, such as, “What 
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kinds of self-care problems do you encounter in living with your illness?”. Depression and lack of 
social support were seen as barriers to “get[ing] on with life”. Furthermore, the authors go on to 
posit that participants fell into one of four categories based on their “Perceived Level of Control” 
(PLoC) over their condition, and their self-efficacy for managing it. Those who were high in both 
appeared to be faring the best, while those who were low in both appeared to be faring the worst. 
 There have been similar findings in heart failure (Riegel & Carlson, 2002). Perceived barriers 
once again included physical limitations, emotional distress, and lack of social support. These 
barriers can be thought of as barriers to both adherence and good medical self-care. In another 
qualitative study on self-care in people with multiple comorbid conditions, a free listing exercise was 
used in 16 interviews to enumerate barriers to self-care (Bayliss, Steiner, Fernald, Crane, & Main, 
2003). Once again, physical limitations, emotional impact of the disease, low self-efficacy, and 
unmet needs for social support were frequently raised as issues. In these studies, little information is 
given about how far emotional health and good social relationships are valued as self-care activities 
in themselves. It is clear, however, that individuals living with these chronic conditions in these 
studies believe that psychosocial factors play a large role in making medical self-management 
possible. 
 There has been comparatively little work on these perceptions in people on in-centre HD for 
ESRD (Curtin, Mapes, Petillo, & Oberley, 2002). 
 
5.2 Methods 
 
5.2.1 Overview 
 
To address the study aims, a combination of focus groups and interviews were employed. 
Focus groups were conducted in 2012 early in the SELFMADE project. Interviews were conducted 
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eighteen months later in 2013 after a period of activity of a ‘self-management facilitator’ as part of 
that project. 
Focus groups were employed as a way of investigating the aims in a manner that promoted 
discussion among participants. Focus groups do not necessarily provide a description of participants’ 
individual viewpoints, but instead allow insight into discussion and ideas (Lehoux, Poland, & 
Daudelin, 2006). However, patient and staff focus groups were held separately, as, “… participants 
who are seen as possessing experience tend to dominate discussions and are deferred to by other 
group members who see them as the experts” (Smithson, 2000). Additionally, this allowed for a 
comparison of themes emerging from staff and patient focus groups. A copy of the focus group 
schedules can be found in appendix G. 
Interviews were conducted 18 months after the focus groups. They provide a more 
confidential setting in which viewpoints that may be considered controversial can be aired, as well 
as allowing for the expression of individuals’ experiences (Kitzinger, 1995). Similar approaches 
regarding recruitment, procedure and analysis were followed for focus groups and interviews. As 
such, methods will be discussed together, with differences noted where relevant. In the intervening 
18 month period, a programme of ‘action research’ activity took place as part of the SELFMADE 
study (see chapter 4 for details). A copy of the interview schedules can be found in appendix H. 
 
5.2.2 Participants 
 
Focus groups: 
A purposive sampling technique was used to ensure a wide range of participants in the focus 
groups (Gobo, 2004). Factors taken into consideration when determining the range of patient 
participants included age, sex, number of years on haemodialysis (in other words, how ‘experienced’ 
they were as renal patients), and ethnicity. The primary consideration when sampling HCP 
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participants was ensuring that a range of roles and levels of seniority were represented. A total of 15 
participants took part in the patient focus groups (including a caregiver), and 15 participants took 
part in the HCP focus groups. Of the 15 patients, 5 participated at Site 1, all women, with a mean age 
of 51.6. Four patients participated from Site 2, 3 of who were women, with al mean age of 54.5. Six 
patients participated from Site 3, including 3 women, with a mean age of 65.7. Staff roles are 
detailed in Table 1. In addition, once coding was complete for the findings and derived themes, 
vicarious respondent validation (Creswell, 2012) was undertaken specifically through facilitated 
discussions with a further 8 patients and 30 staff, purposively sampled from people who could not 
attend focus groups. This ensured a full range of perspectives and confirmed the thematic coding. 
See table 5.1 for an overview of patient and staff participants. 
 
Table 5.1: Patient and staff focus group participants 
 
 
Interviews 
A total of 15 interviews were conducted with patients. Of these, 10 were male. All 
participants had been on dialysis for at least 3 months, with five having more than 5 years of 
experience on dialysis. Five participants were on haemodialysis following the failure of a renal 
transplant. 
Patients HCPs 
15 participants, 6 female 15 participants, 12 female 
Mean age = 60.5 y/o (range = 40–83)  
Mean time on dialysis = 5.7 years (range = 1.3-11.5) 2 CSWs, 7 nurses (bands 5-8), 2 doctors (1 SPR, 1 
consultant), 1 social worker, 1 pharmacist, 1 
housekeeper and 1 manager 
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A total of 10 interviews were conducted with staff involved in the care of people on in-
centre haemodialysis. Of these, 7 were male, and 6 had more than 5 years of experience working in 
their respective dialysis unit. Participants were comprised of four nurses (one staff nurse, one charge 
nurse, one senior sister, and one matron), four Clinical Support Workers (CSWs), one physician’s 
assistant, and one consultant nephrologist. 
 
5.2.3 Setting 
 
Focus groups and interviews were conducted in three dialysis units in East & North Hertfordshire 
NHS Trust. See chapter 4 for a more detailed discussion of each of the units. All focus groups and 
interviews were conducted in a quiet meeting room in the centre where participants dialysed or 
worked. 
5.2.4 Personnel 
 
The author facilitated focus groups and interviews, along with three other members of the 
SELFMADE team. In addition to the author, JR, interviews and coding were undertaken by PW, MO, 
and RB. The final analysis and interpretation were conducted and written up by the author and 
disseminated back to the rest of the team for confirmation. 
 
5.2.5 Procedure 
 
Upon arrival, participants were asked to confirm that they had read and understood 
participant information forms and to sign a consent form. All sessions were audio recorded. 
Recordings were sent to an external transcription service and later checked against the original 
recording by the author, who corrected minor errors in e.g. medical terminology. 
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5.2.6 Analysis 
 
Analysis was undertaken using a thematic approach (Fereday & Muir-Cochrane, 2008). 
Thematic analysis is a methodology with a great deal of flexibility (Braun & Clarke, 2006). However, 
this flexibility means that underlying assumptions need to be made explicit. Thematic analysis used 
here can be considered to be a combination of inductive and deductive, as both a priori themes, and 
themes emerging from the data were considered. A constructionist perspective is employed, as it is 
the social construction of the idea of self-management, and the coherence or tensions of the 
concept between staff and patients that is of interest, rather than any one essential meaning within 
the individual (Holloway & Todres, 2003). 
Focus groups: 
Transcripts were entered into NVivo software (QSR International, 2006). The entire 
qualitative research team participated in coding. A combination of a priori and emerging themes 
were employed. A priori themes were derived from the discussion schedule, primarily “Challenges 
[to self-management]” and “What helps?” Each team member generated codes independently, 
coding the first transcript and then meeting to reach a consensus. Remaining transcripts were then 
independently coded, along with a recording of the first, and the team met once again to check for 
consensus and reach consensus by discussion where discrepancies remained. Next, the team 
organized the codes into coherent themes, wrote them up, reported them to the study steering 
group, and then fed them back to patients and staff members for validation. 
Interviews: 
 Analysis was undertaken solely by the author. Thematic coding was undertaken for each 
transcript in sequence, coding using a priori themes and generating a list of emerging themes which 
were entered into a codebook. After reflecting on emerging codes generated for all transcripts, 
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codes were condensed into themes, and transcripts were coded a second time to ensure all 
transcripts were coded against a complete set of themes. 
Inter-rater reliability: 
 Inter-rater reliability was not considered to be necessary in these analyses, as it frequently 
does not add anything beyond the process of collaborative coding (Armstrong et al., 1997) (Pope, 
2000).  
 
5.3 Results 1: Focus groups 
 
Five core themes were identified. “Challenges” and “What helps?” were the facilitators and 
barriers, and were defined as themes a priori. “Good patient/bad patient”, “Complex balancing acts” 
and “Unit as family” were all themes which emerged during the discussion. See table 5.2 for 
summaries and examples. All five themes were present in both staff and patient focus groups, but 
with some differences in frequency of occurrence and emphasis. These will be addressed throughout 
these results and the discussion. 
 The generation of codes and themes was undertaken as a group by the qualitative 
SELFMADE team. A separate analysis focusing on the “Unit as family” findings have been published 
elsewhere, jointly written by Professor Patricia Wilson and the author of this dissertation (Wilson et 
al., 2014). However, for this reason, an in-depth analysis of the “Unit as family” findings will not be 
included here. 
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Table 5.2: Themes emerging from focus groups 
 
Theme Definition Example 
1. Good patient/bad 
patient 
Categorising patients as ‘good’ or ‘bad’ 
depending on their behaviour 
Patients with low IDWG being 
referred to as, ‘good patients’ 
2. Challenges Barriers to performing self-
management tasks 
Embarrassment about taking 
phosphate binders in public 
3. Complex balancing 
acts 
The task of balancing competing 
medical, social and emotional 
demands 
Choosing to have a drink at 
wedding to celebrate, knowing it 
may make the next dialysis 
session more demanding 
4. What helps? Things that make self-management 
tasks easier 
Support from family or friends 
5. Unit as family The perception that the dialysis unit is 
like a found family 
When a patient dies, they are 
missed like a member of the 
family 
 
 
5.3.1 Good patient/Bad patient 
 
Discussions with Health Care Professionals (HCPs) led to some clear outlines forming about 
what they perceived to be a ‘good’ patient, and what they perceived to be a ‘bad’ patient. 
“... some patients turn up beautifully, religiously, never miss a session. Like they’re anxious 
when their session shifts, it’s because they’re very, very fastidious and those ones would be 
perfect for encouraging self-care because they’re conscientious and involved...” (Female HCP, 
site 1) 
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Discussions around ‘good’ patients tend to include words like, “beautifully”, “religiously”, 
and “fastidious”. They are characterised by being timely in their dialysis and clinic attendance, taking 
their medications as prescribed, and adhering to fluid management goals – the practical elements of 
adherence for an HD patient. The use of ‘religiously’ to indicate ‘compliance’ came up at multiple 
sites: 
“they [young people with social problems] take to not being compliant and they’re our sort 
of failures that never get their head round why they’ve got to come three times a week 
religiously, they pop in when they feel like it and they’re the ones that will never be able to 
self-manage because they can’t manage the basics in life” (Female HCP, site 3) 
Conversely, ‘bad’ patients did not adhere to their prescribed regimen. Non-adherent 
behaviours were described as “naughty”, and “they don’t hear, no matter how many times we tell 
them” (female HCP, site 1). The dichotomy between HCP perceptions of good/bad patients possibly 
reveals two things:  
The first is that HCPs have an idea of what they would like active, engaged patients to be 
like. The second is that HCP expectations of patients’ reasons for non-adherence, and how to better 
encourage them, may need to be managed. This was at one point recognised: 
“But their agenda and their way of life can be quite different, can’t it, and we need staff to 
recognise where they’re coming from and not have, perhaps, expectations that we think we 
would do something in a certain way and we’d be compliant. Well, you know, if you’re in a 
completely different situation in your life, you’ve got kidney problems  maybe you’re not 
going to be like me, we’re quite different and we need to kind of educate ourselves around 
that and manage our own expectations, I think.” (female HCP, site 1) 
Patients sometimes defined themselves as good or bad, again in relation to fluid and 
medication adherence, rather than timekeeping or dialysis adherence: 
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“I’m dreadful taking tablets, I’m dreadful, I’ve got to take phosphate binders, my phosphate 
is very high and my potassium very high, I’m not an ideal patient to be honest...” (female 
patient, site 3) 
Both patients and staff frequently acknowledged that being good or bad did not exist in a 
vacuum, and that many factors contribute to the ability to manage their treatment, as well as 
challenges to living their life in a more general context. 
Some HCPs acknowledged that patients sometimes made decisions about stopping dialysis 
early to spend more time with their family: 
“And I think they think, well if I can shave off half an hour here, I’m going to get home half an 
hour I might just get in time to put them [their children] to bed…” (Female HCP, site 3) 
HCPs also acknowledged that some patients believed that changing their dialysis dose could 
compensate for fluid and dietary non-adherence. However, this was not generally positively 
regarded: 
“They think, I can manage taking three and a half litres off, I feel fine afterwards, my blood 
pressure’s fine but they’re not looking at the bigger picture, that in five or ten years’ time 
they’re actually not going to be able to” (Female HCP, site 3) 
 
5.3.2 Challenges 
 
Living with kidney disease presents a number of challenges, both in terms of self-managing 
treatment, and also managing one’s wider social, familial, and mental life. One theme that seems to 
permeate all of these domains is the desire for some kind of normality. Sometimes this can interfere 
both with adhering to treatment, and with a person’s everyday life: 
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“Well, we have in the past with business people, they don’t want to be, you know, if they’re 
doing their business lunch they don’t want to be taking phosphate right in front of their 
clients so they quite often have a compliance issue which they know when to take the tablets 
but it’s an image, you know, taking tablets in front of clients isn’t the thing to do and 
controlling their diet when they’re entertaining is quite difficult for them so I think from that 
point of view whatever job they’re doing it’s remembering to take their tablets with them.” 
(female HCP, site 1) 
The use of the term ‘compliance’ is often considered outdated in the academic literature in 
favour of ‘adherence’, as the former is considered unnecessarily authoritarian (Aronson, 2007). 
However, it appears to still be in common use among HCPs, and may reveal something about how 
they view the HCP/patient relationship. In addition to wanting to try and preserve some normality in 
the face of loss presented by kidney disease, patients and HCPs identified that inconsistency within 
the dialysis unit, and in the care team, could present an issue, for a number of practical reasons. For 
example, patients may find it harder to communicate about their issues if they feel they are 
constantly restating themselves. Patients may not feel that they are supported or that they are 
understood if they are constantly dealing with new staff who are unfamiliar with them as individuals. 
End Stage Renal Disease (ESRD) is often accompanied by serious comorbidities, including 
diabetes and hypertension. Patients and HCPs recognised that these present additional problems. 
Patients offered diet as a problem: 
“... the only thing is you see being a diabetic, and being on dialysis, the two don’t tally do 
they, they don’t... you could eat something on dialysis, but you couldn’t eat, you know, the 
two don’t come together you see...” (female patient, site 3) 
HCPs across two sites raised the issue of time being precious to patients: 
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“I can understand, if you’re on dialysis three times a week, you don’t want to spend the other 
two days going to a podiatrist [for diabetic patients] and to get your eye test done and go to 
breast cancer screening, why would you want to, because it’s taking a day out of your 
precious days off...” (female HCP, site 1) 
Patients also recognised that time was precious for staff, and that there were practical 
limitations to the resources that could be provided in the unit for their care, although lack of access 
to a dietician and to consultants in the satellite units were issues raised on multiple occasions. 
Both patients and HCPs recognised that the initiation of dialysis was often overwhelming. 
Currently, planned dialysis patients in Hertfordshire receive education about treatment prior to 
dialysis initiation, but little continued formal education after that. It was often felt that patients feel 
overwhelmed and forget much of what they have learned.  
The challenges described above were noted by both patients and HCPs. Some challenges 
were raised by HCPs but not patients, and vice versa. Patients expressed some reservations about 
who is responsible for making decisions about their care – themselves, HCPs (and if so, who), or ‘the 
machine’. ‘The machine’ in a wider context came up as a source of fear and mistrust for patients at 
all three sites: 
“They’re trying to sort out my blood pressure because I looked on my computer and thought 
I’ll try and sort it out. And the reading I got the other day was forty-eight over [inaudible], on 
the computer it said “you’re dead”, which does, that scares me. ” (male patient, site 2) 
 
Other patients expressed an interest in knowing more about the dialysis machines, and what 
the buttons and lights did and meant. Some patients asked their care team questions and were 
satisfied, others were too intimidated to ask or felt that the HCPs were too rushed (their time was too 
precious) to bother them. Peer learning from more experienced patients, described below in “What 
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helps?”, was ventured as a possible solution. However, staff at one site (site 3), did express the idea 
that peer learning (at least informal peer learning) could be problematic and lead to the spread of 
misinformation. 
 
5.3.3 Complex balancing acts and trade offs 
 
Living with chronic diseases, and indeed as a member of the healthy population, involves 
making daily decisions about trade-offs regarding one’s health. For example, drinking alcohol may be 
pleasurable, but too much too often will result in liver failure. Similarly, not everyone enjoys 
exercising, but engaging in regular cardiovascular exercise will lower the risk of coronary heart disease 
and a host of other health problems. Striking a balance between health and day to day happiness 
could be said to be a self-management task that everyone must undertake. 
 
HCPs exhibited various positions on the subject of why HD patients might not adhere to 
prescribed treatment. HCPs also almost universally used the term ‘comply’ and ‘compliance’ – terms 
often regarded as outdated in the self-management literature as indicating an inappropriately 
authoritative relationship between HCPs and patients (Aronson, 2007). Some explanations of 
intentional non-adherence are given above (e.g. patients in their professional work role not taking 
their phosphate binders to appear ‘normal’ in front of clients).  Some staff believed a lack of 
understanding to be the cause: 
 
“And even the older ones, they don’t hear, no matter how many times we tell them, that they 
have to count all their fluids, sometimes they don’t really understand.” (female HCP, site 1) 
 
While this is likely the case for some patients, for many the decision to not adhere was an 
intentional one, and often not taken lightly. 
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“I always ask anyway, now, uh, now that I’ve come to terms with it I always ask to see what 
my blood’s doing, and over six years I know what I can eat and what I can’t eat. And, you know, 
we call it cheating, say if I have a packet of crisps today I won’t have nothing else, and then I’ll 
have a bit of chocolate tomorrow, I won’t have nothing else what I shouldn’t have” (male 
patient, site 2) 
 
“Cheating” or “being naughty” when deciding to make trade-offs were frequent themes, as 
seen in the ‘Good patient/Bad patient’ discussion. At times this emerged as something that both 
patients and HCPs perceive as a “battle” or “taking sides”, with patients on one side and HCPs on the 
other. 
 
One particular exchange between patients and a carer (whose husband was on dialysis), 
during the focus group at site 2 illustrated this. Members of the discussion were informing a male 
patient that he had been eating things that HCPs advised against: 
 
Male patient: “Whose side are you on? (all laugh)” 
Female carer: “I’m on my husband’s side, I want to keep him alive as long as possible.” 
In spite of this determination to keep her husband alive, she still went on to acknowledge 
that sometimes, for example, his loss of appetite meant that she would cook foods that were 
advised against: 
“I’ve always thought, well it’s going to kill him but now, you know, it’s the only thing he’s 
eating so it’s like living on a cliff really isn’t it, you don’t know what you’re doing.” (female 
carer, site 2) 
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In addition, many patients expressed that being happy in what they ate was important, and 
that failing to achieve this could lead to them becoming depressed. Complex balancing acts were 
also apparent for fluid management and social events. Some patients explained that they chose to 
indulge when they went out, or for big occasions. For example, one patient had indulged in a few 
drinks the weekend before the focus group for her son’s wedding. Another patient described how he 
would go down the pub with his friends once a week, but would only have half a pint of lemonade. 
Maintaining an achievable balance between healthful behaviours and staying positive and 
happy was definitely a complex area of challenges. Patients and HCPs also identified a number of 
things that may help with those challenges. 
 
5.3.4 What helps? 
 
The sections above have alluded to some of the things that may help patients to self-
manage. Peer support came back time and again as something that either has helped, or that would 
be perceived to help in the future. This was recognised by patients and HCPs. Peer support was 
identified as helping patients keep their spirits up (“... chivvy each other along...”, female HCP, site 
1), and peer learning was generally considered to be helpful, and some patients were interested in 
the idea of having the opportunity to learn more about the treatment and particularly the dialysis 
machines. However, sometimes peer communication was regarded as a problem by HCPs: 
“[describes a patient talking to another patient about eating and drinking without restriction 
due to their clinical status] … the fact that somebody’s talking to them about that they think they can 
do the same thing. […] So you tend to find sometimes too much information can be bad thing 
(laughs), especially amongst themselves. You have to kind of tell some of them like “no, don’t sort of 
discuss that, you know, with each other” in that respect” (Female HCP, site 2) 
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Discussions around the challenge of managing one’s diet while on dialysis led to some 
suggestions from patients of what might help. The conflicting requirements of diabetic and dialysis 
diets led to the idea that supermarkets and food shops could be involved to include specialist 
sections for more rare conditions like ESRD. Even if this is unrealistic, it provides an idea of issues 
that HCPs may be able to provide some support with, or for which educational materials could be 
developed. On a related note, patients at another site noted that dialysis diet information sheets are 
almost always oriented around what a patient cannot eat, not what they can. There was recognition 
that this will vary based on comorbidities, and that a tailored approach would help: 
“... it’s [dietary advice] got to be hugely tailored, obviously as I say we’ve got different 
conditions, obviously some of us pass urine, some of us don’t and that’s going to have an 
effect on what’s left in your blood and other things so there are going to be some conditions 
but I suspect they could probably break it into groups and say, you know, you’re a Group A 
and you’re a Group F...” (male patient, site 1) 
Tailoring of this kind was a central theme to discussions of education. As mentioned in 
‘Challenges’, imminent new dialysis patients receive pre-dialysis education, but often feel 
overwhelmed and  forget much of what they learn. Additionally, much of the information will be 
meaningless until they have a context in which to place it. This was recognised frequently, and the 
issues repeatedly identified were: that it needs to be tailored to the patient, that timing is important, 
and that to some degree it needs to be ongoing throughout the course of treatment: 
“Yeah, they’re overwhelmed when they first come on and it’s too much and they take home 
the booklets and then the little bits they want to know, how am I going to get here, what 
kind of thing do I have to do, all the little rules that you know to follow. All that and the 
important stuff is forgotten because there’s just too much to take in, so a little reminder, 
regularly.” (female HCP, site 1) 
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‘Little rules’, and tips and tricks seemed to be something that could be shared. For example, 
the type of phosphate binding medication (large swallowed tablet or flavoured chewable tablet) was 
important to patients across different sites, as well as how to remember to take them/have them to 
hand. Some medications have to be taken in the morning, and those were specifically stated to not 
be a problem. However, for phosphate binders, which need to be taken throughout the day with 
food, forgetting was raised as a frequent issue, in addition to intentional non-adherence as discussed 
earlier. One patient pulled out a large bottle of pills from a rucksack, which he kept with him so that 
he would have a plentiful supply at all times. Another shared a strategy where he would have some 
medications stored in his briefcase for work, some in the car, some at home, so that he would have 
both reminders and a supply of medications where they were needed. 
A good portal of information and resources also came up as something that may help. Some 
patients frequently took ‘dialysis holidays’, where they take up free slots at other units (usually 
arranged online or over the phone) elsewhere in the country, or even abroad, allowing them to still 
have that freedom. However, a lack of readily available information about holidays seemed to be a 
barrier for some people, and this varied by site. While site 1 had a folder of useful resources patients 
could access, site 3 did not, and staff did not appear to have anywhere to direct one patient who 
particularly wanted to take a dialysis holiday to visit his daughter. Additionally, a number of helpful 
resources, such as the ‘Freedom Dialysis’ website and a magazine called, ‘Candis’, with information 
about travel insurance for the chronically ill emerged from these discussions. 
One tool that has great potential use for patients wishing to self-monitor their clinical 
markers online is Renal Patient View (RPV). HCPs voiced support for RPV, but did not think that many 
of their patients used it. This was borne out in patient focus groups, where the vast majority were 
not even aware of it. Some patients did not own computers and had no interest in online tools. 
Some did not own a computer, but had relatives access useful websites on their behalf. Some 
patients seemed very interested in RPV, but were simply unaware of it. HCPs tended to agree that 
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they did not do much to promote the service. Making patients more aware of tools like this may be 
something that could help those who wish to be more involved in self-monitoring. 
Amidst all these challenges and facilitators, there was an interesting dynamic that emerged 
from both patient and HCP focus groups. For better or worse, there seemed to be a strong 
perception from many that the dialysis units were a kind of family. 
 
5.3.5 Unit as family 
 
Both HCPs and patients expressed that they felt the unit was, at times, like a family. This 
could often be seen as a metaphor in the subtext. For example, one HCP came across very much as a 
father figure trying to look after his naughty children: 
“I mean particularly, you know, particularly a problem for the young or older children, you 
know, we have, I call them children because it’s like we have a few patients sort of 18 to 22 
don’t we? We have a few patients and they are incredibly difficult to cope because, you 
know, they see their friends going out and about and running around and…” (male HCP, site 
3) 
However, many patients and HCPs raised the idea of the unit as a family explicitly, and 
where they did, it was generally in a very positive light, as something that helps: 
“... the people, yeah are great, it’s like a little family I think, you know, you’re all there for the 
same purpose and it helps you forget about your other problems as well I suppose and then 
because I was the first year when I come in, I learnt from other people how to cope with it.” 
(female patient, site 3) 
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HCPs across sites expressed a similar notion. At one site they went on to describe how they 
had been told by ex-dialysis patients (who had been successfully transplanted) or the carers of now 
deceased patients, that they missed the family once they were no longer attending the units: 
“... if we’ve got patients who have carers say, we had one recently, an elderly lady whose 
daughter was the carer and she did everything with her and she said, I really feel like you’re 
my family and her daughter died and she was so lost because she didn’t even have us, she 
could come in and see us but that contact was lost and they do see us as family and we see 
them as family, when we lose a patient it really hits us and it’s a big impact.” (female HCP, 
site 2) 
 Interestingly, sometimes the HCPs did not see themselves as the elders in the family 
dynamic: 
“… because the older patients who have grandchildren, quite nice actually they treat us as 
their children” (Female HCP, site 3) 
Recognising this ‘family’ dynamic may be important to managing the relationships in the 
units, that are key to ensuring patients are supported in their efforts to manage their treatment and 
their lives. 
 
5.4 Discussion 1 (focus groups): 
 
The thematic analysis was conducted in accordance with the principle of homogeneity 
within themes/heterogeneity between themes (Braun & Clarke, 2006). It is therefore telling that 
despite adhering to this principle, the concept of time and time being precious appeared in 
numerous themes. Staff felt they did not have enough time to devote to patients. Patients felt that 
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their treatment was a huge drain on their time that was preventing them from getting on with their 
lives. 
 There was a great deal of overlap between what staff and patients regarded as important 
medical self-management tasks. Adhering to fluid restrictions, taking medications, restricting the 
consumption of certain foods, and attending dialysis were all frequently identified by both groups. 
For HCPs, this appeared to be a black and white subject; patients who adhered were ‘good’, those 
who did not were, ‘naughty’. Some patients had clearly internalised this, and thought of themselves 
as ‘not ideal’ patients. Those that staff perceived as ‘good’, those who turned up to dialysis regularly 
and on time, and controlled their IDWG and dietary markers, were seen as good candidates for self-
management support. However, one might argue that those who are doing these things are already 
self-managing effectively (from a clinical perspective, at least). This idea may speak volumes about 
what HCPs believe self-management is – ‘compliance’. It may be that the idea that only those who 
are self-managing well should be encouraged to self-manage would be worth challenging. It may be 
the case that clinical staff do not view it as their job to change the world-view or behaviour of those 
who do not look after themselves – but this would be at odds with the frequent instances of staff 
and service users discussing ‘telling off’ or ‘being told off’ for high IDWG during dialysis sessions. 
Giving patients a ‘telling off’ is not consistent with the ethos of self-management, where people 
make their own healthcare decisions. Furthermore, it may be counterproductive, as there is 
evidence that threatening health messages are more likely to be ignored when they are put across 
aggressively (Armitage, Harris, & Arden, 2011). Instead, inducing self-compassion (or self-
affirmation) may be a more functional way to engender behaviour change (Wileman et al., 2014).  
 For many other patients however, there were frequent explicit or implicit references to 
complex balancing acts. Ultimately, these arise from tensions between medical needs, and social and 
emotional needs. They can involve cutting dialysis short to see family, or eating ‘forbidden’ foods 
because they were comforting, or going out and drinking with friends. The idea of living on a cliff 
132 
 
edge raised by a carer was a powerful metaphor – balancing her husband’s continued survival by 
adhering to guidelines, which she greatly valued, against maintaining his will to eat at all, and thus 
his will to live. It was clear from many discussions with patients that emotional and social outcomes 
were highly valued, and that treatment had to work for them, not necessarily the other way around. 
 By contrast, staff were highly focused on the idea of patients taking personal responsibility. 
This is highly concordant with the concept of patient activation, or an individual’s readiness to take 
responsibility for aspects of their care. Any deviation from prescribed medical regimen was usually 
considered irresponsible. Only one social worker expressly voiced the idea that the patient’s 
perspective may be substantially different to their own, and that their goals may be different to 
those that HCPs have in mind. The theme of taking personal responsibility for many patients came 
back to the idea of complex balancing acts; it was evident that they believed that their role in their 
care was to take good care of health, but not necessarily when doing so was perceived to conflict 
with their ability to look after their emotional health or their ability to work or otherwise socially 
function. 
 Social support was frequently cited as being valuable. HCPs tended to view the support of 
other patients as being important to the emotional wellbeing of other patients. People on dialysis 
expressed a similar notion, but with the added idea that a lot of learning of practical self-
management skills could take place. HCPs thought this might be harmful, and promote the spread of 
misinformation. 
 From a psychological perspective, it is clear that HCPs believed that patient activation was an 
essential element of good patient self-management. Discussions frequently centred around self-
management being for the ‘right’ kind of people, and that certain people had the right mindset, 
while others did not. Some were seen as hopeless cases (“They don’t hear, no matter how many 
times we tell them”), who would never achieve that mindset, which conflicts with the aims of 
behaviour change interventions that attempt to move people along the ‘stages of change’ (Molaison 
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& Yadrick, 2003). The qualities of an activated patient were fastidiousness, conscientiousness, and a 
desire to stick to treatment in the face of difficult circumstances. 
 It is interesting that depression did not surface as a potential barrier to self-management 
from the staff perspective. While it was acknowledged that living with ESRD is difficult, emotional 
impact was usually discussed in terms of newer patients being ‘overwhelmed’ and taking time to 
adjust. Patients reported a similar feeling of being overwhelmed initially, but it was clear that 
striking a balance between physical and emotional health was a daily activity that did not end after a 
period of adjustment. It may be that HCPs do not recognise distress, or that they do not consider it 
to be relevant to self-management, a concept which tends to be categorised as compliance in this 
group. While patients discussed the balancing act of doing what makes them feel okay emotionally 
with medical needs, depression was not discussed. This may be more of a product of the focus group 
environment and the presence of others, or may reflect a tendency to avoid thinking about or 
discussing the problem, an approach to ESRD self-management that is discussed in further details in 
the interviews below. 
 It is also interesting that staff identified a lack of patient engagement as a barrier to medical 
self-management, and that several patients identified ‘not thinking about’ their illness and 
treatment as a coping strategy. While avoidant coping is often regarded as being maladaptive 
compared to, for example, approach based coping, empirical evidence shows a more complicated 
picture, where different coping styles are more or less effective in different situations (de Ridder & 
Schreurs, 2001; Roesch & Weiner, 2001). 
Other emotions, such as guilt or shame, and a desire for normality, were all additional 
potential emotional barriers to optimal medical self-management. The idea of not feeling able to 
take one’s medication in front of business clients for fear of appearing weak was a powerful example 
of barriers that were not strictly practical in nature, and could be based on the psychological impact 
of living with the condition. ESRD and its treatment present many challenges to the previously held 
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self-image of the individual, and fear of appearing abnormal or weak are common concerns. These 
challenges to self-image are often regarded as part of the biographical adjustment to a disease 
(Corbin & Strauss, 1985) sometimes included in the ‘social’ side of the self-management triangle 
(Lorig & Holman, 2003). 
From these discussions, it appears that staff caring for people with ESRD view self-
management as a predominantly medical task, characterised by adherence above all else. Patient 
activation was viewed as the most important trait for predicting who would make a ‘good’ self-
manager, although other emotional and social factors were acknowledged as feeding in to the ability 
to medically self-manage. 
By contrast, patients viewed self-management predominantly as a balancing act. Good 
medical outcomes were only one set of goals. According to these focus groups, factors that may 
contribute to medical self-management behaviours include: 
 Patient activation – Readiness to take responsibility for care 
 Social support from family and friends 
 Participation in the unit as a ‘found family’ 
 Emotional factors such as depression, guilt, shame 
The relationship between social, emotional and medical self-management may be a tripartite 
reciprocal one. Patients identified their emotional wellbeing as being dependent on social support, 
as well as how their treatment was going. ‘Good dialysis’ days would leave them feeling better. In 
turn, the idea was expressed that they would feel more able to go out and socialise if they were 
feeling good, and if their treatment was going well. 
Five themes were identified when discussing self-management with groups of staff and 
patients; “Good patient/bad patient”, “Complex balancing acts”, “What helps?”, “Challenges”, and 
“Unit as family”. These focus groups were conducted at the same time that baseline quantitative 
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measures used in chapters 6 and 7 were taken. Follow up interviews were then conducted 18 
months later. During this time, a “self-management facilitator” had been introduced to the units. 
These interviews were partially evaluative of the project, as well as further exploring the perceptions 
of self-management. Themes surrounding these perceptions are described next. 
 
5.5 Results 2: Interviews 
 
A series of interviews were conducted with a separate sample to further explore behaviours 
that patients thought were important for self-management, and to assess whether their dialysis unit 
had done anything to aid self-management in the 18 months since the focus groups took place. 
With a set of self-management topics established in the focus groups, interviews were 
oriented towards some of the topics that arose. The analysis was guided by three research 
questions: 
1) What self-management tasks have patients been involved in over the previous 18 months? 
2) What are the goals of those self-management tasks, from the patient’s perspective? 
3) What is the role of the dialysis unit? 
A key driver behind this analysis was the focus group finding that staff and patients have 
different perspectives on what self-management entails, with patients balancing medical advice 
against emotional coping and social functioning, while staff are understandably almost solely 
focused on clinical outcomes. 
Quantitative data on self-management behaviours elsewhere in this dissertation (see 
chapters 6 and 7) was collected using the self-management scale developed by Curtin and colleagues 
(Curtin et al., 2004). In order to facilitate methodological triangulation, this scale was used to 
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provide a set of a priori codes for the categorisation of self-management behaviours. These 
categories include suggestions to (healthcare) providers and selective symptom management, for 
example. See appendix A for a full list of subscales. 
In order to address the questions, transcripts were coded by the author. Self-management 
behaviours were coded for which self-management category they fell into. They were also coded for 
the goal of the behaviour. Goal codes were condensed into themes, which will be reported here. See 
table 5.3 for a summary. 
 
See table 5.3 for a summary of themes emerging from these interviews. 
Table 5.3: Themes emerging from interviews 
Theme Definition Example 
1. Preventing or 
reducing unpleasant 
symptoms 
Actions taken to prevent or reduce the 
occurrence of uncomfortable 
symptoms both on and off dialysis 
Maintaining a low IDWG to 
prevent ‘going hypo’ during 
dialysis 
2. Coping by 
forgetting 
Behaving in a way that helps the 
patient forget about ESRD or dialysis 
Not seeking information about 
dialysis on non-dialysis days, as 
it would be a reminder about 
dialysis 
3. Relieving boredom 
and reducing waiting 
times 
Behaviours that reduce the monotony 
of the dialysis process, or make the 
process quicker 
Performing self-cannulation as a 
way of getting on dialysis faster 
4. Getting on with life The act of getting on with one’s life 
despite ESRD, or self-management 
behaviours that enable this 
Indulging in food or drink during 
social occasions such as 
Christmas 
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5.5.1 Preventing or reducing unpleasant symptoms 
 
 As a central concern for dialysis patients, diet and fluid management was discussed during 
the interviews. One of the most common reasons for attempting to adhere to guidelines on fluid and 
dietary intake was the avoidance of unpleasant symptoms. Those who claimed to take shared 
responsibility in care often stated that the reason they kept their fluid and phosphate under control 
was to avoid unpleasant symptoms that accompany dialysis when a large amount of fluid needs to 
be removed: 
Patient(P) 9 female: “I only take off what I feel I want to take off and then ask for advice 
when I go back to the clinic on a regular basis, but I probably don’t take off enough fluid, I’ve 
passed out a couple of times after having too much taken off and I think it’s probably scared 
me a bit. It’s a horrible sensation so, I’m a little cautious with my fluid.” 
 This avoidance of on-dialysis complications were also the motivation behind certain 
suggestions to (healthcare) providers. Where patients had previously had bad experiences with 
having too much fluid removed, they described negotiating their dry weight (their weight when 
excess fluid has been removed by dialysis) with staff to avoid this in future: 
P5, male “… I went hypo the other week. But it’s, the dialysis had finished and I’d just been 
taken off, you know, I couldn’t believe it and next thing you know I got oxygen mask on. 
That’s a bit, see it’s a bit scary, it’s not very nice but I don’t know why that happened. But no, 
it’s pretty well under control, you know, they’ve got, they are good. And I can see the sister, 
when I saw her last time I said “look, I still think because of that would you please increase 
my dry weight again?” and they have done.” 
Similarly, exercise during dialysis was popular because of symptom reduction. In months 
prior to the interviews, intradialytic exercise bikes had been introduced to the dialysis units. Some of 
the participants interviewed had been piloting these bikes during their dialysis sessions. Several 
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participants praised the fact that the bikes reduced cramp during dialysis, which they were very 
positive about: 
P6, female “I love it [the exercise bike], I really do, it’s especially helpful for someone like me 
because sometimes in here my legs do ache” 
In a similar vein, self-needling as part of self-care on haemodialysis was practiced by one 
respondent as she had previously experienced pain when staff were responsible for her needling. 
P4, female “One of the nurses couldn’t do it and it took him like five attempts, and it hurt. 
And then not long after that it went wrong and they done a new site, and I just thought, 
“Right, I’m not having that again. I’ll do it myself.”” 
 During discussions about managing diet and fluid, long term survival was not mentioned by 
any of the participants, only short term symptoms. 
 
5.5.2 Coping by forgetting 
 
 A number of participants expressed the desire to forget about kidney disease and dialysis 
when they were not present, expressing a desire not to be involved in self-care on haemodialysis or 
shared responsibility in care due to wanting to forget about dialysis to emotionally cope. 
P10, male “But I try to make them off days if you like and not think about my dialysis on the 
days I’m not here and at weekends. I like to do something totally different. 
Interviewer: “It’s having a break from it, making sure…” 
P10: “A complete break, and I think you need that otherwise your mind becomes bogged 
down with all that’s going on with you, so yes.” 
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In addition to wanting to get on with their lives and relieving monotony, fear was cited as a 
motivation for this avoidant approach, which extended to active information seeking: 
P9, female: “At the beginning I kept going on the internet and looking it all up and I got so 
confused, and some of it’s so frightening when you start reading it, but no I’m quite happy 
for someone else to do that [monitoring diet and providing dietary information] for me.” 
To some extent this seemed to extend to a form of impression management, where patients 
tried to keep their illness away from their family members by not showing how it affected them. 
P6, female: “Yeah. Yeah, I think that’s best sort of. I mean sometimes, I mean I’m tired when I 
get off of here so sometimes they notice like on the Saturday, you know the kids are there so 
and I go to bed, I’m so tired, I go to bed but apart from that I do try and really, really keep it 
away from family.” 
 Coping by forgetting appeared to be associated with not being interested in participating in 
care in general, and with not wanting to participate in self-care on haemodialysis. 
  
5.5.3 Relieving boredom and reducing waiting times 
 
 During discussions about self-care behaviours during haemodialysis itself, participants 
frequently brought up the topic of boredom. In addition to reducing symptoms, the most common 
source of praise for the intradialytic exercise bikes was the fact that they seemed to help alleviate 
on-dialysis boredom: 
P11, male: “I’d say the benefit [of the exercise bike] is you do feel better and it does relieve 
the boredom for however long you’re going to do it (laughs)” 
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Several participants stated that they wished they could be doing things that were useful to 
alleviate the boredom. For some that was working, while others stated a preference for being given 
tasks to do while on dialysis: 
P9, female: “… unless they can find us something to do while you’re lying here, something 
that we could do to help, perhaps the staff. I don’t know what, but something maybe. We 
used to roll bandages years ago but they don’t do that anymore do they (laughs)? So I don’t 
know, but it would be nice to feel we were doing something as well.” 
The desire to reduce boredom was often closely associated with the idea of saving time, 
both for the patient and for staff. The idea of self-needling and setting up the dialysis machines 
particularly appealed to one participant for its potential to save time: 
P9, female: “Yes, I think I might try doing my own needling, I’d like to give it a whirl, but I 
have to, it will be a little while, I need confidence” 
Interviewer: “What do you see as the motivations for doing that yourself?” 
P9: “Just speeding things up a bit and helping the nurses out a little bit, because if you can do 
it yourself it’s much quicker isn’t it? So, yes, that’s what I’d like to do.” 
The idea of increasing knowledge about the machines to be able to turn off alarms was also 
cited as a potential way to save time for the staff, freeing them up to help other patients: 
P6, female: “Yeah, it would be interesting just to go over the machines and sort of know how, 
especially the modern ones, to know how they work because then you can, it just saves so 
much time, it really does. I mean if someone’s putting someone on and, it does, it just saves 
so much time, it would be logical for people to just lean over [and switch the alarm on their 
dialysis machine off]. I mean it’s just logic isn’t it?” 
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 The idea of reducing boredom and saving time co-occurred during discussions about the 
waiting room and transport in the form of suggestions to providers: 
P3, female: “A bit of music, something or other. Well, I mean, sometimes they have, they 
have had it now and again. It’s not an automatic thing, you know, to put it on, but someone 
will put it on. Yeah. While we have a good chat and all that. (Laughs)” 
  
5.5.4 Getting on with life 
 
Some participants expressed fitting dialysis into their everyday lives, including work, into 
suggestions to providers. Some expressed that they did not think the system was designed in such a 
way that it was responsive to such suggestions, for example when discussing availability of dialysis 
timeslots that fit in with work: 
P10, male: “I think there should be some sort of capacity in the system for them to cope with 
people’s requests on that sort of thing. And I don’t think it’s been done at the moment.” 
The same was true of the balancing act of shared responsibility in care, with attempts to 
keep IDWG and phosphate down tempered by a desire to enjoy important occasions: 
P4, female: “It was after Christmas, obviously. They [blood results for dietary markers] were 
all over the place but they just said it was down to Christmas… You’ve got to live” 
This balancing act led some to make certain concessions to their wants, but not others. As in 
the focus groups, social drinking occasions and venues became seen as no-go areas, often causing 
patients to feel isolated and like they had lost friends: 
P7, male: “I mean I do allow myself one cup of tea a day, first thing in the morning. I like to 
have a cup of tea and then for the rest of the day it’s like sucking ice cubes and things like 
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that, you know, which, you know, you do learn to live with it but at the same time, you know, 
I mean I’ve lost a lot of mates through it really. I mean I don’t see my friends anymore, you 
know, where normally you could go and have a couple of pints and you just can’t do that no 
more. “ 
 
5.6 Discussion 2: Interviews 
 
5.6.1 Motivations for self-management behaviours 
 
This analysis aimed at establishing what the goals of various patient self-management 
behaviours were. A common theme among the people interviewed is that even those who appeared 
to have their diet and fluid, for example, well under control, were often not interested in 
participating in the dialysis process. The avoidance of unpleasant symptoms, unsurprisingly, came 
out as the most frequently cited theme when discussing self-management behaviours. The most 
salient motivation for self-management appears to be preventing on-dialysis complications. In both 
the focus groups and interviews, there appeared to be a very common, explicit, ever-present fear of 
‘going hypo’ on dialysis and experiencing dizziness, blackouts, and other unpleasant symptoms. In 
the interviews, at least, this motivation to avoid unpleasant symptoms was far more frequently 
referenced than anything to do with length of survival. The avoidance of death was almost 
completely absent from participant responses, although there may be other reasons for this. For 
example, it may be that participants felt it was not appropriate in the context of these interviews, or 
wanted to avoid thinking about or discussing the subject. 
Trying to forget about dialysis appeared to be a very common coping strategy, that almost 
every participant in the interviews talked about in some capacity. This could be regarded as an 
emotional self-management strategy, regardless of whether one may consider it adaptive or 
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maladaptive. It bears similarities to avoidant style coping, which is often associated with many 
negative outcomes (de Ridder & Schreurs, 2001). There is some evidence that avoidant coping may 
be associated with mortality in people with ESRD. However, some participants talked about this 
strategy as being an almost ‘one day on/one day off’ approach, where on dialysis days they had no 
choice but to think about their condition and treatment, and so on their off days they would try to 
forget about it. This ties in closely with the finding that time is precious from the focus groups; 
dialysis days are regarded by many patients as being too demanding and time consuming to allow 
for other activities, and involve feeling tired or drained. Therefore maximising the non-treatment 
related use of non-dialysis days is an attempt to capitalise on what little precious time they have 
available, and to regulate the difficult emotions associated with the demands of ESRD and its 
treatment. It may be that acceptance and adjustment would be more adaptive ways of coping. 
In some cases, such as avoiding seeking out information that caused concern, this strategy 
appeared to be motivated by avoidance of unpleasant emotional states, in much the same way that 
many self-management behaviours were motivated by the aim of avoiding unpleasant symptoms. It 
may be, however, that in reality these two goals often conflict, as avoiding thinking about medical 
self-management tasks may result in poorer dietary and fluid control, resulting in more unpleasant 
symptoms. For many it seemed that coping by forgetting was simply out of wanting to get on with 
their life, and boredom with thinking about ESRD and dialysis. 
During discussions about self-needling and other shared haemodialysis care behaviours, 
many patients did not seem interested in participating, and some overtly stated wanting to be taken 
care of. This was sometimes related to coping by forgetting; wanting to have to think about their 
treatment as little as possible, even while receiving dialysis. For others this was about fear of 
needles, or fear of the dialysis machines and their competence. One patient stated that the ability to 
engage further in dialysis self-care was down to a question of confidence, or self-efficacy as it is 
referred to in psychological literature. Perhaps it is unsurprising that in-centre patients would not be 
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particularly interested in participating in their own dialysis, as many people capable of doing so 
would already be engaged in home dialysis. However, as there are often practical constraints that 
prevent home haemodialysis (such as lack of space in the home), or peritoneal dialysis (infection, 
personal preference), in-centre self-care haemodialysis care should not be overlooked. 
Indeed, some individuals were interested in self-care haemodialysis behaviours. The 
motivations behind participation appeared to involve the desire to save time, or relieve boredom. 
Boredom while waiting for, or on, dialysis, and a feeling that time in constrained while not on 
dialysis, appear to be two of the most universal experiences from all the patients participating in the 
work described in this chapter. It is perhaps therefore unsurprising that the prospect of engaging in 
more of their own dialysis would be of interest more to address these problems than because of any 
perceived medical benefit. 
Getting on with life appears to be an overarching aim for many on dialysis. Coping by 
forgetting appears to be one way in which participants do this, while others saw engagement in their 
care to be a way of reducing complications and allowing them to continue their lives, although 
sometimes both sentiments were expressed within the same interview. As in the focus groups, this 
balancing act between engagement and getting on with life by not thinking about dialysis came out 
as possibly the perceived central task in self-management.  Medical self-management tasks were 
frequently perceived as being sufficiently disruptive as to be almost diametrically opposed to getting 
on with life, and this may explain why avoiding thinking about treatment was a common approach. 
 
5.6.2 Self-management behaviour categories 
 
 The self-management behaviour subscales proposed by Curtin and colleagues appeared to 
be a useful way of categorising the medical self-management behaviours of patients. Of note is that 
comparatively few instances of ‘defensive’ self-management behaviour (selective symptom 
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management, assertive self-advocacy, and impression management) were raised as issues. Where 
assertive self-advocacy and impression management were discussed, it was in relation to those 
outside the health service (for example, complaining to a Member of Parliament about state 
benefits) or trying to keep the difficulties of dialysis away from the family. No examples of selective 
symptom management were raised, but this was not specifically probed for by the interviewer. 
 
5.7 Combined summary 
 
 This chapter has examined the concept of self-management for ESRD, both by asking what it 
consists of, and what it is for. This was achieved first by exploring what self-management means to 
patients and staff, and secondly, by further exploring the motivations behind carrying out these 
behaviours. 
 A series of focus groups established five themes that emerge when discussing self-
management with patients and staff; good patient/bad patient, challenges, complex balancing acts, 
what helps?, and unit as family. Within these themes, a number of specific self-management tasks, 
facilitators, and barriers were identified. These fed into a series of interviews conducted 18 months 
later, as well as the introduction of new self-management support initiatives such as intradialytic 
exercise bikes and peer support.  
The focus groups revealed that while the five themes emerged for both patients and HCPs, 
each had a different focus to the other, with patients apparently having different goals to HCPs, 
raising the question of who self-management, and self-management support initiatives, are for.  The 
interviews were thus analysed to further explore self-management tasks in light of the motivations 
behind patient actions. Four themes were identified: Preventing or reducing unpleasant symptoms, 
coping by forgetting, relieving boredom and reducing waiting times, and getting on with life. These 
goals reveal that the way in which patients approach a whole range of self-management tasks, from 
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information seeking to performing dialysis related tasks like self-cannulation, are influenced 
primarily by the desire to minimise physical, emotional, social, and biographical disruption. 
Any conceptualisation of self-management in ESRD should take into account the disparities 
in both definition and goals that occurs between patients and staff involved in their care, as well as 
the similarities. 
 
5.8 Conclusion 
 
 HCPs and patients agreed on many aspects of what constitutes ‘good’ medical self-
management, but patients have a wider range of social and emotional goals, which HCPs 
predominantly saw as the means to the end of good medical self-management. Both groups 
identified a range of social and emotional elements that, whether an outcome or process, may 
contribute to successful medical self-management for in-centre HD. Many of these factors concord 
with the self-management literature for other chronic diseases such as diabetes and heart failure. 
The idea of the dialysis unit as a found family was a powerful idea that exemplified the importance 
of social support and learning. 
 The following chapter will quantitatively investigate some of the self-management 
behaviours covered here, and their associations with psychological status. 
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6.1 Introduction 
 
 Chapter 5 explored how patients and healthcare professionals (HCPs) conceptualise self-
management and the things they do to take care of themselves. Responses were mapped on the 
tripartite model of self-management that focuses on emotional, social and medical factors. The 
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present chapter will use cross sectional data to explore the relationships between self-management 
behaviour and psychological status. 
As stated in the introductory chapters, self-management can be thought of as what people 
do. There are a number of theoretical drivers of these health and quality of life promoting 
behaviours. Typically, the literature has focused on self-efficacy (Bandura, 1977). Self-efficacy forms 
one part of Bandura’s Social Cognitive Theory (SCT). Bandura defines perceived self-efficacy as, 
“people's beliefs about their capabilities to produce designated levels of performance that exercise 
influence over events that affect their lives”. While other factors such as outcome expectancies 
(what they think will happen if they successfully perform that behaviour) are important, self-efficacy 
has most frequently been tested, and often comes out as a predictor of adherence (Bandura, 1994, 
p. 71). In a prior study using SCT variables to predict variations in physical activity among people with 
ESRD, self-efficacy, but not outcome expectancies, emerged as significant (Patterson, Umstattd 
Meyer, Beaujean, & Bowden, 2014). More recently, the concept of ‘patient activation’ has come into 
focus. Based on the Transtheoretical Model of behaviour change (Prochaska & Velicer, 1997), 
patient activation is the concept of how ready an individual is to change their behaviour. The 
concept includes, but is not limited to, self-efficacy, and how strongly one identifies with the idea of 
being central to one’s own care (Greene & Hibbard, 2012). There has been little work to date on how 
patient activation many influence self-management behaviours in ESRD. 
Other drivers of self-management behaviours may include mood. There have been 
documented links in ESRD between depression and adherence in both chronic illness generally, and 
ESRD specifically (DiMatteo, Lepper, & Croghan, 2000), while there have been mixed findings on the 
relationship between depression and survival in the ESRD population (Gee, Howe, & Kimmel, 2005). 
Social support is also predictive of mortality in ESRD, and may play a role in the relationship between 
depression and mortality (Plantinga et al., 2010). It is known that depression and anxiety are highly 
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correlated, and there is a case that the two factors are related to an underlying concept of 
‘psychological distress’ (Norton et al., 2013). 
While there have been prior studies in ESRD examining mood and adherence, and self-
efficacy and adherence, no work has looked at a wide range of self-management behaviours in 
relation to those combined factors. The results presented here are baseline results from a 
longitudinal study into self-management in patients receiving in-centre haemodialysis for ESRD (the 
SELFMADE Study). A number of psychological factors described above were studied, in addition to 
the BHDS to measure self-management behaviours. In this chapter, the question of which 
psychological factors predict self-management behaviour will be explored. 
 
6.2 Methods  
 
6.2.1 Design and procedure 
 
Data were obtained for 104 people on maintenance haemodialysis for ESRD across three sites in 
Hertfordshire, UK. Questionnaires were administered while participants were dialysing, a method 
that has been shown to produce comparable results for depression screening to off-dialysis 
assessment (Chilcot, Wellsted, & Farrington, 2008). Data for clinical parameters was extracted from 
the local hospital database. The study was approved by Cambridge South Research Ethics 
Committee. All participants gave informed consent for participation in the study. 
 
6.2.2 Setting 
 
Questionnaires were administered at sites 1, 2 and 3 in East & North Hertfordshire NHS Trust. For 
more information, see “Setting” in chapter 4. 
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6.2.3 Participants 
 
Eligible patients were approached across three dialysis centres in Hertfordshire. The sample 
consisted of the first consecutive 104 patients to consent, although a roughly proportional number 
of participants were approached relative to the size of the unit. All participants were adults, as care 
and life responsibilities are more likely to be undertaken by the family in paediatric haemodialysis, 
and these skills will be learned as they transition to adult services  (Watson & Warady, 2011). All 
participants were able to speak at least basic English, as some questionnaires were unavailable in 
translated forms, and translation was beyond the scope of this study. Participants had at least 3 
months of experience of life on dialysis, so that they had some experience of the situations 
described in the self-management questionnaire. While comorbidity was not an excluding factor (as 
comorbidity is present in the majority of people with ESRD, and exclusion would result in an 
unrepresentative sample), people due to receive a transplant or with very poor prognosis were 
excluded, due to the longitudinal nature of the study. Comorbidity status was recorded to be 
included as a confounding variable. 
The following data were collected for each patient: age, sex, dialysis vintage, residual native 
kidney function  (as interdialytic urea clearance – KRU),  Charlson Comorbidity Index (Charlson, 
Szatrowski, Peterson, and Jones 1994),  dry weight , and interdialytic weight gain (IDWG) and pre-
dialysis plasma phosphate level,  as markers of patient adherence to aspects of their treatment. 
6.2.4 Materials 
 
All potential participants were provided with an information sheet and an explanation of the 
study by a member of the research team. Those electing to participate were asked to provide signed 
consent, and provided with a pack of questionnaires. Questionnaires used included: 
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 PHQ-9, a tool to screen for depression, based on DSM criteria for major depression 
(Kroenke et al., 2001). 
 GAD-7, a tool to screen for anxiety, based on DSM criteria for general anxiety 
disorder (Spitzer & Kroenke, 2006). 
 The Self-Efficacy in Chronic Disease 6 item scale (SECD-6), a tool developed by Kate 
Lorig and colleagues to assess general self-efficacy in chronic disease (Lorig et al., 
1996). 
 The Patient Activation Measure 13 item scale (PAM-13), a scale derived from the 
Transtheoretical model of behaviour change, assessing how important a patient 
views their role in their own treatment, and their confidence in this regard (Hibbard, 
Mahoney, Stockard, & Tusler, 2005).(Hibbard et al., 2005). 
 The Brief Illness Perception Questionnaire (B-IPQ), a short version of the illness 
perceptions questionnaires developed by Weinman et al. (Broadbent, Petrie, Main, 
& Weinman, 2006). It assesses illness cognitions relating to Leventhal’s self-
regulatory model of illness beliefs (Leventhal, Leventhal, & Contrada, 1998). While 
each domain of illness perceptions can be included in analyses as separate 
parameters, a summary score was used here in accordance with advice in the paper 
by Broadbent et al. due to the number of other variables being assessed. 
 The EQ5D, a short 5 item inventory assessing health related quality of life (Rabin & 
de Charro, 2001). An additional sixth question uses a visual analogue scale to assess 
overall perceived health. 
 The Brief Dialysis Symptoms questionnaire was created for this study, based on 
clinical judgement regarding common symptoms experienced by people on HD. The 
questionnaire asks whether an individual experienced each of 16 of the most 
common symptoms for people undergoing HD for ESRD. They are then asked, if they 
did experience the symptom, how much it bothered them, on a likert scale from 1 
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“Not at all” to 5 “Very much”. Results were coded by scoring a 0 if the symptom was 
not present, and 1-5 if it was present, based on how much it bothered the 
participant. 
 
6.2.5 Statistical analysis 
 
Means and standard deviations were used to describe the participants, including a 
breakdown by dialysis unit. Pearson correlation matrices were constructed to analyse the basic 
relationships between variables. Based on these matrices and prior theory, hierarchical linear 
regression models were constructed. Variables were entered in an a priori theoretically driven 
fashion to avoid the problems of inappropriate variable selection by automatic methods such as 
forward and backwards stepwise regression (Thompson, 1995). Regression models were checked for 
compliance with assumptions using visual methods including kernel density and QQ plots. 
Multicollinearity was checked using Variance Inflation Factor (VIF). All models were found to be 
within acceptable parameters, and all predictors had a VIF of < 2 (Belsley, Kuh, & Welsch, 2004). All 
statistical analyses were conducted in STATA 11 (StataCorp, 2009). 
Relationships between variables included in these regression models were further 
investigated using mediation analysis. The Sobel-Goodman method was used to investigate the size 
and statistical significance of the indirect effect between variables (Sobel, 1982). This was followed 
by using the Preacher-Hayes method for estimating confidence intervals using bootstrap resampling 
(Preacher & Hayes, 2004). 
See chapter 4 for more details on hierarchical regression, mediation and bootstrap 
resampling.  
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6.3 Results 
 
6.3.1 Descriptive statistics 
 
The demographic properties of the patients in the sample are shown in table 1. The mean 
age of the sample was 63.6 (SD = 15.3), which is roughly in line with the UK national average age of 
66 for people on HD (Renal Association, 2013). The majority of the sample was male (66.3%), which 
is typical of UK haemodialysis populations. The majority of participants came from the two largest 
dialysis units (Centre 1= 51, Centre 2 = 35), with the fewest coming from the smallest unit (Centre 3 
= 18). Clinical variables were all within expected boundaries. 
Summary statistics for psychological variables are also displayed in table 6.1. Patient 
activation was used as a continuous scale for the purposes of subsequent analysis, but for reference, 
the values for each cut-off point were; 37 participants in the pre-contemplation phase, 20 in 
contemplation, 27 in action, and 19 in maintenance. 
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Table 6.1: Descriptive statistics for participants  
 
Variable     
Age (years; mean, SD) 63.6 (15.3%)    
Male n(%) 69 (66.3%)    
Female n(%) 35 (32.7%)    
Centre 1 n(%) 51 (51%)    
Centre 2 n(%) 35 (31.7%)    
Centre 3 n(%) 18 (19.2%)    
     
Variable Mean Std. Dev. Min Max 
Self-report scales     
Self-efficacy (SECD-6) 6.9 2.0 2.5 10 
Patient Activation (PAM-13) 55.1 12.7 32.2 100 
Illness Perception (B-IPQ) 49.3 10.4 15 70 
Depression (PHQ-9) 7.3 5.8 0 27 
Anxiety (GAD-7) 4.5 4.9 0 21 
     
Self-management scale     
SM suggestions to providers 4.1 1.5 2 11 
SM haemodialysis 15.9 5.4 7 41 
SM Information seeking 5.0 2.0 2 12 
SM alternative therapies 2.1 0.7 0 6 
SM symptom management 7.9 3.0 0 17 
SM assertive self-advocacy 4.0 1.7 0 12 
SM suggesting improvements 3.5 1.3 0 9 
     
Clinical variables     
Dry weight (kg) 73.3 14.8 50.3 113.8 
Charlson Comorbidity Index 4.2 3.0 0 15 
IDWG (kg) 1.4 0.8 0.4 3.83 
Phosphate (mmol/l) 
 
1.7 0.4 0.7 3.35 
 Mean SD Median IQR 
KRU (ml/min/1.732) 0.90 1.32 0.01 0.01 – 1.47 
 
Note: IDWG = interdialytic weight gain, KRU = residual renal urea clearance 
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6.3.2 Correlations between psychological variables 
 
Correlations for psychological variables are presented in table 6.2. Significance for all 
correlations was determined after applying Bonferroni correction for multiple comparisons. 
There was a significant association between self-management and depression (r = 0.33, p < 
0.05), and self-management and anxiety (r = 0.36, p < 0.01). However, these associations are 
positive; that is, the higher the screening score for depression or anxiety, the higher the level of self-
reported self-management behaviours. This was further examined in tables 6.3 and 6.4 (see later). 
Table 6.2 shows no basic correlations between self-efficacy and self-management (r = -0.13, p > 
0.05), or patient activation and self-management (r = 0.14, p >0.05). 
Self-reported health status, as measured by the EQ5D, was significantly positively related to 
self-efficacy (r = 0.54, p < 0.001), and negatively related to depression (r = -0.40, p < 0.001) and 
anxiety (r = -0.35, p < 0.01). Self-efficacy was negatively correlated with depression (r = -0.56, p < 
0.001) and anxiety (r = -0.50, p < 0.001) – the higher a person’s self-efficacy, the less likely they were 
to be depressed or anxious. Self-efficacy was also negatively related to illness perceptions (r = -0.32, 
p < 0.05).  
Symptoms were significantly positively related to depression (r = 0.62, p < 0.001) and anxiety 
(r = 0.53, p < 0.001). The more symptoms bothered the individual, the more likely they were to be 
depressed and anxious. Symptoms were also negatively correlated with self-efficacy (r = -0.50, p < 
0.001), but positively correlated with self-management behaviours (r = 0.40, p < 0.001). The more 
bothersome symptoms were present, the less confident an individual felt in managing their 
condition, but the more they reported doing to manage it. 
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Table 6.2: Zero order correlations between psychological variables, self-management behaviours, 
and symptoms 
 
Correlation 1 2 3 4 5 6 7 
1 BHDS        
2 EQ5D -0.18       
3 Self-efficacy -0.13 0.54***      
4 IPQ-R -0.32* -0.28 -0.32*     
5 PAM-13 0.14 0.27 0.41*** 0.02    
6 PHQ-9 0.33** -0.40*** -
0.56*** 
0.36** -0.2   
7 GAD-7 0.36** -0.35** -
0.50*** 
0.33* -0.32* 0.73***  
8 Symptoms 0.4*** -0.24 -
0.50*** 
0.2 -0.15 0.62*** 0.53*** 
 
 
Breaking the relationships between depression and self-management subscales down, it 
appears that depression was significantly positively related to information seeking (r = 0.36, p < 
0.01), assertive self-advocacy (r = 0.33, p < 0.05), and impression management (r = 0.41, p < 0.001). 
These subscales have been described in previous work ‘defensive’ subscales, which may represent 
unhealthy attempts to manage one’s illness alone, or possibly due to a lack of trust in healthcare 
professionals (Curtin et al., 2004). 
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Table 6.3: Zero order correlations between depression and self-management behaviour subscales 
 
Correlation 1 2 3 4 5 6 7 8 
1 PHQ-9         
2 SM suggestion 0.24        
3 SM HD 0.08 0.10       
4 SM Info 0.36** 0.22 0.21      
5 SM alt 0.06 0.26 0.09 0.08     
6 SM Select 0.28 0.28 0.20 0.29 0.36**    
7 SM Advocacy 0.33* 0.40* 0.28 0.37** 0.02 0.33*   
8 SM Imp 0.41*** 0.40*** 0.06 0.30* 0.15 0.27 0.33*  
 
Note: Items 2 to 8 are subscales of the self-management behaviour subscales. These are: 2 
Suggestions to providers, 3 Haemodialysis related activities, 4 Information seeking, 5 Alternative 
therapies, 6 Selective symptom reporting, 7 Assertive self-advocacy, and 8 Impression management 
 
Given the apparent distinction between different styles of self-management behaviours 
identified by Curtin et al. (2004), two composite subscales were created; defensive self-management 
and cooperative self-management. Defensive self-management was the mean of selective symptom 
reporting, assertive self-advocacy, and impression management (mean = 4.18, SD = 1.24). 
Cooperative self-management was the mean of suggestions to providers, haemodialysis behaviours, 
use of alternative medicine, and selective symptom management (mean = 7.50, SD = 1.84). 
 
158 
 
Table 6.4: Zero order correlations between psychological variables and defensive self-
management 
 
Correlation 1 2 3 4 5 
1 Defensive self-management      
2 Self-efficacy -0.30*     
3 B-IPQ 0.29* -0.32*    
4 PAM-13 -0.19 0.41*** 0.02   
5 PHQ-9 0.49*** -0.56*** 0.36** -0.20  
6 GAD-7 0.46*** -0.50*** 0.33* -0.32* 0.73*** 
 
Correlation matrices were re-run with these new subscales and psychosocial variables, 
shown in table 6.4. Cooperative self-management did not correlate with any of these variables, and 
so was not investigated further in this analysis. However, defensive self-management correlated 
with self-efficacy, illness perceptions, depression, and anxiety. 
 
6.3.3 Regressing psychological variables on self-management behaviours 
 
Hierarchical linear regression was used to model the relationship between self-
management, psychological distress, patient activation, and self-efficacy. Age, sex, residual kidney 
function, dry weight, and comorbidity were included in the baseline model as control covariates. 
Several models were constructed. As the PHQ-9 and GAD-7 were significantly correlated with self-
management, and we would theoretically expect them to be related to self-management, these 
were included in the model first. Despite finding no basic correlations, we would theoretically expect 
self-efficacy and patient activation to be related to self-management, and so these were included 
next to check for interactions with psychological distress. The steps in creating the final model are 
shown in table 6.5. 
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The baseline model explained 20.1% of the variance in self-reported self-management 
behaviours. This model was statistically significant. In the second step, depression measured by the 
PHQ-9 was added, explaining an additional 3.5% of the variance (F change = 4.47, p = 0.037). For the 
final step, patient activation was added, explaining an additional 3.3% of the variance (F change = 
5.38, p = 0.022). The final model explained 27.9% of the variation in self-management behaviour 
scores. 
 
Table 6.5: Regression model predicting variation in self-management behaviours 
 
Model 1 R2 = 0.201     F = 4.91(5,98)     P < 0.001 
 β p 
Age -0.007 0.005 
Sex -0.138 0.051 
KRU -0.42 0.088 
Dry weight -0.001 0.735 
Comorbidity 0.005 0.673 
Model 2 
(+ PHQ-9) 
β = 0.015 R2 = 0.236   F = 4.99(6,97)  p < 0.001   F change = 4.47(1,97)   p = 0.037 
Model 3  
(+ PAM-13) 
β = 0.016 R2 = 0.279   F = 5.20(,94)  p < 0.001   F change = 5.38(1,94)   p = 0.022 
 
Anxiety was included as a step after depression in an exploratory model, but did not explain 
any additional variance. This is not surprising, as depression and anxiety are highly correlated in the 
observed data (table 6.2), and as we would expect from the background literature (Norton et al., 
2013). Self-efficacy did not make any significant contribution to the model over depression, and so 
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was not included in the final model. As previously noted, depression and anxiety were highly 
correlated, and results that held true for depression also held true for anxiety. For the purpose of 
the following regression and mediation analysis, depression was used as a single marker of general 
psychological distress. 
A hierarchical regression model including the same covariates in table 6.5 was constructed, 
this time predicting the variation in the defensive self-management composite subscale. Self-
efficacy, depression, and illness perceptions were then added to the model in individual steps. The 
results are presented in table 6.6. Self-efficacy and depression both significantly improved the 
model, but illness perceptions did not. Changing the order in which predictors were added, 
beginning with illness perceptions, resulted in illness perceptions and depression significantly 
improving the model while self-efficacy did not, implying self-efficacy and illness perceptions 
account for a similar portion of the variance in defensive self-management scores. 
Table 6.6: Hierarchical regression with self-efficacy and depression predicting defensive self-
management 
 
Model 1 R2 = 0.082     F = 1.70(5,96)     P = 0.141 
 β p 
Age -0.171 0.055 
Sex -0.112 0.657 
KRU 0.123 0.888 
Dry weight 0.008 0.339 
Comorbidity -0.21 0.647 
Model 2 
(+ self-efficacy) 
β = 0.167 R2 = 0.163   F = 3.08(6,95)  p = 0.009   F change = 9.23(1,95)   p = 0.003 
Model 3  
(+ PHQ-9) 
β = 0.059 R2 = 0.215   F = 3.69(7,94)  p = 0.002   F change = 6.301(1,94)   p = 0.014 
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6.3.4 Mediation analysis 
 
As self-efficacy explains a greater portion of the variance in defensive self-management 
scores, and is of particular theoretical interest in self-management, mediation analysis was 
conducted on the relationship between self-efficacy, depression, and defensive self-management 
scores. 
The Sobel-Goodman method was used. Self-efficacy was entered as the predictor, defensive 
self-management behaviours entered as the dependent variable, and depression entered as the 
mediator. Significant relationships were found between self-efficacy and self-management, self-
efficacy and depression, and depression and self-management. The indirect effect was found to be 
significant. This was confirmed using bootstrapping based on 1000 resamples. 
Defensive self-management behaviours were regressed on self-efficacy (path c).  This model 
was significant F(1, 103) = 9.86, p < 0.01. Next, depression was regressed on self-efficacy (path a). 
This model was significant F(1, 103) = 46.9, p < 0.001. Defensive self-management behaviour was 
regressed on depression and self-efficacy (paths b and c’). The model was significant F(2, 102) = 
15.12, p < 0.001. Using the Sobel-Goodman test, the indirect effect was significant (coefficient = -
0.15, p < 0.001). Bootstrapping using 1000 resamples was used to obtain confidence intervals for the 
indirect effect (coefficient = 0.15, standard error = 0.05, 95% confidence intervals -0.25 to -0.05). 
In order to test for an inverse relationship between self-efficacy and depression, the same 
analysis was conducted post-hoc, with depression as the predictor and self-efficacy as the mediator. 
Here the indirect effect was not significant. From this cross section of data, it appears that 
depression mediates the relationship between self-efficacy and defensive self-management 
behaviour, but that the reverse is not true. 
 
 
162 
 
6.4 Discussion 
 
The aim of the study was to explore which psychological factors predict self-management 
behaviours in people on in centre-haemodialysis for ESRD. 
6.4.1 Depression, anxiety, and psychological distress 
 
In the observed data from this study, depression and anxiety were highly correlated. 
Furthermore, in almost every case, depression and anxiety produced highly similar results in every 
analysis they were included in. For this reason, depression and anxiety will be referred to as 
‘psychological distress’ unless a finding is relevant to one variable but not the other. 
 
6.4.2 Relationships between psychological variables 
 
 Correlation of an array of psychological variables revealed some interesting relationships. 
Self-efficacy was highly positively related to health status as measured by the EQ5D; people who 
were more confident at managing their condition had better health status. Further, health status 
and psychological distress were inversely related; people with worse health status were more likely 
to be depressed and anxious. 
 
6.4.3 Relationship between psychological variables and self-management 
 
For univariate correlations, only psychological distress was related to self-reported self-
management behaviour. This concurs with previous literature from other diseases. For example, in a 
review of self-reported self-management behaviours in Coronary Heart Disease, psychological 
distress was related to performance of fewer self-management behaviours (such as breathing 
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techniques, use of and incentive spirometer, and physical exercises) at home following bypass graft 
surgery (Fredericks, Lapum, & Lo, 2012).  
The findings regarding relationships between self-management behaviours and 
psychological variables were surprising for two reasons. First, neither self-efficacy nor patient 
activation were related to self-management behaviours in the basic analysis. A host of prior 
empirical work links these factors to self-management behaviours, and so they were added to the 
regression analysis after psychological variables. 
The second surprising finding was that psychological distress was positively correlated with 
self-management behaviours. That is, the higher the score on distress screening tools, the higher the 
number of self-reported self-management behaviours. The summed total of the self-management 
scale is a representation of how much a person is ‘doing for themselves’, but certain subscales are 
known to relate to different ‘styles’ of self-management (Curtin et al., 2004). By breaking the scale 
down into its component subscale totals (table 6.3) and relating these back to depression, it 
emerges that only the subscales relating to defensive behaviours are significantly related to 
depression. 
Depression and patient activation emerge as predictors when modelling self-management 
scores using hierarchical regression. This remains true after controlling for common confounders in 
this patient group in the first step of the model: age, sex, residual kidney function, dry weight, and 
comorbidity. Anxiety did not significantly add explanatory power to the model, but the exact same 
steps were repeated with anxiety instead of depression, yielding almost identical results. This is not 
surprising given how strongly correlated depression and anxiety are in the literature and in the 
observed data here (Burns & Eidelson, 1998). 
 When breaking self-management down into its two component subscales of 
cooperative and defensive behaviours, it appears that self-efficacy and depression predict defensive, 
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but not cooperative self-management. These predict defensive self-management scores even after 
controlling for known confounding variables. A mediation analysis suggested that, furthermore, 
depression mediates the relationship between self-efficacy and self-management behaviours. Given 
that many interventions to alter self-management and patient involvement hinge on self-efficacy, 
this analysis suggests that the presence of depressive symptoms may play a key role in the success 
or failure of those interventions. Therefore, treating depression may be a key first, or concurrent, 
step in modifying self-management behaviours, in addition to fostering self-efficacy.  
The fact that the greater the self-efficacy, the less severe the perceptions of the illness, 
warrants further exploration, as there is a debate as to whether it makes theoretical sense to sum 
the domains of illness perceptions into a single summary score, given how distinct the domains of 
the scale are (Broadbent et al., 2006). Often perceiving an illness as more severe may simply mean 
that the individual is aware of the reality regarding the severity of their condition, and may be 
considered adaptive rather than maladaptive (Hurt et al., 2014). However, an in depth analysis of 
illness perceptions goes beyond the scope of this dissertation. Given the relationship between illness 
perceptions and mortality, this could produce interesting avenues for development of future 
interventions. 
 
6.4.4 Relationship between bothersome symptoms and self-management 
 
 Interesting zero order correlations for symptoms emerged. Symptoms were measured by 
asking how many symptoms individuals experienced, and how much they bothered them. This 
proved to be positively correlated with psychological distress. This relationship is unsurprising, as 
individuals who are distressed  are more likely to hold negative perceptions (Detweiler-Bedell, 
Friedman, Leventhal, Miller, & Leventhal, 2008). Additionally, worse symptoms may also be the 
cause of psychological distress. This relationship has been demonstrated in a number of studies in 
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which reduction in somatic symptoms was associated with reduced psychological distress, including 
when there was no change in physiologic measures of illness (Katon, Lin, & Kroenke, 2007).  
The more numerous and bothersome the perceived symptoms, the lower an individual’s 
self-efficacy, while self-reported self-management behaviours were more numerous and frequent. 
This means that individuals reporting worse symptoms reported that they felt less confident in 
dealing with their illness, while reporting that they did more to manage it. It may be that those who 
are experiencing bothersome symptoms, and are engaging in proactive self-management strategies 
without symptom reduction, feel that they have less control over their condition and those 
symptoms. 
Awareness of the impact of these different domains of self-management, and how they may 
variably affect confidence and behaviour, may be of particular importance when deciding what to 
measure in future research, and when designing interventions. 
 
6.4.5 Strengths and limitations 
 
 Although the mediation model is highly suggestive of causation, the use of a cross sectional 
design means that it is not possible to reliably infer causation from the observed data. It is therefore 
not clear whether psychological distress prompts defensive self-management behaviours, or 
whether defensive self-management behaviours increase the likelihood of distress. This study did 
not investigate the role of social support, but future work could investigate the relationship between 
defensive self-management behaviours, psychological distress, and social isolation, which may be 
another mediator in this relationship, alongside patient activation. 
 Strengths of the research include a robust sample size, a sample that is representative of the 
wider UK renal population in terms of screening scores for psychological distress, and the 
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examination of a novel combination of psychological factors in relation to a broad range of self-
management behaviours. 
 
6.4.6 Conclusion 
 
Psychological distress, self-efficacy, and patient activation are associated with self-
management behaviours in people with End Stage Renal Disease. These results support and go 
beyond previous findings that there may be different ‘styles’ of self-management, and that 
defensive ‘do it all by oneself’ self-management behaviours may be associated with psychological 
distress, a trait not shared by people who engage in cooperative self-management behaviours. 
Furthermore, self-efficacy predicts defensive self-management, and depression may mediate this 
relationship. If so, this has important implications for how interventions to modify self-management 
behaviour are conducted. 
This chapter has explored how psychological variables predict self-management behaviour in 
this sample. The next chapter will examine the impact of self-management behaviours on clinical 
outcomes. An investigation of the relationship between self-management behaviour and associated 
psychological variables on clinical status and survival over time is presented in the next chapter. 
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7.1 Introduction 
 
 Findings presented so far have demonstrated that the concept of what constitutes ‘good’ 
self-management varies between healthcare professionals (HCPs) and patients. They have also 
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shown that defensive self-management behaviours such as selective reporting of symptoms and 
assertive self-advocacy are associated with higher levels of psychological distress, and lower self-
efficacy. Evidence has also supported the hypothesis that there are two subtypes of self-
management behaviour; cooperative and defensive, and that these may have different relationships 
with emotional status. 
 The present chapter presents a novel analysis of the relationships between self-
management behaviours, psychosocial status, and adherence as indicated by IDWG and phosphate. 
An analysis of the relationship between self-management and survival among people on 
haemodialysis will also be undertaken. This will be investigated using data captured at three time 
points (baseline, 9 months, and 18 months follow-up) from people on in-centre haemodialysis in the 
UK. It is hypothesised that self-management behaviours will predict changes in clinical status over 
time, as well as predicting survival. 
 
7.1.1 Background 
 
 Compared to cross-sectional work, theoretically driven longitudinal studies into self-
management have been comparatively rare. There is often a paucity of data on which to base 
hypotheses about change over time, but this makes collecting this data especially important. 
Hypotheses used to guide the analysis presented here were developed based on findings presented 
in chapter 6, and the background literature, some of which is covered in overview in chapters 2 and 
3. A summary of relevant prior work is presented below. 
 
7.1.2 Changes in patient activation, self-efficacy, and self-management behaviour over time 
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Most analyses of patient activation have been cross sectional, despite being framed as a 
useful tool for affecting behaviour prospectively in clinical practice (NHS England, 2013). In the work 
that has been conducted among chronic disease populations, it has generally been found to be fairly 
stable when no intervention is present. For example, in a group of 287 people with diabetes in the 
USA, patient activation did not change over 6 months where no intervention was present, although 
activation was associated with self-management behaviours like foot checking, eye examinations, 
and exercise (Rask et al., 2009). In another study with participants without chronic illness, changes in 
activation were associated with a change in health behaviours like exercise and eating breakfast 
(Harvey, Fowles, Xi, & Terry, 2012). As discussed in previous chapters, given cross sectional 
associations between activation and self-management behaviour (e.g. Smith, Pandit, Rush, Wolf, & 
Simon, 2014; Alegría, Sribney, Perez, Laderman, & Keefe, 2009), we may expect in the present study 
that if activation changes over time, so too will self-management behaviour. We may expect 
activation to change over time in an ESRD population, as this is what has happened over the course 
of the limited longitudinal observational work on the PAM in this population (NHS Kidney Care, 
2013). 
As addressed in chapter 6, self-efficacy is associated with self-management behaviour in 
multivariate models. They have also been shown to be correlated in previous studies when 
measured concurrently among people with CKD ( Curtin et al., 2008). Studies among people with 
ESRD that have looked at self-efficacy over time have mostly been small, self-efficacy based 
intervention studies looking at clinical markers of adherence. For example, in a 12 week self-efficacy 
intervention versus control group study, self-efficacy increased in the active group and was 
associated with reductions in IDWG (Tsay, 2003). In another study, self-efficacy increased over the 
course of the study, and was associated with a small decrease in serum creatinine levels while GFR 
remained relatively stable (Lin, Tsai, et al., 2013). Given the focus on enhancing self-efficacy used in 
these interventions, it may be that it is the change in self-efficacy that affects the change in self-
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management – although Social Cognitive Theory (SCT) would argue that this is a reciprocal 
relationship. An improvement in one domain will affect change in the other. 
 
7.1.3 Relationship between self-management behaviour and clinical status or adherence 
 
 Self-management as a set of behaviours can be difficult to disentangle from adherence as a 
single concept, and the two ideas are often conflated (see chapters 2 and 3 for discussion of this 
topic). While adhering to prescribed treatment may well be considered self-management behaviour, 
it is a very narrow aspect of it. The self-management scale from Curtin et al. (2004) was specifically 
chosen for this study as it represents broader topics in self-management, such as information 
seeking and patient-provider communication, while not asking about adherence. This means that 
broader self-management could be teased apart from clinical markers of adherence, in this case 
IDWG and phosphate. 
 In a previously described study, self-management behaviour did not change over time, but 
serum creatinine did (Lin, Tsai, et al., 2013). It may be that the specific behaviours that were asked 
about did not adequately capture lifestyle changes that were produced as a result of modifying self-
efficacy. 
  
 There is some suggestion for example, that health related information seeking is related to 
adherence – but the relationship is not always a positive correlation. In the USA, a large national 
study found that information seeking was associated with attending breast, cervical and colorectal 
screenings on schedule (Shneyderman et al., 2015). Similarly, information seeking in Inflammatory 
Bowel Disease (IBD) predicted medication adherence (Pittet et al., 2014). In a more nuanced look at 
the topic, Carter and colleagues (2013) looked at different types of medication information seeking 
in people using multiple medicines. They found that patients seeking information from autonomous 
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sources (such as looking something up on the internet) were more likely to be non-adherent than 
those who did not. Whether or not patients sought information from healthcare professionals was 
unrelated to adherence. 
 Engagement in shared decision making can also be regarded as a self-management 
behaviour. In a study of shared decision making in type-2 diabetes, no relationship was found 
between shared decision making and health outcomes, although the authors attribute this to 
statistical power (Branda et al., 2013). 
 
7.1.4 Self-management and survival 
 
 The relationship between self-management behaviours as a broad measure and survival has 
not been looked at in detail in ESRD. When considering adherence, it is often taken for granted that 
adhering to a prescribed treatment will alter clinical status and mortality risk. It is known, for 
example, that high IDWG, hyperphosphetamia and skipping dialysis sessions is associated with 
increased risk of mortality (Saran et al., 2003). However, while hyperphosphatemia is a known risk 
factor for cardiovascular events and all-cause mortality, successfully adhering to dietary changes and 
use of phosphate binders does not necessarily modify that risk (Covic & Rastogi, 2013).  
Outside of CKD, there is some mixed evidence about whether or not self-efficacy can predict 
survival. Two recent studies asked whether self-efficacy can predict survival in older, not necessarily 
ill, adults. One found that the 12-item version of the General Self-efficacy Scale predicted decline in 
physical function in this population, but not mortality (Hoogendijk et al., 2014). Another found that 
‘sense of control’ (a concept related to self-efficacy) did predict 5 year mortality (Chipperfield et al., 
2012). However, self-efficacy for managing disease is not only a specific domain, but also involves 
specific tasks to mitigate specific disease risks, so extrapolating  from a generally well population 
may not be so useful. A five year study in COPD found that self-efficacy predicted mortality. 
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However, when Forced Expiratory Volume (FEV, a measure of lung function) was included as a 
covariate, self-efficacy’s contribution to the model became insignificant. 
There is little data on whether patient activation is associated with mortality. In a meta-
analysis of patient activation-based intervention studies for people with type-2 diabetes, Bolen et al. 
(2014) found low evidence for such interventions to have any impact on mortality. 
As higher IDWG is known to be a risk factor for mortality, and that improving self-efficacy 
and self-management behaviour can reduce IDWG (Saran et al., 2003), it is therefore theoretically 
plausible that direct measurement of self-management behaviour may allow prospective 
modification of mortality risk. It is unclear whether self-efficacy and patient activation should predict 
survival. If they did, we might expect this to be a result of changes in self-management behaviour. It 
may be that, once again, there are different approaches to shared decision making, or that a match 
between patient preferences and the service provided is important. Among psychiatric patients, it 
was recently found that treatment adherence was greatest when patient preference for their level 
of involvement was congruent with the type of participation they actually achieved, regardless of 
whether this was a high or low level of involvement (De las Cuevas, Peñate, & de Rivera, 2014). 
We might reasonably expect clinical status reflecting adherence to be associated with self-
management scores. It is worth noting however, that often the picture is more nuanced, and there 
are often different types of self-management and patient engagement. 
 
7.1.5 Hypotheses 
 
Based on the literature discussed above, and findings from chapter 6, two hypotheses were 
generated to guide the following analysis: 
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1. Self-management behaviour, patient activation, self-efficacy, and depression symptoms will 
significantly contribute to models predicting clinical status over the whole 18 months, after 
time and other covariates have been controlled for 
2. Self-management behaviour, patient activation, self-efficacy, and depression symptoms will 
predict survival over follow-up 
 
7.2 Methods 
 
7.2.1 Participants 
 
Data were taken from following up participants described in chapter 6 over 18 months. This 
includes baseline data (some of which is described in chapter 6), 9 month follow-up, and 18 month 
follow-up.  
Eligible patients were approached across three dialysis centres in Hertfordshire. The sample 
consisted of the first consecutive 104 patients to consent, although a roughly proportional number 
of participants were approached relative to the size of the unit. All participants were adults, as care 
and life responsibilities are more likely to be undertaken by the family in paediatric haemodialysis, 
and these skills will be learned as they transition to adult services  (Watson & Warady, 2011). All 
participants were able to speak at least basic English, as some questionnaires were unavailable in 
translated forms, and translation was beyond the scope of this study. Participants had at least 3 
months of experience of life on dialysis, so that they had some experience of the situations 
described in the self-management questionnaire. While comorbidity was not an excluding factor (as 
comorbidity is present in the majority of people with ESRD, and exclusion would result in an 
unrepresentative sample), people due to receive a transplant or with very poor prognosis were 
excluded, due to the longitudinal nature of the study. Comorbidity status was recorded to be 
included as a confounding variable. 
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7.2.2 Questionnaires 
 
As described in chapter 4 (methods), questionnaire data were collected in the dialysis units, 
while participants were dialysing. Questionnaires included the self-management behaviours on 
dialysis questionnaire, PHQ-9, self-efficacy in chronic disease 6 item questionnaire, and the Patient 
Activation Measure 13 (PAM-13).  The BHDS, PHQ-9, and, self-efficacy in chronic disease scale were 
administered at baseline, 9 months, and 18 months. Participant feedback during baseline data 
collection indicated that questionnaire packs were considered overly lengthy. In order to reduce 
participant burden during 9 month follow-up, the PHQ-9 and PAM-13 were omitted from 
questionnaire packs, reducing the total number of items to be completed. All questionnaires were 
administered at 18 month follow-up to allow pre-post comparisons over the whole 18 months. 
 
7.2.3 Clinical status 
 
Information on clinical status was collected from routine measures recorded on the 
RenalPlus database, accessed at Lister Hospital, Stevenage. In addition to residual kidney function 
(KRU) and Charlson comorbidity score, used as covariates in chapter 6, data were collected on latest 
interdialytic weight gain (IDWG) value in kilograms, latest serum phosphate in mmol/l, and three 
month averages for both. While latest scores give a more immediate picture of how a participant is 
doing clinically closest to the time they are filling in a questionnaire, IDWG can vary substantially 
from one dialysis session to the next. Including 3 month averages in addition to latest values allows 
analyses of how a patient is managing their fluid in general. IDWG was also converted to IDWG as a 
proportion of dry weight ([IDWG in kilograms ÷ dry weight] x 100), to account for higher expected 
IDWG for heavier participants. 
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7.2.4 Statistical methods 
 
A brief overview of logistic regression, mixed modelling, and survival analysis is provided in 
chapter 4 (methods).  
Basic exploration of data was conducted using Pearson’s correlation, t-tests, and McNemar 
tests of proportions. Modelling was conducted using a combination of multilevel modelling, logistic 
regression, Kaplan-Meier and Cox proportional hazard analyses. A brief outline of these modelling 
methods follows; for more detail, see 4.10 Statistical analysis. 
Multilevel models (MLMs) are regression models that take into account ‘nested’ structures 
in data, where observations (level 1 variables) are expected to be correlated based on common 
groupings (level 2 variables). In the following analysis, participant level observations at a given time 
point such as IDWG or self-management behaviour score are treated as level 1 variables. These are 
nested within participant, the level 2 variable. In practice this allows for correlation within 
participants (intraclass correlation or ICC) over repeated measures to be quantified and controlled 
for. As observations were collected from three different locations, research site was also tested as a 
third level variable and ICC assessed. All predictor variables were grand mean centered where 
appropriate, as discussed in each model. Time as a predictor was not grand mean centered, but 
instead left untransformed. 
Logistic regression is a form of regression that is capable of handling a binary response 
variable, using either continuous or dummy coded categorical predictors. Here it was used to assess 
whether observations that were ‘missing’ or ‘non-missing’ for questionnaire items at 18 month 
follow up appeared to be due to systematic variation in observed demographic, clinical and 
psychological variables. 
Survival analysis methods allow investigation of ‘time to event’ data. The event of interest in 
this analysis was mortality. Kaplan Meier survival curves were used to visualise cumulative survival 
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over time for different groups, with participants stratified into one of two groups based on their 
baseline score for variables of interest. Log rank tests were used to test for differences between 
these basic groupings. While these analyses cannot handle covariates such as age or comorbidity, 
they were used to explore basic effects between potential predictors and survival. In order to further 
investigate observed group differences, Cox Hazard Proportion regression was used. Cox regression 
allows ‘hazard’ (chance of the event of interest occurring) to be regressed on multiple continuous 
and categorical predictors. This allows for controlling of covariates, and a more robust analysis of the 
contribution of predictors of interest after controlling for covariates. 
 
7.3. Results 
 
The results will begin with an overview of univariate change over time for IDWG, phosphate, 
self-management, self-efficacy, patient activation, and depressive scores. To address hypothesis 1 
(predicting IDWG and phosphate over time), the relationships between these variables will be 
modelled.  Hypothesis 2 (predicting survival) will then be addressed. 
7.3.1 Univariate change over time 
 
 Change over time can be seen in table 7.1. IDWG, mean self-management, 
cooperative self-management, and defensive self-management remained mostly stable across the 
three time points over 18 months. Self-efficacy decreased from the start (m = 6.90, SD = 2.04) to the 
end of the study (m = 6.53, SD = 2.02), but this change was not significant (paired samples t-test, t = 
0.91, df = 35, p = 0.37). Depression decreased from the start (m = 7.1, SD = 5.82) to the end of the 
study (m = 5.68, SD = 5.31), but this was also non-significant (paired samples t-test, t = 1.58, df = 33, 
p = 0.12). Patient activation increased from the start (m = 52.09, SD = 13.64) to the end of the study 
(m = 60.71, SD = 14.57), and this increase was significant (t = 3.02, df = 37, p < 0.01). Phosphate 
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decreased from the start of the study (m = 1.71 m/mol, SD = 0.42) to the end of the study (m = 1.60 
m/mol, SD = 0.40), and this result was significant (paired samples t-test, t =3.70, df = 157, p < 0.001).  
 
Table 7.1 Descriptive statistics for clinical, behavioural and psychosocial variables over time 
 
 Baseline 9 month follow-up 18 month follow-up 
 N Mean(SD) N Mean(SD) N Mean(SD) 
IDWG (KG) 103 1.44(0.80) 83 1.43(0.80) 78 1.45(0.77) 
Phosphate 
(m/mol) 
104 1.71(0.42) 83 1.71(0.44) 78 1.60(0.40) 
Cooperative SM 104 7.50(1.84) 50 7.47(1.49) 38 7.65(1.84) 
Defensive SM 104 4.18(1.24) 50 4.08(1.06) 38 4.08(0.85) 
Self-efficacy 104 6.90(2.04) 50 6.63(2.02) 36 6.53(2.61) 
PAM-13 104 53.54(13.6
4) 
- - 38 60.71(14.5
7) 
PHQ-9 101 7.46(5.82) - - 35 5.6(5.31) 
 
 
7.3.2 Attrition for self-management observations 
 
At baseline, 104 participants gave consent and filled in all questionnaires. Between baseline 
and 9 month follow-up, 14 patients died, 8 received transplants, 2 switched from HD to PD, and 1 
moved out of the area, totalling 25 patients (remaining n = 81). 50 participants were successfully 
followed up at 9 months (50 out of 81 = 61%) Between 9 month follow-up and 18 month follow-up, a 
further 8 patients died, and 6 received transplants, totalling 14 patients (remaining n = 65). Thirty 
eight participants were successfully followed up at 18 months (38 out of 65 = 58%). Unsuccessful 
follow-up of participants was most frequently due to changing dialysis shifts, participant holidays, 
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and temporary hospitalisation. This overall attrition rate is similar to another recent study of the 
PAM (NHS Kidney Care, 2013). 
In order to assess whether overall loss to follow-up was systematic, which would preclude 
further analysis of longitudinal self-management data, a combination of logistic regression and 
Little’s test (Little, 1988) was used.  The aim was to assess whether data were Missing Completely At 
Random (MCAR) or Missing At Random (MAR). 
Whether or not data were missing at follow-up for each of the self-management variables 
was binary coded, 0 (present) or 1 (missing). A series of logistic regression models were conducted, 
where missing status for each self-management variable in turn was treated as the response 
variable, and other self-management variables and age, sex, comorbidity and KRU were entered as 
predictors. None of these six models returned a significant result for any of the predictors, indicating 
that whether data were missing or not was not systematically related to variables observed in the 
study. 
Additionally, when all variables above, plus IDWG and phosphate, were entered into Little’s 
Test, no relationship between predictors and whether follow-up values were missing or not emerged 
(Little’s MCAR test, chi2 = 81.63, df = 82, p = 0.491). Based on observed data, data were therefore 
assumed to be MCAR. This means that based on observed data, there did not appear to be a 
systematic reason for missing data. Methods of analysis could therefore remain unaffected by 
missing data, but results should still be interpreted with an awareness of the attrition rate. This rate 
of attrition is lower than in a study of the PAM in dialysis patients published by NHS Kidney Care 
(2013), in which of 296 participants at baseline, 72 (24%) completed the PAM at 12 month follow-up. 
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Table 7.2: Proportion of patients in each stage of patient activation at baseline and 18-month 
follow-up 
 
Stage of activation Baseline count 
(%) 
Died Transplant 
/transfer 
Follow-up 
count (%) 
Pre-contemplation 38 (36.54%) 4 3 4 (10.53%) 
Contemplation 20 (19.23%) 2 3 10 (26.32%) 
Action 27 (25.96%) 4  0 14 (36.84%) 
Maintenance 19 (18.27%) 5 5 10 (26.32%) 
     
Total n 104 15 11 38 
 
It appears that the proportion of participants in each category has moved from the lower 
stages of activation to higher stages of activation (see table 7.2). For example, 36.84% of participants 
were in the pre-contemplation stage at baseline versus 12.82% in pre-contemplation at follow-up. 
By contrast 18.27% were in the advanced maintenance phase at baseline, compared to 25.64% at 
follow-up. Due to low power, stages 1 and 2 were combined into a ‘low activation’ group, and stages 
3 and 4 combined into a ‘high activation group’. Restricting analysis to only the 38 participants 
responding at both the start and the end of the study, at baseline n = 23 (60.53%) were in the low 
activation group, and n = 15 (39.47%) were in the high activation group. At 18 month follow-up, n = 
10 (26.32%) participants were in the low activation group, and n = 28 (73.68%) were in the high 
activation group. A McNemar test showed a significant difference in observed versus expected 
events (McNemar’s chi2 = 8.05, d.f. = 1, p < 0.01), suggesting that a significant shift from low 
activation at the start of the study to high activation at the end of the study. 
 
Hypothesis 1: Self-management behaviour, patient activation, self-efficacy, and depression 
symptoms will significantly contribute to models predicting clinical status over the whole 18 months, 
after time and other covariates have been controlled for 
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7.3.3 Multilevel models and the effect of research site 
 
General background on MLMs is provided in chapter 4, and described briefly in the methods 
of this chapter.  
Two separate MLMs were constructed; one modelling the variation in IDWG, and another 
modelling variation in phosphate. Both models constructed here included multiple observations 
(baseline, 9 month, and 18 month follow-up) for each participant, for the response variable (IDWG 
or phosphate) and predictors (e.g. self-management behaviour). These observations were ‘level 1’ 
variables. As we would expect observed values for each participant to be more related to each other 
than to the whole sample, participant ID was the ‘level 2’ variable.  That is, data were ‘clustered’ 
within participant. It is also possible that observations at each research site may be clustered, and 
that research site may need to be included as a ‘level 3’ variable.  
A simple regression analysis was used to test for differences between sites across outcome 
variables for each model. In each case, no significant differences between sites were found. Each 
initial model for IDWG and phosphate was run first with research site included as a level 3 variable 
to allow assessment of the Intraclass Correlation (ICC). These initial models (not shown) resulted in 
an ICC of <0.0001, and as such was negligible. By contrast, the ICC for participants (level 2) was 0.49. 
Therefore a 2 level model was used, and an equation setting out the components of the model will 
be provided in section 7.3.5. 
 
7.3.4 Correlations between IDWG and self-management variables 
 
Table 7.3 shows correlations between IDWG and self-management variables.  
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Table 7.3 Zero order correlations for clinical, behavioural, and psychosocial variables 
 
 1 2 3 4 5 6 7 8 9 10 11 
1. IDWG (baseline) 1           
2. IDWG (9 months) 0.52*** 1          
3. IDWG (18 months) 0.69*** 0.36** 1         
4. Phosphate (baseline) 0.22*** 0.14 0.17 1        
5. Phosphate (9 months) 0.20 0.09 0.19 0.76*** 1       
6. Phosphate (18 months) 0.17 -0.01 0.28* 0.67*** 0.63*** 1      
7. Defensive SM 0.14 -0.10 0.06 0.16 0.24* 0.30** 1     
8. Cooperative SM 0.34*** 0.17 0.20 0.24* 0.31** 0.29** 0.44*** 1    
9. Self-efficacy 0.16 0.24* 0.10 0.01 -0.7 -0.11 -0.30** -0.03 1   
10. PAM-13 0.08 0.25* -0.10 -0.09 -0.07 -0.13 0.03 0.18 0.36*** 1  
11. PHQ-9 -0.06 -0.12 0.01 0.13 0.26* 0.21 0.47*** 0.23* -0.56*** -0.21* 1 
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IDWG at baseline was correlated with mean self-management scores, but not at follow-up. 
This appears to be due to the cooperative subscale also being correlated with IDWG at baseline, but 
not follow-up. Defensive self-management was not correlated at any time point. Both self-efficacy 
and patient activation were correlated with IDWG at 9 months, but not baseline or 18 month follow-
up. Baseline depression measured by the PHQ-9 was not correlated with IDWG at any time point. 
 
7.3.5 The relationship between IDWG and self-management 
 
 In order to assess the relationship between self-management variables and IDWG over time, 
mixed models were built. A model with time as the only predictor was the starting point (model 1). 
Log likelihood change was then assessed in subsequent steps as demographic covariates were added 
(model 2), followed by self-management behaviours (model 3), then patient activation (model 4), 
then depression (model 5). Random slopes were added for cooperative and defensive self-
management in model 6. In order to improve statistical power when estimating precision around 
parameter estimates, multiple imputation was used for self-management variables, based on 10 
imputations. This only applies to parameter estimates, not log likelihood, as log likelihood cannot 
normally be calculated when using multiple imputation (Meng & Rubin, 1992). All predictors other 
than sex (a binary predictor) were grand mean centred to aid in the interpretation of the intercept. 
The models can be seen in table 7.4. 
 The equation for the final model (model 6) is as follows: 
 
 Where Yij is IDWG for each participant for each observation (i) nested within participant (j). 
γ00 is the fixed intercept for the model; that is, the value of IDWG when all predictors are either zero, 
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or at their grand mean (for those that were grand mean centred). γ10 is the fixed slope for 
cooperative self-management, and μ1j is the variance of slopes for each participant around  γ10, in 
other words a measure of whether the relationship between cooperative self-management and 
IDWG is similar across participants or not. This fixed slope plus between slope variance component is 
repeated for defensive self-management (γ20 + μ2j). The following coefficients, γ30(timeij) to γ90(phqij) 
are the fixed regression coefficients for the remaining variables. μ0j is the random intercept, or 
variance of the intercept for each participant for all predictors around the overall intercept for all 
participants combined (γ00). Finally, rij represents the residuals for each observation nested within 
participant.  
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Table 7.4 Steps for building an MLM predicting IDWG as a proportion of dry weight 
 
Notes: Values in brackets represent 95% confidence intervals 
Parameter Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Intercept 2.00 (1.78, 2.20)* 2.01 (1.86, 2.29)* 2.06 (1.84, 2.27)* 2.06 (1.85, 2.28)* 1.96 (1.24, 2.70)* 1.94 (1.21, 2.67)* 
   Level 1       
Time 0.01 (-0.01, 0.01) 0.01 (-0.04, -0.01) -0.01 (-0.01, 0.01) -0.01 (-0.01, 0.01) -0.01 (-0.01, 0.01) -0.01 (-0.01, 0.01) 
Age  -0.03 (-0.04, -0.02)*** -0.02 (-0.04, -0.01)*** -0.02 (-0.04, -0.01)*** -0.27 (-0.04, -0.01)*** -0.03 (-0.04, -0.01)*** 
Sex  -0.21 (-0.56, 0.12) -0.17 (-0.50, 0.17) -0.16 (-0.50, 0.17) -0.17 (-0.51 , 0.18) -0.17 (-0.51, 0.18) 
Comorbidity  0.04 (-0.02, 0.10) 0.03 (-0.03, 0.09) 0.03 (-0.03, 0.09) 0.03 (-0.03, 0.09) 0.03 (-0.03, 0.09) 
KRU  -0.20 (-0.32, -0.08)*** -0.17 (-0.29, -0.05)** -0.17 (-0.29, -0.05)** -0.16 (-0.28, -0.03)* -0.16 (-0.28, -0.03)* 
Cooperative SM   0.10 (0.01, 0.19)* 0.10 (0.01, 0.19)* 0.09 (0.01, 0.19)* 0.09 (0.01, 0.18)* 
Defensive SM   -0.05 (-0.20, 0.10) -0.50 (-0.20, 0.10) -0.03 (-0.20, 0.13) -0.03 (-0.19, 0.12) 
PAM-13    0.01 (-0.01, 0.02) -0.01 (-0.01, 0.01) 0.01 (-0.01, 0.02) 
PHQ-9     -0.03 (-0.06, 0.01) -0.03 (-0.06, 0.01) 
   Level 2       
Intercept (σ2) 0.79 (0.65, 0.96)* 0.63 (0.50, 0.80)* 0.63 (0.50, 0.80)* 0.63 (0.50, 0.81)* 0.62 (0.48, 0.80)* 0.71 (0.53, 0.94)* 
Cooperative SM      0.01 (0.01, 0.01) 
Defensive SM      0.18 (0.03, 1.13)* 
LL 371.05 363.23 278.31 278.87 274.18 274.00 
-2* log likelihood  15.64* 169.84*** -1.12 9.38* 0.36 
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 In Model 1, time is the only predictor included in the model, and the slope is non-significant 
as IDWG remained relatively stable at each time point. As time was uncentered, the intercept shows 
that mean IDWG for all participants at baseline was 2.00 (95% CI = 1.78, 2.20). 
 In model 2, age, sex, comorbidity and KRU were added to model 1. Slope for age (β = -0.3, 
95% CI = -0.04, -0.02) and KRU (β = - 0.20, 95% CI = - 0.32, -0.08) emerged as significant predictors of 
IDWG. IDWG decreased as age and KRU each increased when all other variables, including time, 
were held constant. LL significantly improved from model 1 to model 2 (2 x LL change = 15.64, p < 
0.01, df = 4). 
 In model 3, defensive and cooperative self-management were each added to model 2 
simultaneously.  The fixed slope for defensive self-management was non-significant, but for 
cooperative self-management was significant (β = 0.10, 95% CI = 0.01, 0.19). As cooperative self-
management increased, so did IDWG. The improvement in overall model fit from including self-
management behaviour was large (2 x LL change = 169.83, p < 0.001, df =2). 
 In model 4, patient activation was added to model 3. The slope for patient activation was 
not significant (β = 0.01, 95% CI = -0.01, 0.02), and its addition did not substantially change 
relationships observed in model 3. Log likelihood slightly increased, indicating worse model fit. 
 Model 5 added depression to model 4. As there was no mid-time point data for depression, 
only baseline values were included and it was treated as a time-invariant predictor. The slope for 
depression negatively related to IDWG, but this relationship was not significant (β = -0.03, 95% CI = -
0.06, 0.01). Model 5 showed significantly better fit than model 4 (2 x LL change = 9.38, p < 0.001, df = 
1). 
 Model 6 tested the addition of random slopes for self-management behaviours, to test 
whether accounting for between-person variation in slope for IDWG regressed on self-management 
improved model fit, and whether slopes for IDWG on self-management for each individual were 
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significantly different from the mean IDWG on self-management slope for all participants. The 
improvement in LL was negligible from model 5 to model 6 (2 x LL change = 0.36, p > 0.20, df = 2). 
The random slope estimates indicated that slopes for the relationship between defensive self-
management and IDWG significantly varied from the mean slope for all participants combined (β = 
0.18, 95% CI = 0.03, 1.13). In model 6, the fixed slopes for age, KRU, and cooperative self-
management remained significant predictors of IDWG. 
 
7.3.6 Correlations between phosphate and self-management variables 
 
 Table 7.3 shows correlations between phosphate at baseline and self-management 
variables. Self-management and phosphate were positively correlated with phosphate at baseline (r 
= 0.26, p <0.01), 9 month (r = 0.34, p < 0.01), and 18 month follow-up (r = 0.31, p < 0.01). This 
relationship was apparent for cooperative self-management, and for defensive self-management at 
both follow-up times, but not at baseline. Self-efficacy and patient activation were not correlated 
with phosphate. Depression was correlated with phosphate at 9-month follow-up only (r = 0.26, p < 
0.05). 
 
7.3.7 The relationship between phosphate and self-management 
 
 Mixed models for phosphate were built using the same method as for IDWG. Models were 
built by adding predictors in a theoretically determined fashion, all predictors besides sex were 
grand mean centred, log likelihood change was assessed using non-imputed data, while parameter 
estimates reported here were obtained using multiple imputation. The steps in building the model 
can be seen in table 7.5. The equation for the combination of predictors is the same as for IDWG, see 
7.3.5 (predicting IDWG with self-management variables). 
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 Model 1 treated each phosphate observation as the level 1 response variable. Participant ID 
was used as the level 2 variable. Time was entered as the only predictor, with a random intercept 
and fixed slope. Time was significantly related to phosphate (β = -0.01, 95% CI = -0.01, -0.01). 
Between baseline and 18 month follow-up, phosphate decreased. Model log likelihood was -93.93. 
 In model 2, demographic covariates were added as predictors with random intercepts and 
fixed slopes. Age (β = -0.01, 95% CI -0.01 to -0.01) and comorbidity (β = -0.04, 95% -0.07 to -0.01) 
were significantly negatively associated with phosphate. Model 2 did not significantly improve fit 
over model 1 (2 x LL change = 3.06, p < 0.20, df = 4). 
 Model 3 added cooperative and defensive self-management to model 2. Neither cooperative 
self-management (β = 0.01, 95% CI = -0.01, 0.03), nor defensive self-management (β = -0.02, 95% CI 
= -0.07, 0.03), were related to phosphate. Model fit was significantly improved over models 1 and 2 
(model 3 v model 2 2 x LL change = 24.40, p < 0.001, df = 2). 
 Model 4 added patient activation to model 3. Fixed slope for patient activation against 
phosphate was not significant, and significantly worsened model fit (2 x LL change = -4.58, p < 0.05, 
df = 1). In a separate model, self-efficacy was entered instead of patient activation for this step. 
Results were highly similar. 
 Model 5 added depression to model 4. Depression was not significantly related to phosphate 
in the model. Model fit was marginally worsened again compared to model 5 (2 x LL change = -0.15, 
p > 0.20, df = 1).   
 Model 6 added random slopes for cooperative and defensive self-management to model 5. 
The variance for the defensive self-management slope was significant (β = 0.90, 95% CI = 0.03, 0.26), 
indicating that the relationship between defensive self-management and phosphate varied between 
participants compared to the mean relationship between the two for all participants. Fixed slopes 
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for time and comorbidity remained significant, while age was reduced to non-significance. Model 6 
did not significantly improve fit over model 5 (β = 1.12, p < 0.20, df = 2). 
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Table 7.5: Steps for building an MLM predicting phosphate 
 
Notes: Values in brackets represent 95% confidence intervals 
Parameter Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Intercept 1.73 (1.65, 1.80)* 1.74 (1.66, 1.83)* 1.73 (1.65, 1.82) 1.75 (1.66,1.83) 1.74 (1.65, 1.83) 1.71 (1.59, 1.83) 
   Level 1       
Time -0.01 (-0.01, -0.01)* -0.01 (-0.01, 0.01)* -0.01 (-0.01, -0.01)* -0.01 (-0.01, -0.01)* -0.01 (-0.01, -0.01)* -0.01, (-0.01, -0.01)* 
Age  -0.01 (-0.01, -0.01)* -0.01 (-0.01, 0.01) -0.01 (-0.01, 0.01) -0.01 (-0.01, 0.01) -0.01 (-0.01, 0.01) 
Sex  -0.06 (-0.20, 0.08) -0.06 (-0.20, 0.08) -0.06 (-0.20, 0.09) -0.05 (-0.20, 0.09) -0.03 (-0.18, 0.12)  
Comorbidity  -0.04 (-0.07, -0.01)** -0.04 (-0.07, -0.02)*** -0.04 (-0.07, -0.02)*** -0.04 (-0.07, -0.02)*** -0.04 (-0.07, -0.02)*** 
KRU  -0.02 (-0.07, 0.03) -0.02 (-0.07, 0.04) -0.02 (-0.07, 0.03) -0.02 (-0.07, 0.04) -0.01 (-0.06, 0.04) 
Cooperative SM   0.01 (-0.01, 0.03) 0.01 (-0.01, 0.03) 0.01 (-0.01, 0.03) 0.01 (-0.01, 0.04) 
Defensive SM   -0.02 (-0.07, 0.03) -0.02 (-0.06, 0.03) -0.20 (-0.06, 0.02) -0.03 (-0.08, 0.03) 
Self-efficacy    0.01 (-0.01, 0.03) 0.01 (-0.01, 0.03) 0.01 (-0.01, 0.03) 
PHQ-9     0.01 (-0.01, 0.02) 0.01 (-0.01, 0.02) 
   Level 2       
Intercept (σ2) 0.35 (0.30, 0.41) 0.30 (0.25, 0.36) 0.30 (0.25, 0.36) 0.30 (0.25, 0.36) 0.30 (0.25, 0.36) 0.30 (0.24, 0.36) 
Cooperative SM      0.01 (0.01, 0.01) 
Defensive SM      0.09 (0.03, 0.26)* 
LL 93.93 92.40 80.20 82.49 82.56 82.00 
-2* log likelihood  3.06 24.40*** -4.58 -0.14 1.12 
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Hypothesis 2: Self-management behaviour, patient activation, self-efficacy, and depression 
symptoms will predict survival over follow-up 
7.3.8 Survival analysis 
 
To first explore whether self-management variables could predict survival in this population, 
basic Kaplan-Meier curves and tests of simple associations were employed. Each continuous 
predictor variable was split into a binary predictor along its mean to allow for a graphical exploration 
of basic survival differences between high and low scores for each variable. 
Self-management behaviours (as well as cooperative and defensive subscales) and patient 
activation did not predict survival. However, self-efficacy did predict survival, with high self-efficacy 
predicting longer survival times (see figure 7.1). 
To investigate whether this relationship would change in the presence of covariates, a Cox 
hazard regression was run, using self-efficacy (this time as a continuous predictor), and age, residual 
kidney function, sex, and comorbidity included as covariates (see table 7.6). Self-efficacy remained a 
significant predictor in the presence of these covariates. 
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Figure 7.1: Kaplan-Meier survival curve stratified by self-efficacy 
 
Table 7.6: Multivariate Cox Hazard regression predicting survival using self-efficacy and covariates 
 
 Hazard ratio (SE) P 95% CIs 
Self-efficacy 0.70 (0.08) < 0.01 0.55, 0.88 
Age 1.00 (0.02) 0.99 0.97, 1.04 
KRU 0.88 (0.15) 0.45 0.62, 1.23 
Comorbidity 1.12 (0.09) 0.14 0.96, 1.31 
Sex 1.52 (0.72) 0.38 0.60, 3.84 
    
Model parameters N = 103, -2xLL = 174.23, LR chi2 = 12.78 (5 d.f.), p < 0.05 
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7.4 Discussion 
 
This chapter explored the relationships between self-management behaviours, psychological 
factors, and clinical status and outcomes cross-sectionally and over time. While self-management 
behaviours were associated with IDWG as hypothesised, the direction of the relationship was 
initially surprising; higher cooperative self-management scores were predictive of higher IDWG after 
controlling for time, age, sex, comorbidity, and residual renal function. 
The three study sites displayed similar characteristics in terms of clinical and psychological 
parameters. This is not surprising as they are located in the same NHS Trust, but it is interesting that, 
for example, site 3 did not show any deviation in observed behavioural, psychological and clinical 
variables compared to sites 1 and 2, given the older population (see chapter 6 for breakdown of 
demographics by site). This may be due to the smaller sample size drawn from site 3. 
Over time, IDWG remained stable, while phosphate levels decreased. The improvement in 
phosphate control may be due to programmes that were underway in the units to try and achieve 
this aim. Without programmes aimed at improving it, we may have expected phosphate control to 
remain relatively stable in established patients (Melamed et al., 2006). Particularly interesting is that 
over this period, patient activation increased. The fact that the units were attempting to emphasise 
the role of self-management for people on dialysis was associated with an increase in patient 
activation at the same time that phosphate was decreasing is interesting, but correlations and MLMs 
did not show an association between phosphate and patient activation. 
Where appropriate, patient activation was treated as a continuous variable, as higher scores 
indicate greater levels of activation. However, Hibbard and colleagues recommend using cut-points 
to classify people into stages of activation: pre-contemplation, contemplation, action, or 
maintenance (Hibbard et al., 2004b). As one would expect with the rise in continuous activation 
scores, participants did appear to ‘shift up’ through the stages of activation, from pre-contemplation 
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and contemplation towards action and maintenance, indicating that people’s perceptions about 
their role in care had shifted. That activation should increase over time is consistent with findings 
elsewhere in UK dialysis populations (NHS Kidney Care, 2013). In chapter 5, staff identified high 
patient activation as being a key component for patient adherence, and for patients to be ‘good’ 
self-managers. The fact that patient activation increased was therefore a goal of initiatives within 
the Trust, and it was encouraging to see activation increase over the course of the study. The fact 
that activation was not associated with the decrease in phosphate warrants further investigation in 
future work. 
 In a cross section at baseline, IDWG and self-management were positively correlated; higher 
self-management was associated with higher IDWG. However, it is possible for particularly low 
IDWG to be unhealthy, as fluid intake is still required to maintain life. IDWG and self-management 
were positively correlated both when including IDWG as an absolute value, and when calculating it 
as a proportion of dry weight to account for baseline differences in body size.  In chapter 6 it was 
found that the division into ‘defensive’ and ‘cooperative’ subscales that Curtin et al. (2004) proposed 
proved to be a useful distinction when examining the relationships between those behaviours and 
depression and anxiety (which were higher when defensive behaviours were high), and self-efficacy 
(which was low when defensive behaviours were high). Curtin et al. only used self-report measures 
of physical functioning, and no markers of clinical status, so there are no previous results to directly 
compare the findings here against. 
Cooperative self-management was positively correlated with IDWG, a relationship which 
was not present for defensive self-management. This relationship persisted when using a mixed 
model taking account of within-participant covariance, factoring in time and background covariates. 
This seems counterintuitive, but it is important to remember that the behaviours assessed by the 
scale do not include self-reported adherence. Instead, it appears that in the observed data, those 
who were more likely to engage in behaviours like contributing to decisions about how much fluid to 
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take off, or make suggestions to healthcare professionals about their care, had higher IDWG. 
Specifically, the ‘shared care in haemodialysis’ subscale appears to be most responsible for the 
relationship. It may be that those who engage in their own dialysis, and decisions about how much 
fluid to remove (for example), are more likely to select less stringent criteria than originally 
suggested by HCPs. Examples of patients negotiating higher dry weight values can be seen in 
chapters 5 and 8. 
The finding that cooperative self-management and IDWG are positively associated is initially 
surprising. While a comparison of the BHDS and IDWG has not been made before, it may be 
expected from the self-management literature that those who show greater engagement with their 
care will have lower IDWG. It may be that in this sample, those who were identifying themselves as 
involved in their care were also choosing to drink more fluid between sessions, for example. At the 
time of the study, in-centre self-care haemodialysis was not standard practice in the dialysis units 
studied, with a relatively small number of patients doing more than weighing themselves. 
Furthermore, patients relying on increased dialysis dose to compensate for high IDWG due to poor 
fluid adherence was identified as an ongoing problem by HCPs in chapter 5 (Good/bad patient). 
Elements of self-care haemodialysis was, to an extent, actively discouraged at the time of the study. 
In this context, self-care haemodialysis may in fact have been less of a cooperative behaviour, and 
more of a defensive or even ‘antagonistic’ behaviour. Official policy was that patients should not 
change the settings on their own machines, for example. It may be that the participants who were 
trying to be more engaged in their own dialysis were those willing to be ‘told off’, something which 
occurred both with trying to change machine settings and coming into the dialysis unit with a high 
IDWG. 
The units involved in the research have since initiated an official in-centre self-care 
haemodialysis programme, where patients can engage in more of their own dialysis, supported by 
HCPs only as necessary. This may change the dynamic between self-care haemodialysis behaviours 
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and IDWG. Additionally, the influence of cooperative self-management on IDWG was small, and 
increased risk of mortality from higher IDWG tends to be observed only when IDWG is particularly 
high. However, this is an important finding to further investigate in future work. Randomized or 
cluster randomized controlled trials of self-care haemodialysis programmes may give a better 
picture of whether there is in fact a relationship here, and whether that relationship is casual in 
nature. 
Defensive self-management was positively correlated with phosphate at 9 and 18 month 
follow-up, and cooperative self-management was positively correlated with phosphate at all three 
time points. These effects were not apparent in the fixed slope parameters when included in an 
MLM with covariates, but both cooperative and defensive self-management did significantly 
improve the model fit. This implies that self-management behaviour may be important in 
understanding phosphate levels, but not how they change over time. 
Self-efficacy predicted survival. This effect has been observed elsewhere, such as in COPD, 
although studies on the topic are sparse (Kaplan, Ries, Prewitt, & Eakin, 1994). Self-management 
behaviour, both cooperative and defensive, did not predict survival. It may be expected that self-
efficacy influences survival by affecting self-management behaviour, and that therefore self-
management would act as a mediator between self-efficacy and survival.  However, given the lack of 
any basic association between self-management and survival, no mediation analysis was warranted 
(Preacher & Hayes, 2004). Furthermore, given that self-management was associated with higher 
IDWG in multivariate models (and phosphate, in zero order correlations), it may be possible for self-
management behaviour to be related to higher mortality due to being related to higher IDWG and 
phosphate, which are known risk factors for mortality in this population (Saran et al., 2003). This was 
not what was observed here however; survival was higher throughout the period of follow-up for 
those with higher self-management scores, both for defensive and cooperative self-management, 
but these differences were non-significant. There are many factors that contribute to mortality in 
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this population, and how self-management may fit into this picture in larger samples is beyond the 
scope of this dissertation. 
   
7.5 Concluding remarks 
 
 Cooperative self-management behaviours, such as shared haemodialysis care, were 
associated with higher IDWG over time, when controlling for a variety of demographic and 
psychological variables. This is contrary to the hypothesised relationship, that greater self-reported 
self-management behaviours would result in lower IDWG. However, examining these specific 
behaviours in relation to clinical markers of adherence is both novel and exploratory, and warrants 
further investigation. Similar relationships were observed in zero order correlations between 
cooperative self-management and phosphate, and defensive self-management and phosphate, but 
these relationships did not remain significant in multivariate models. Self-efficacy predicted survival 
in multivariate models controlling for demographic variables, but self-management behaviours did 
not. 
 In the next chapter, cognitive interviews based on the BHDS will be described. This will allow 
for an exploration of possible issues with the questionnaire, and an exploration of what participants 
are thinking when reaching their answers, and thus what is being measured. This will allow for both 
a more informed interpretation of the results described in chapters 6 and 7, and to lay the 
groundwork for improving the scale if necessary.   
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8.1 Introduction  
 
The aim of this chapter is to develop a series of suggestions for assessing self-management 
among people on haemodialysis. This will include an exploration of the Behaviours in Haemodialysis 
Scale (BHDS) using cognitive interviews, before summarizing lessons learned throughout this 
dissertation, and making a number of general suggestions for measuring self-management, as well 
as suggestions specific to the BHDS. 
The empirical chapters so far have demonstrated that self-management is appraised as 
consisting of different aims and focus between patients and HCPs (chapter 5). They have also 
demonstrated that certain ‘defensive’ self-management behaviours are associated with higher levels 
of psychological distress when including patient activation and self-efficacy (chapter 6). While these 
findings are novel, they are not surprising in light of the background literature. What is potentially 
more surprising is the finding that certain cooperative self-management behaviours may be 
associated with higher IDWG and phosphate levels (chapter 7). 
The BHDS developed by Curtin et al. (2004) is the focus of the present chapter. This 
questionnaire was adequately developed (see chapter 4, methods, for more detail), but during 
questionnaire administration for chapters 6 and 7, some participants expressed confusion at certain 
items, and others did not appear to be worded clearly. The surprising results in chapter 7 led to the 
decision to further explore the questionnaire items qualitatively, with the potential to revise the 
scale in the future. 
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As a starting point, patients on home haemodialysis were interviewed. People on home 
haemodialysis are generally considered to be more engaged in their own care, with those on in-
centre haemodialysis frequently being considered those who are too old, frail or ill to dialyse at 
home (Woods, Port, Stannard, Blagg, & Held, 1996). This view was expressed frequently by HCPs in 
the focus groups and interviews in chapter 5. Additionally, participants interviewed in chapter 5 
frequently had little or no experience in behaviours such as self-care (or shared care) haemodialysis, 
as self-care haemodialysis was not promoted in the dialysis units at the time of writing. This 
provided a useful perspective, but made it difficult to explore such behaviours in any detail. This 
information is desirable, as there is an increasing drive in the UK to promote in-centre self-care 
haemodialysis (Dainton & Wilkie, 2013). 
 Home haemodialysis patients were therefore considered a ‘gold standard’ starting point for 
exploring the BHDS where levels of engagement in care across a wide range of behaviours were 
likely to be high. Future work will extend this qualitative work into in-centre populations. Another 
advantage of starting with people on home haemodialysis is that it will allow the development of a 
home version of the BHDS to accompany the in-centre version. 
The study was conducted with two specific aims: 
1) To identify structural issues with items in the BHDS 
2) To explore social and emotional issues arising in response to questions about cooperative 
behaviours, and in response to questions about defensive behaviours, in order to contextualise the 
results from chapters 5, 6 and 7. 
 The first aim relates to the difficulties participants appeared to have answering certain 
questions. Using a method known as ‘cognitive interviewing’, specifically using a think-aloud 
method, issues arising as participants describe their thought processes in answering the questions 
could be assessed.   
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This think aloud process, and the rich, in-depth answers it yields allowed more in-depth 
exploration of the questions that were only quantitatively addressed in chapters 6 and 7. This allows 
the second aim to be addressed. The authors of the BHDS proposed that the scale could be divided 
into eight subscales based on factor analysis. They then proposed that, based on the qualitative 
work that led to the selection of items, these subscales could be divided into ‘defensive’ and 
‘cooperative’ subscales. Cooperative subscales represented behaviours that involved working with 
healthcare practitioners, while defensive subscales represented selectively keeping symptoms to 
oneself, or taking matters to higher authorities to get better care. ‘Cooperative’ implies a certain 
amount of social support. Further, the developmental work by the original authors, as well as the 
work described in chapter 6, demonstrates that ‘defensive’ behaviours appear to be associated with 
higher levels of psychological distress. This warranted further investigation. 
Chapter 7 built upon this work by looking at how it related to change over time, and also 
how it related to clinical outcomes and survival. However, while administering the questionnaire, 
there were comments from participants about items being confusing, and individual items were 
being missed. When asked if there was a reason why an item was missing, participants sometimes 
identified this as a mistake, and others because they felt a question was not applicable or difficult to 
answer. 
  
 The BHDS was developed to allow better measurement of self-management behaviour 
specifically among people on dialysis for ESRD. It has been discussed in a number of papers since its 
development, although the scale itself has not been widely deployed (Griva et al., 2011; Appleby, 
2013). Similar questionnaires exist, and appear to be more widely used in other chronic conditions, 
particularly diabetes (Toobert et al., 2000; Schmitt et al., 2013). A scale exists for assessing self-
management behaviours in people on peritoneal dialysis, but the practical behaviours measured are 
sufficiently distinct to render it inappropriate for those on HD (Wang et al., 2014). Another scale, 
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which included some emotional factors among people on dialysis was developed in Taiwan, but 
remained part of an unpublished Masters thesis (Li, Jiang, & Lin, 2014).  
Another set of scale items closer to the BHDS used here were generated in collaboration 
with 13 nephrology nurses, and included sets of behaviours centred around themes such as 
advocacy and knowledge seeking (Costantini, Beanlands, & Horsburgh, 2011). However, a final 
version of this scale does not appear to have been published, and no relevant psychometric data 
appear to exist. 
As the BHDS used here was developed for people on in-centre haemodialysis, adaptations 
may be needed if a version is also to be used for people dialysing at home. This is a secondary aim of 
these cognitive interviews. In addition, some items on the questionnaire appeared problematic 
during data collection reported in chapters 6 and 7. Missing items, or direct comments from 
participants during scale collection were more common for this questionnaire than for other scales.  
Aim 2 of the interviews related to emotional and social aspects of self-management that 
may arise while answering questions. For example, interviews and focus groups reported in chapter 
5 indicated that perceived social pressure to conform influenced the performance of adherence 
related behaviours for some individuals, and this may extend to other self-management behaviours. 
Perceived social support is also often seen as an important determinant in an individual’s 
performance of self-management behaviour, particularly the support of a significant other where 
present. Emotional factors, including mood and anxiety, are often found to be important in the 
performance of self-management behaviours, and this association was found in chapters 6 and 7, 
where the presence of depressive and anxious symptoms were associated with the more frequent 
performance of ‘defensive’ self-management behaviours. 
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8.2 Methods 
 
8.2.1 Overview 
 
The overall aim was to generate suggestions for measuring self-management behaviour in 
future research. In addition to drawing on the work already described in previous chapters, cognitive 
interviews using the ‘think-aloud’ method were used to address structural and thematic issues in the 
BHDS. Guided by these aims, the questions addressed in the following cognitive interviews are: 
1) What structural issues arise when patients respond to the BHDS, and how can they be 
improved? 
2) Do social and emotional factors contribute to responses to the BHDS? 
These two aims were addressed separately, by coding each interview twice – once for 
structural issues (aim 1), and once for social and emotional factors (aim 2). See chapter 4 (methods) 
for more detail on coding and analysis. 
A copy of the BHDS can be found in appendix A. 
 
8.2.2 Participants 
 
 A total of 8 participants were interviewed, four female and four male, with a mean age of 64 
years. Participants were approached in clinic by their consultant nephrologist and given information 
about the study. Those agreeing to take part were then contacted by the author, and interviews 
were arranged. Consent was taken just prior to the interview. All participants were selected from 
Central Manchester University Hospitals NHS Foundation Trust. 
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8.2.3 Approval 
 
Ethical approval for this work was provided by NRES Committee North West, REC reference 
14/NW/0272 (see appendix F). 
 
8.2.4 Procedure 
 
Patients were first approached by a consultant nephrologist in clinic, who briefly explained 
the study and provided those interested with an information sheet explaining the study. Details of 
those interested were passed to the author, who gave participants at least two days to think about 
the study. The author then phoned participants to confirm their participation, and arranged for an 
interview to be conducted in the participant’s home at a time convenient to them. Consent was 
obtained for all participants, and interviews lasted between 30 and 60 minutes. All information 
sheets included information on where to seek additional support if they were troubled by any of the 
discussion topics, as well as contact details for the investigator. In one case a participant became 
emotional during the interview, and in another a participant expressed symptoms of depression. In 
both cases, the author proceeded according to protocol, asking participants if they would like to 
stop, offering verbal support, and ensuring they were aware of counselling services available to 
them. Both participants opted to continue, and were already in contact with relevant support 
services. 
8.2.5 Cognitive interviewing & analysis 
 
Audio recordings of interviews were transcribed by the author and entered into NViVO 10 
(QSR International, 2012). Responses were coded by question to allow side-by-side comparison of 
responses, as well as provide a structure for thematic hierarchies. Each question was assigned to one 
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of two node classifications; cooperative or defensive, as defined by Curtin et al. scale (Curtin & 
Mapes, 2001; Curtin et al., 2004; Curtin et al., 2002). 
Cognitive interviewing is a technique of conducting interviews, usually using a questionnaire 
or proposed questionnaire items as the template. By asking the participant to either think-aloud, or 
through the use of well thought-out probes, the aim is to ascertain the thought processes behind 
answering a given question, rather than just getting an answer. This allows for the identification of 
issues such as difficulty understanding terminology, ambiguity of meaning, strategies used for 
recalling information and difficulty accurately recalling information from events a long time in the 
past. For this reason, it is most frequently used in questionnaire design, before the final instrument 
is rolled out. It can, however, also be used to get more information about what goes through 
people’s minds when faced with existing questionnaires. Examples of previous use include 
developing the US National Cancer Institute’s Patient Reported Outcomes Common Terminology 
Criteria for Adverse events (PRO-CTCAE, Hay et al. 2013) and the PROMIS Pediatric Peer 
Relationships Scale (DeWalt et al. 2013). 
Cognitive interviewing has been used in a number of conditions and scales. For example, the 
CollaboRATE study involved using in-depth cognitive probes to create a very brief scale that could 
effectively measure patient perceptions of shared decision making, using three highly refined 
questions (Elwyn et al., 2013). 
See chapter 4 for more detail on cognitive interviewing. 
Each transcript was then coded a second time for potential issues, using the following a 
priori categories frequently occurring in other cognitive interviewing studies (Knafl et al., 2007): 
 Limited applicability: The question might not be answerable by everyone that the 
questionnaire is aimed at 
 Unclear reference: It is unclear what a question is referring to 
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 Unclear perspective: Whose perspective is the participant meant to be answering from? 
 Wording/tone: Participants may not understand a particular word. The wording tone 
may be considered inappropriate or offensive 
 Descriptive quantitative data for the themes that emerge around problems encountered 
for each question will be used to provide a summary of the problems encountered. 
 
  Additional codes were generated for any other salient issues arising that may relate to the 
process of how a participant answers the question, generated as coding proceeded. 
Each transcript was then coded a second and final time for examples of emotional and social 
issues arising during exploration of the interviews. These codes were then explored by question 
classification; defensive or cooperative. 
A process of thematic coding was used for rounds two and three of the process (Braun & 
Clarke, 2006; Fereday & Muir-Cochrane, 2008). Previous studies in CKD have used this thematic 
process to explore self-management behaviours such as prescription altering and the use of 
complimentary medicines (Williams & Manias, 2014). 
Questions are coded SM1 (Self-Management 1) to SM34. 
 
8.3 Results of structural analysis 
 
As there are 34 items in the BHDS, and some issues occur across multiple items, issues will 
first be considered by type, before specific problematic items are considered in more detail. 
8.3.1 Frequency or duration 
 
206 
 
The timeframe for the behaviours reported in the questionnaire was 6 months. This 
sometimes presented some difficulties. For some, 6 months is a long period of time for remembering 
specific incidents, particularly if they do not refer to seemingly important or impactful behaviours or 
incidents. Additionally, certain behaviours are much more prevalent early in the process of adapting 
to dialysis. For example, SM11, “Looked for additional kidney diet information?” was sometimes 
difficult for participants to answer, as they may have diligently looked up large amounts of 
information on the subject when they first started dialysis, but not done so in the last 6 months. This 
does not, presumably, indicate a low information seeking self-management behaviour, but rather 
appropriate behaviour based on circumstances. For example: 
Interviewer (I): Have you looked for additional kidney diet information? 
Patient 8 (SU8): No. Not really. 
I: Is that something that you would have done in the past? 
SU8: In the past, maybe, but now... 
I: But because you've been doing it so long...? 
SU8: Exactly. I know what's what. 
However, some did see this as an ongoing exercise: 
I: Interesting. Err, looked for additional kidney diet information? Again [you've put] all the 
time 
SU6: I do it all the time, yes 
I: So is that an ongoing thing? 
SU6: It is an ongoing thing, because sometimes things change. The thing you wanting is good 
and another time they tell you is not good. So what I decided is now everything in 
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moderation. Because what I find is... I've spoken to myself, you know self-talk, and I said to 
myself, "Eat everything you want... in moderation". I said, "That's the advice I have given you 
and that's it. Forget every other diet information out there. Do what I say." And that's what I 
do. So there's nothing I can tell you now I don't eat. There's nothing I tell you I don't drink. 
My motto is everything in moderation. And my blood results have been perfect [claps]  
 
Difficulty remembering due to the 6 month time period, combined with potential 
misunderstandings about whether a question was asking about whether a participant had ‘ever’ 
performed a behaviour, versus within the 6 month time window was evident in various items 
throughout the questionnaire, with different items proving difficult for different participants. For 
example: 
SM3: “Asked staff or a doctor to do something differently because you thought there was a better 
way?” 
I: Ok. Erm, have you asked staff or a doctor to do something differently because you thought 
there was a better way? 
SU1: Hmmmm [long pause, approximately 8 seconds], no 
I: Ok, you hesitated there, is there... what were you thinking might be something that you 
would have asked to do different, or is it just "no"? 
SU1: No, it's just the case you have to think things because it's been years since I've been on 
haemo. It's a long time to be at home dialysing. 
Some participants would simply include examples from long before the 6 month timeframe 
in arriving at their affirmative answer to questions. 
SM1: “Asked for a change in treatment based on information you learned on your own? 
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SU7: Yes, sometimes I've done that, yes. 
I: Have you got any examples perhaps? 
SU7: Err, well, it, I've, this is now err, because I found out I have epo and this is like years 
back, and I went to my GP, and err, the first thing he said was he's not going to do it. And I 
can't remember totally because err, they said it's too expensive or something like that. And 
because I was much younger then I just started shouting and yelling and things like that in 
his office are you with me? 
When asked for general comments about the questionnaire at the end of the interview, one 
participant volunteered the following: 
SU1: No, no, your questions are ok to answer, but obviously some of them you need to think 
about... it's a time thing, when you've been on a long time, it's hard to recall certain incidents 
like, like you need an answer to, that's the only thing really 
I: Yeah, so some of those questions here it's asking about things that you might have tried 
differently for example, so you find that quite difficult to think back 
SU1: Yes, yes of course. To specific incidents... that's the only thing. 
I: So when you're thinking about, when you're trying to give an answer to those questions 
and you can't think of anything specific, you just give a generally impression of what you 
think you might have done in the past, what sounds like something you might have done. 
SU1: Yes. 
 
8.3.2 Limited applicability 
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As the BHDS was developed for people on in-centre haemodialysis, there are a number of 
questions that were answered as ‘all the time’ in almost all cases. This may produce ceiling effects if 
the questionnaire were to be used quanitatively with people on home haemodialysis. These items 
may be considered to be of limited applicability from a quantitative perspective, particularly those 
relating to performance of dialysis itself such as self-cannulation. Items SM4 to SM10 pertain to self-
management behaviours conducted during haemodialysis, and as such were almost always 
answered as, “All the time” by all participants. For example, item 4, “Cleaned or prepared your 
access site for needle placement?” was answered as “All the time” by all eight participants.  
However, when talking through their answers, SU4 indicated that their partner had become 
involved in the process, perhaps indicating that a more useful question may be related to whether 
informal carers are involved in the process. 
SU4: But erm, now he's doing it himself. Wash your hands… 
I: That's interesting, now he's getting involved 
SU4: Yeah, he does, "Ooo, you must wash your hands again", "Have you put Purell on?" So 
it's quite funny, you know, coming from being saying, "Ooo you must do that", yes I know! 
[both laugh] 
SM5, “Weighed yourself?” and SM6 “Helped decide where the needles should be placed?” 
similarly elicited universally affirmative answers.  
SM7, “Helped to decide the blood flow rate”, and SM8, “Helped decide how much fluid 
should be taken off?”  again resulted in universally positive answers, but required more thought or 
explanation behind the answer. While both of these are prescribed by the patient’s nephrologist, 
participants sometimes alluded to making adjustments for themselves, based on discussions with 
their care team. 
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For example, when asked about deciding the blood flow rate: 
SU2: Well it's basically prescribed, you do it over night, 8 hours overnight, three nights a 
week, err, then, you're err, you have the blood flow as low as you can get it really. So I dialyse 
on a rate of about 220 [cc/min, or cubic centimetres per minute], now this afternoon the 
dialysate flow was about 300, erm, now this afternoon because I was doing four hours 
because I'm having this biopsy tomorrow, erm, my dialysate flow is up to 500, only doing four 
hours, and I can increase the actual blood flow to about 250. Keep it at 250 because I use a 
16 gauge needles, and you shouldn't really go above 250 for 16 gauge needles. 
I: Ok, erm, and is that sort of something you decided by yourself... 
SU2: In discussion 
I: Yeah. Ok, with your doctor? 
SU2: Yeah, mainly dialysis nurses 
 
How much fluid needs to be removed is a decision that is usually guided by a prescribed 
formula – whatever the participant weighs above their dry weight should be removed in any given 
dialysis session. While all participants answered that they decide how much fluid to remove, there 
were clear differences in how much thought and agency they put into this.  
SU2: [My dry weight is] 64.5 [kg], and then, any weight above that is the amount of fluid I 
take off, so if I'm err, a kilo over weight, above 64.5, I take one litre of fluid off. So it's a sort 
of formula really. 
For others it was a process that involved more complex decision making 
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SU4: No, I decide erm, depending on what my weight is, and my blood pressure. And whether 
I've cheated [laughs] So that I've... if you've been out, you might have had more to drink, you 
think "ooo, better take a bit more off". I don't really like taking more than 2kg off. 
‘Cheating’ came up in interviews and focus groups reported in chapter 5. It is interesting that 
here the participant still describes it as such when they are the one responsible for making the 
adjustments to their dialysis dosage, and managing the consequences of their dietary and fluid 
choices. 
One participant described how she modified her target weight from that prescribed by her 
care team, to one that she felt took into account her sickle cell disease: 
SU6: The doctor say my target weight is 79.5[kg]. But I make my target weight 80 when I'm 
dialysing. The reason being that I need that shock absorber for myself. I need the 500ml in 
me, because of my sickle. You see with the sickle cell I'm supposed to drink loads of fluid, and 
with the kidney failure I'm supposed to be on fluid restriction. So when the doctors have 
finished their own, as regards to my kidney, I modify it as regards to me […] So you know, is 
err, is a juggling act with me. I know I'm complicated, and you know, I've always been all my 
life. My doctors say I'm special [interviewer laughs], what can you do with somebody who's 
special? [participant laughs], you know. 
The diversity of thought processes and practical activities involved in all eight participants 
arriving at the answer, “All the time” suggests that there may be subtleties not being captured by 
these questions when it comes to participants on home haemodialysis. 
 
8.3.3 Unclear reference, wording, or misunderstanding 
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In some cases, participants reported not being clear on what a question meant. In others, it 
appeared that they were answering a different question to the one that had been asked. Sometimes 
this was as a result of ‘Conflicting clauses’, while in others it may be that it was not clear to what the 
question was referring. 
SM26: “Acted more cheerful than you felt so that staff would give you better care?” 
SU2: Err, no I don't think so. Don't think I have a lot of control over how I feel [both laugh] 
No. I mean, I felt a bit fed up this morning after I'd been down there, because some things 
were taking a long time to do 
As was common for this question, the participant talked about how much control they had 
over how they felt, or why they felt the way they felt, rather than whether they acted more 
cheerfully to affect the quality of their care. 
 I: Acted more cheerful than you felt so that staff would give you good care? 
SU3: I have done that, yes 
I: Is that something that you sort of do generally day to day, with everyone? 
SU3: I am, I am, yes. I am. They always call me smiley [interviewer laughs] Well, yeah, you 
see, that's what I mean by that, I always look on the good side of things, and be positive 
There were cases where there was confusion around whether non-renal behaviours were to 
be included in response to questions that were not specifically about aspects of renal care such as 
dialysis: 
SM22: “Have you consulted a higher authority to officially complain regarding an issue or problem?” 
SU4: [pause] No. 
I: Ok. What were you thinking when you were... 
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SU4: I was just thinking about my leg accident... because, but, that wasn't really to do with 
renal much. I was in the hospital and I got on the bus, err, and I, I, I fell badly on the bus, 
because he took off really quickly, erm, and I went to the hospital transport. But that's 
nothing to do with renal things, is it? 
 
8.3.4 Difficulty producing an example 
 
Sometimes participants would respond affirmatively to questions, but would not be able to 
provide an example when probed, indicating that they were going more by a general ‘feeling’ than 
by thinking back to specific instances. This was sometimes related to the “Frequency or duration” 
code 
SM20, “Tried out different ways to handle problems or symptoms?” 
SU1: Errrm, I would imagine so over the years, yes 
I: Can you maybe think of any specific examples, or? 
SU1: [Pause, 2 seconds] Not at the moment, not when you put me on the spot […] If I were 
dialysing a short time I'd probably be able to tell you but, as I say, a long time to come up 
with an answer for that 
 
8.3.5 Conflicting clauses 
 
Sometimes participants would answer a question one way, while their think-aloud answer 
would reveal that this was because they were not taking into account a given clause in the question. 
For example: 
SM17: “Handled problems or symptoms by yourself so you wouldn’t have to talk about them?” 
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SU5: Yes... I suppose I do really, I just get on with it really […] 
I: So is it to not trouble other people, or is it because you don't feel comfortable talking about 
things? 
SU5: No I don't think so, I'm that sort of person anyway. I've always been in the situation 
where I have to deal with things, so I do. I deal with things, mostly. 
 
In this example, the participant was answering “A lot of the time” to the question, “Do you 
handle problems or symptoms by yourself?” without taking into account the second part of the 
question, which asked about whether this was to avoid talking about those problems or symptoms. 
It may be that two-part questions would be more appropriate here. 
 
Questions SM9, “Watched the care you received to make sure everything was done right?” 
and SM10, “Stayed awake (when you would rather sleep) to make sure treatment was going ok?” 
resulted in the thought process in arriving at an answer appearing to be incongruent with the given 
survey answer. This appeared to be due to the conditional clauses in the questions. For example:  
I: Do you watch the care that you receive to make sure that everything was done right? 
SU4: I mean, yes yes, to a certain extent. I mean I thought that because I was in a specialist 
renal centre I was ok, but I was interested in what was happening, and how it was 
happening. Particularly since I was having to adjust the amount of Fragmin that I got, and 
the length of time that I was on 
I: Yeah. So that was more a sort of interest thing than anything? 
SU4: Oh yes, I was never in any queries about their quality of the care.  
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The participant answered in the affirmative to the question, but their think-aloud answer 
and follow-up probe revealed that this had nothing to do with “making sure everything was done 
right”. An active interest in what is going on may be considered a form of patient engagement, but 
their response was not necessarily an answer to the question that had been asked. 
Similarly, for SM10 regarding staying awake: 
SU5: Dialysis... well up 'til recently I've never been able to sleep on dialysis. But I have found 
in the last 2-3 weeks that I can do some sleeping, erm, although when I tried this morning my 
arm moved so the alarms went off, so that woke me up. I do... I can sleep some of the time 
on dialysis, but not always. 
I: Mhmm. Being able to sleep or not is not related to trying to see if treatment's going ok, it's 
something different? 
SU5: Yeah, really, yeah 
The fact that answers do not always align with what the question is really asking, by not 
factoring in important clauses, is not necessarily the fault of the question, as these clauses are 
clearly stated. However, it is important to note that the thought processes that lead to these 
affirmative answers do not always pertain to what the question is actually asking. In either case, 
when questions are frequently misinterpreted, responses should be interpreted with this in mind, or 
considered altogether unhelpful. 
In cases of limited applicability, it would seem to be prudent to have a ‘Not applicable 
option’, a suggestion that participants agreed with when asked during the interviews. 
 
8.3.6 Incongruous answers 
 
216 
 
In many of the cases discussed above, one answer was sometimes given as the question 
answer (e.g. “Never”, “All the time”), while the participant’s think-aloud answer implied that this 
was answer was ‘incorrect’ (using the information that they gave). In some of the quotes explored in 
the previous sections, this appeared to be attributable to elements of question design. However, in 
some cases, it appeared that the participant had simply misunderstood the question, or changed 
their mind part way through thinking about their answer. 
SM32: “Asked questions or made decisions about your care with your staff or your doctor?” 
SU6: I'll do that all the time, yeah. Sometimes now, I take the decision and then inform them 
later that this is what I'm doing, because you don't see them all the time. So when I see them 
I tell them, "This is what I'm doing now". You know. And when they have an appointment to 
come, then I leave a note for them for any new thing I'm doing so they will know about it, 
you know. So, yeah. I do that all the time. 
I: So would you say you take more decisions by yourself, or that it's more shared decision 
making. 
SU6: No, I take decisions by myself now, because like I said, once you're doing it at home, you 
see the doctor every 3 months or 6 months or whatever, if your blood results are good, and 
for me I see the nurse every 6 weeks. So it's not everything I will talk about the nurse and 
doctor before I do it, no no, there are things I need to do immediately and then tell them 
later. So, that's what I do. 
This question appears to be awkwardly worded, as it contains multiple behaviours which 
may result in different answers. Asking questions and making decisions are two distinct actions. 
Additionally, the initial sentence clause, “Asked questions or made decisions…” may be answered in 
the affirmative, while disregarding the second clause. 
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8.3.7 Wording or tone 
 
In some cases, specific words caused some confusion. Most commonly, this related to the 
use of the word, “care” or “caregiver” 
I: Mhmm. What do you understand by the term "caregiver", there? 
SU3: Well, somebody from hospital, you know. A nurse, a doctor, a home sister... anybody 
like that. Or even, even [participant’s husband], really. Erm. If it's [participant’s husband], 
and he's doing something wrong, then I'll say, "Oh no, we don't do it this way, have to do it 
that way." And erm, but he's... 
And 
I: Have you spoken up to a caregiver because you thought they were doing something 
wrong? 
SU5: Have I spoken up...? 
I: To a caregiver 
SU5: Care... you mean the nurses?  
And 
I: Taken responsibility for parts of your care or treatment? 
SU5: Erm. [pause] I don't really know... I mean... I usually talk it over with them anyway so... 
I'm not really sure about that one because…  I can't really answer that one 
While not a question on the BHDS, when told the questionnaire would be about self-care 
behaviours, this term also caused some confusion 
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I: Just a few more questions asking you about how often you've done some of these self-care 
behaviours and things like that. The options are never, a few times, a lot of the time, or all of 
the time. And it's over the last 6 months. 
SU7: What do you mean? Do you mean self... 
The same participant also seemed to misunderstand what was being asked in the question, 
SM26, “Acted more cheerful than you felt so staff would give you good care?” 
SU7: Yeah, when you know that you're going to get good care from somebody, you feel sort 
of like, happy? You know, that someone's looking after you 
I: So you'd say it's the other way around? 
SU7: Sorry what, how is that? 
I: So, you feel more cheerful when you know you're going to see someone who gives you 
good care 
SU7: Yeah 
 
8.3.8 Specific items 
 
Out of all questions, those which most commonly gave rise to issues detailed above were: 
SM26, “Acted more cheerful than you felt so staff would give you good care” 
These were mostly issues around wording (“care”), and conflicting clauses (“acting cheerful” 
“so staff would give you good care”). 
SM31: “Adjusted your phosphate binder dose to the size of your meal” 
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This was a case of limited applicability; three of the eight participants were not taking 
phosphate binders at the time of the study due to long dialysis hours and well controlled phosphate. 
 
8.3.9 General comments on acceptability 
 
The questions asked were not seen as intrusive, and when asked, “Do you feel like there 
were any ‘right’ or ‘wrong’ answers?”, participants universally said they did not. Acceptability did not 
appear to be an issue with this questionnaire from the perspective of the participants. 
 
 
 
8.4 Results from social and emotional analysis 
 
8.4.1 Emotional 
 
For the most part, responses to the questionnaire did not cover a substantial amount of 
social and emotional issues. This is because the questionnaire itself only touches on these issues in 
passing. However, where participants raised social and emotional issues, they frequently were 
discussed together. 
 SM26, “Acted more cheerful than you felt so staff would give you good care?” (Defensive) 
SU2: I think probably I do Yeah occasionally. Yeah. Probably my wife's quite good at sussing 
out how I am, how I feel [both laugh]. She's got me taped. 
I: Of course 
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SU2: And she cheers me up a lot, aight, you know, when I feel a bit down 
This participant said that they did act more cheerful than they felt, in response to this 
question from the ‘defensive’ subscale, but this led to them talking about the social support they 
received in a very positive light. 
Answering the same question, another participant made it very clear that they would not 
attempt to hide how they felt, physically or emotionally, regardless of the social context they were 
in: 
SU6: Nope. If I'm not well, if I'm having a [sickle cell anaemia] crisis here I would be 
screaming, I don't care if you're here, and I'm in a lot of pain I always scream out in pain. 
Until that pain goes then I will sleep or relax or whatever. There's really no point in hiding 
this. 
One question generated a particularly emotional response from the participant, SM16, “Kept 
problems or symptoms to yourself so as not to bother staff or your doctor?” (cooperative) P3 
became tearful and upset as they thought through their response aloud. They explained that they 
felt extremely guilty about the amount of care that they had received on the NHS, and that they felt 
they were not giving enough back to society. 
SU3: ... you know. I really have had so much, I feel so... [sniffs, starting to cry] upset 
about that. That I've had so much and other people are going without drugs... you 
know, when you see cancer patients and... hanging on to life. And I feel... I've had so 
much... I've been so fortunate... 
SU3: Just. Sometimes I just feel. As if I'm not giving anything back, when you know, 
I've had so much. [pause] And sometimes I sort of console myself by thinking, "Well, I 
nursed [participant’s husband]'s mum with cancer." And she didn't... she stayed at 
home until the last few days. And then I had [participant’s husband]'s dad living with 
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us for ten years so he didn't have to go into, until he was 90-odd, so he didn't have to 
go into a home. And... my dad, I looked after him, because mum and dad were 
divorced, and he died, same year as [participant’s husband]'s dad. And now my 
mum's 83, and she's needing more care. I just feel the last few years as if... I've taken 
a lot, and not put much back in, you know. Erm. And [participant’s husband] says, 
"Well you do, you do do quite a bit..." 
SU3: Exactly, exactly. So that's it. Sometimes I do feel... very privileged, and, and, and 
embarrassed, or guilty, more than embarrassed. Thinking, "I daren't tell people I'm 
having something else done", because they must be thinking, "Well how ever much 
more is this woman going to have?" [laughs], you know. 
This reaction seems to have been more due to the illness and nature of the cognitive 
interviewing process, and the detail in which the participant was answering, rather than an inherent 
property of the question itself. Talking about serious illness can often produce strong emotional 
reactions, even when the topics are of a day to day technical nature. This illustrates the point that 
technical and medically focused self-management behaviours are only part of life on haemodialysis. 
Participants are also required to manage their mental health. Additionally, in the example above, the 
participant was coping with difficult perceived social stigma that may or may not have any basis in 
reality in this particular instance. 
 During general discussion during the interview, not in response to any specific question, one 
participant stated that: 
SU7: [verbal hesitation] Well, since the last or so year I've been feeling really depressed you 
know, really down, it's just err... sometimes you feel like err, the example would be if a dog or 
animal would be in pain, put it down, you know. Sometimes I feel sort of like in that sort of 
like, sort of like... it might be better just to end it all rather than... in a way... You know, err, 
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and then you don't... it's like err... there's nothing that you [verbal hesitation] to look forward 
to rather than getting up and dialysing, you know. When you've done the dialysing you sort 
of recover and then you're dialysing again 
 This same participant stated that: 
SU7: I've got no friends at the moment, to say, you know, because over the time people just 
disconnected with me and err. Err, even while I was sort of well, you know, so called, "well" 
with the transplant because you know... it's... it's all like give and take really isn't it? Because 
I cannot offer anything to anybody, erm, so it's like erm, you need to offer people, even with 
friends there should... there's sort of like... it's difficult really, because you've got to be sort 
rich[?], err, you've got to have stuff [half laughs] to... and you've got to be able to entertain 
people as well, you know, so over the time just... they the few friends I had just sort of 
disconnected. The same with the relatives as well, over time. Err, disconnected and what's 
happened, I don't know if it's me being the thingy, it's just that the [verbal hesitation] the 
sort of err, you know. People say one thing in front of you, and one behind and so on and so 
forth are you with me, you know. You know, they're acting... there's an act people put on and 
err, you know I cannot sort of take that anymore. I cannot tolerate it anymore really. Over 
the time, over the last what, err, 15-20 years, I you know, I've sort of made a decision to 
dissociate myself with friends and relatives, and err, I find err, it's just they give you more 
problems than help to tell you the truth. They create problems within your household as well. 
Err, I just find people... I've not found anybody... any common thinking... so I'll, I disassociate 
with people now. I don't go out or anything. 
This seems to exemplify the relationship between low social support and low mood among 
some people on dialysis. The interviewer followed up on this response and ensured that the 
participant was aware of the availability of psychological support. The participant was already aware 
of available services, and receiving support from a consultant clinical psychologist. The picture this 
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presents is complicated. The individual seems to have chosen isolation, while simultaneously feeling 
lonely. The burden of haemodialysis was clearly a major cause of emotional distress, and they chose 
isolation over social support, which may perpetuate the emotional distress and make coping with 
the medical challenges life on dialysis presents harder still. 
 
8.4.2 Social 
 
One participant spoke about how she had the support of a friend, and how they involved 
both their partner, and their friend’s partner in mutual support. 
SM12, “Asked family, friends, or dialysis patients for info regarding kidney disease and its 
treatment?” (cooperative) 
SU3: One friend. I talk to. And... we sometimes talk about erm, different things with regards 
to not particularly dialy... well sometimes dialysis but it's normally about the knock on effects 
[…] We might eat, ring each other, three times a year, four times a year? And just have a 
chat. And occasionally she comes round with her husband. And the two husbands'll have a 
chat as well, and we'll have a good talk. And erm, yeah. So it's, I think it's sometimes good as 
well, as I say. For the partners to be able to have a talk, and have a moan about things 
[laughs] 
Answering the same question, another participant talked about using a Facebook group for people 
on dialysis to seek information 
[Discussing a Facebook group for people on dialysis] 
SU6: I'm on the list for transplant. And that's something I've never experienced, so I go to this 
site. So I listen to people who've been through it and what they went through, or what 
they're still going through and things like that 
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The role of family members, particularly significant others, was vitally important.  
SM11, “Looked for additional kidney diet information?” (cooperative) 
SU7: Yeah, I do that while the, nowerdays my wife does it more than me and I get shouted at 
if I [both laugh] if I don't follow the diet, are you with me? 
This question in particular seems to be explicitly about cooperative actions – seeking 
information from sources of social support. 
 
8.5 Summary 
 
The themes emerging during the structural analysis of the interviews are shown in table 8.1. 
Misunderstandings often arose because of wording, because participants answered one clause of a 
question without taking into account the whole question, and due to some self-management 
behaviours not neatly fitting into the 6 month timescale provided. Findings are discussed in detail, 
and potential improvements will be presented. 
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Table 8.1: Summary of themes emerging from cognitive interviews, and frequency of themes 
Category Definition Example Frequency of code Arose in questions 
Frequency or duration Comments or examples of the 
participant having difficulty 
remembering how often an 
action was performed, or how 
long ago 
 8 instances 1, 3, 11, 20, 22, 25, 27 
Limited applicability Comments noting groups or 
situations for which the item 
would not be appropriate 
 21 instances 3, 4 (x4), 5, (x3), 6(x3), 
7(x2), 8(x2), 9, 16, 29, 
31(x3) 
Unclear reference, 
wording, or 
misunderstanding 
Comments about lack of clarity 
regarding what aspect of the 
family or condition, or situation 
the item is intended to address 
 15 instances 2, 4, 7, 8, 20, 22, 26, 28, 
32, 34 (x2) 
Difficulty producing 
an example 
Participant finds it difficult to 
make a general answer concrete 
with an example 
 2 instances 20, 27 
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Conflicting clauses When a participant answers ‘yes’ 
to one part of a question and ‘no’ 
to another 
“Do you watch the care that 
you receive to make sure 
everything was done right?” 
“Yes I watched care but not to 
make sure it was done right” 
8 instances 9, 10(x2), 16, 17, 26, 27, 
30,  
Incongruous answers The answer does not make sense 
in light of the question asked 
 7 instances 11, 16, 24, 26 (x2), 30, 31 
Wording or tone A specific word is identified as 
being unclear or ambiguous, or 
the tone of the question is 
regarded as being inappropriate 
 6 instances 9, 21, 24, 26 (x2), 34 
Emotional Emotional factors identified in 
think-aloud response to the 
question 
 17 instances 2, 10, 11, 12, 13, 16, 22, 
25, 26 (x6), 28, 30, 34 
Social Social factors identified in think-
aloud response to the question 
 17 instances 2, 3, 4, 6, 8, 9, 11, 12 (x2), 
20, 22, 25, 26 (x3), 33,  
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8.5.1 Structural  
 
The structural analysis revealed that common problems included difficulties recalling the 
frequency of a behaviour, or remembering whether it was performed within the specified timeframe 
of 6 months. This was observed in eight different questions, and is likely to be more of a function of 
how the timescale is specified over the questionnaire as whole than for specific items.  
Some questions were not applicable to the participant; most commonly questions relating to 
haemodialysis, including SM4, “Cleaned/prepared your access site for needle placement?”, SM5, 
“Weighed yourself?”, and SM6, “Helped decide where the needles should be placed?”. Similarly, the 
more general SM34, “Took responsibility for parts of your care of treatment?” was considered to be 
taken as a given for people on home haemodialysis on several occasions, and all participants 
answered affirmatively. 
In some cases, it was unclear what the question was referring to, although this was spread 
out across different questions. Notably, SM34 again came up as being an unclear for five different 
participants, indicating the question may be too vague to be helpful.  
Sometimes participants had difficulty producing an example – although this was the least 
common issue that occurred, being observed only twice, in response to SM20, “Tried out different 
ways to handle problems or symptoms?” and SM27, “Talked regarding a treatment or medicine you 
learned about, hoping the information might work for you?”. 
 Sometimes conflicting clauses were a problem, where a participant would answer 
affirmatively to the first part of a question, regardless of the conditional clause; this was most 
commonly observed for questions. This occurred for two participants in response to SM10, “Stayed 
awake (when you would rather sleep) to make sure treatment was going ok?” 
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A discussion of these findings is presented, followed by suggestions for modifying the scale 
based on these findings. For a summary of the categories, their definitions, and examples, see table 
8.1.  
8.5.2 Social and emotional 
 
While the questionnaire is largely focused on the medical side of self-management, the 
characterisation of some subscales as being, “defensive” and others as being, “cooperative” does 
imply more and less socially focused behaviours. 
Naturally, SM26, “Acted more cheerful than you felt in order to get good care?” tended to 
elicit responses with both emotional and social components. One participant noticed that he does 
act more cheerful than he feels, but his wife spots this and cheers him up anyway. Another 
participant noted that she does not act more cheerful for healthcare professionals, but does for 
social acquaintances as she gets tired of explaining herself. Another participant noted that she does 
not care what anybody thinks, and expresses herself freely whether they are healthcare 
professionals or social acquaintances.  This question is considered to be part of the “Impression 
management” subscale, one of the defensive subscales. The first participant indicated that he 
believes that he does, and that he may conceal when he’s feeling down – but that his wife 
counteracts this by being able to interpret his non-communication and cheer him up. The second 
indicated that the question was context dependent for her, answering in the negative to the whole 
question (it specifies acting cheerful to get good care from staff), but indicating that she does 
conceal her feelings from social acquaintances out of tiredness with repetition. The final participant 
answered in the negative, indicating that she did not, and that she was happy with things being this 
way. 
SM12, “Asked family, friend, or dialysis patients for more information about kidney disease 
and its treatment?” also induced responses about social status. Most participants said they did not, 
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but those who did expressed the idea that they found this helpful, either from a friend face to face, 
or virtual support over the internet. Talking to a friend about kidney disease and its treatment was 
expressed as being more helpful as a form of emotional support for one participant, and a way of 
coping with fear of future complications and comorbidity. 
 
8.6 Discussion of findings 
  
8.6.1 Structural 
 
A number of issues common to questionnaire design and wording were found for the BHDS, 
along with some less common. Problems with the timescale over which people were asked to 
remember, items with limited applicability, and unclear reference were found. Additionally, some 
items had multiple clauses, and participants would respond to the first part of the question without 
taking into consideration the modifying clause. These findings will be considered here, along with 
suggestions for improving the scale to take account of these issues. See table 8.1 for a summary of 
codes definitions and examples. 
 Some of the most common issues cropping up during the interviews related to assessing 
frequency of behaviours, or answering in accordance with the duration specified in the 
questionnaire. As the responses offered are, “Never”, “A few times, “A lot of the time”, or, “All the 
time”, it is important for the participant to be able to gauge the frequency of a behaviour. Most 
participants did not struggle to give one of these frequency based answers, although sometimes 
they would answer that they had performed a behaviour, while being unable to give any examples. 
In these cases it appeared that the participant was giving an answer based on the fact that it, 
“sounds like something they would do”, rather than because they could think of concrete examples 
where it happened. In these cases it may be that the accuracy of their estimate may be in question. 
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 More problematic tended to be the specified time period of 6 months. For certain items, 
participants had difficulty remembering back over this time period. For others, the behaviours in 
question were most likely to have been performed before this time period began, especially if they 
were experienced dialysis patients. For example, finding out information about kidney diets was 
likely to have been performed at the initiation of dialysis. While two participants expressed that it 
was a matter of ongoing interest because evidence based information may change over time, it is 
unlikely that the core of renal dietary advice will change every 6 months. Therefore it may be 
unreasonable to classify constant checking on this front as a practical self-management behaviour. 
Staying current with such advice is an indicator of active interest, whereas constantly checking may 
be considered obsessive. The structure of questions and responses in the BHDS makes it difficult to 
assess the value of this item. 
 It may be that in some cases, a different time frame should be incorporated into the 
question itself, or alternatively, every question should come with its own time-period specification. 
 Another common problem that cropped up across the BHDS was that of limited applicability. 
For participants on home haemodialysis, questions regarding the practice of self-administering 
haemodialysis were of limited applicability and will experience ceiling effects, as they will always be 
performing these behaviours themselves. As such, different versions of a questionnaire would be 
required for people dialysing at home and those dialysing in-centre. In some cases, their informal 
carers helped with these behaviours, and this may be something useful to capture. Negotiations 
around dry weight and blood flow rate produced some interesting responses in this home 
haemodialysis sample, but may still experience ceiling effects should a home BHDS be developed, 
indicating questions would need to be reframed. Many definitions hold that the role of carers is very 
much part of the self-management picture, and that practical support is important in addition to 
social support, but this is not captured in the questionnaire. Additionally, asking about adjusting 
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phosphate binder dose to the size of a meal does not make sense if the participant has not been 
prescribed phosphate binders in the first place. 
 The most logical solution to these kinds of problem is to include a ‘not applicable’ option in 
the questions. Items marked as ‘not applicable’ could then be missed off, and a pro-rata score 
formed of only items with a response included. While participants may be tempted to use this 
answer for questions where they do in fact have an applicable answer, this should reduce the 
problem of missing items. During data collection for chapter 6 and 7, non-completion of items in the 
self-management questionnaire were (where possible) followed up by asking participants to 
complete the missing items and why they might have missed them. While some participants simply 
accidentally missed the questions, some indicated that they had not provided an answer because 
the item was not-applicable, and they did not want to, “mess up” the results by providing an answer. 
 Some items resulted in participants identifying that it was unclear what the question was 
referring to. In some cases, this was due to individual wording. For two participants, the word, 
“care” was sometimes problematic, and in three cases the word, “caregiver” was unclear. It is clear 
that some participants saw the term, “caregiver” as referring to staff only, while others saw it as 
referring to their informal carers such as their partner or family. It may be helpful to clarify these 
questions by being more specific, or giving examples embedded in the question. 
 The final issue that frequently cropped up, that was particularly highlighted by the think 
aloud/elaborated answers given in these interviews, was that of questions with multiple clauses. 
This sometimes resulted in incongruous answers, whereby the ‘survey answer’ (e.g. “All the time”) 
did not align with the content of the elaborated answer. For example, asking a participant if they’ve, 
“handled problems or symptoms by yourself so they wouldn’t have to talk about them”, and the 
participant answering that this is something they have done all the time in the last 6 months, only to 
reveal that they were answering affirmatively to having handled problems or symptoms by 
themselves, but that this had nothing to do with having to talk about them. 
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 Such questions may benefit from being split into multiple parts, i.e. “Handled problems or 
symptoms by yourself?” followed by, “If yes, was this so you wouldn’t have to talk about them?” 
(with a not applicable option in case the answer to the first part is no). Alternatively, two separate 
questions could be used. 
 While the focus of these interviews was on the structural issues inherent in the BHDS, the 
importance of social support was frequently visible. While the questions asked here focused on 
practical tasks, the importance of social support for psychological wellbeing was also identified.  
 
8.6.2 Social and emotional factors 
 
Despite only being addressed tangentially in the scale, social and emotional elements did 
feature in participants’ answers to questions posed during the cognitive interviewing process. They 
were sometimes raised at the end, during the general debriefing session in which the interviewer 
asked for their thoughts on the questionnaire. Where social issues were raised, such as support from 
family or friends, this was in response to ‘cooperative’ style questions as one would expect. Where 
emotional issues were raised, this was often in response to ‘defensive’ questions. This is not 
surprising, as data reported in chapters 6 and 7 revealed that depressive mood as measured by the 
PHQ-9 was related to the defensive subscale, but not the cooperative subscale. 
The fact that social and emotional factors make an appearance, for example in the form of 
‘acting more cheerful than you felt’, but that these dimensions are not more directly addressed, 
presents the question of whether ‘self-management’ scales do in fact measure the full range of self-
management. In the next section, a series of suggestions for integrating these variables into future 
studies of self-management follows. 
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8.7 Suggestions for measuring self-management 
 
This section will address how to take some of the lessons on conceptualising and measuring 
self-management in ESRD in future research, drawn from the findings of this chapter, and the 
broader dissertation. The discussion will progress from general points about measuring self-
management in ESRD, to specific suggestions about the BHDS. 
 
8.7.1 Lessons learned 
 
 A more comprehensive summary of the findings of the work presented in this dissertation 
can be found in chapter 9: Discussion. However, a brief summary of some key lessons learned about 
conceptualising and measuring self-management will be presented here.  
In chapters 2 and 3, the literature reviews on self-management across chronic illnesses in 
general, and specifically in ESRD, revealed that self-management is usually conceptualised as 
comprising of medical, social, and emotional components (Lorig & Holman, 2003; Coleman & 
Newton, 2005). However, these reviews also revealed that in empirical quantitative work, both 
observational and interventional, self-management is operationalised as only including medical 
tasks, and more specifically adherence.  In fact, “self-management” is often used as a synonym for 
adherence (Costantini, 2006). In many other cases, self-management is recognized as comprising a 
number of skills, such as decision making and taking action, but the focus remains on medical 
outcomes, and is rarely operationalised as including the balancing acts between medical tasks, social 
tasks, and emotional tasks that emerge time and time again from work with patients (see chapter 5, 
in addition to the present chapter). Further, many studies use self-efficacy as the outcome for an 
intervention to improve self-management, despite the fact that Lorig and colleagues in the Self-
Management in Chronic Disease Programme (SMCDP) have argued that self-efficacy is a ‘weak 
outcome’ that is itself a predictor of self-management behaviour (Lorig & Laurent, 2007). 
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 For patients at least, the concept of medical, social and emotional issues being important 
appears to hold true. In chapter 5, one of the most consistent themes to emerge was that of self-
management as a, “balancing act” between what keeps one healthy, keeps one happy, and allows 
one to maintain a social role within the world. Staff understandably appeared to be more focused on 
medical aspects, specifically adherence, and this may explain why empirical papers on the topic tend 
to focus on this aspect. 
 Chapter 6 empirically supported the findings of the authors of the BHDS, that psychological 
distress appears to be associated with more defensive self-management behaviours. This may 
indicate that doing more by oneself, or keeping problems to oneself, may be the result of depression 
and anxiety. Chapter 7 found basic associations between these defensive behaviours and phosphate 
control, which would suggest that these behaviours may not only be associated with poorer 
emotional wellbeing, but may also result in poorer medical outcomes. However, this did not hold 
true in multivariate models, indicating that the variance was explained elsewhere. 
 The cognitive interviews exploring the scale in greater depth presented here would suggest 
that the terms ‘cooperative’ and ‘defensive’ may be misleading in some cases. The use of alternative 
therapies for example, may be seen as a ‘defensive’ act, rather than a cooperative one, particularly 
in the language it is couched in; ‘alternative’ therapy suggests one that is used in place of treatment 
recommend by a healthcare professional, whereas ‘complementary’ is more commonly used to 
denote an adjunct therapy, often those aimed at relaxation (UK National Health Service, 2015). A 
complementary therapy may indicate taking steps to maintain one’s emotional wellbeing while 
proceeding with recommended treatment, while an alternative therapy may involve a rejection of 
treatment recommended by doctors. The former may be seen as cooperative, while the latter as 
defensive.  
 All of this illustrates an important point when measuring any latent concept, but that seems 
to be particularly pertinent in self-management; one’s terms must be well defined and 
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operationalised, and a consensus definition would aid comparison and interpretation between 
studies. 
 One thing that remains clear is that self-management is often a ‘messy’ concept without a 
neatly defined and universally accepted language. This is perhaps exemplified by a recent attempt to 
create a ‘taxonomy of self-management’ (Taylor et al., 2014). This was part of a metareview of the 
literature on self-management in chronic illnesses. The aim was to produce an accepted set of terms 
used in self-management to aid the review. This was based on previous work codifying active 
components of behaviour change techniques (Michie et al., 2013). However, the conclusions of 
Taylor et al. were that it simply wasn’t possible to do this for self-management, as the language used 
was too diverse across the literature. Taylor et al. ran into similar problems with identifying the 
appropriate self-management literature in the first place, as it is a broad and often poorly defined 
concept. 
 The following is a list of general suggestions for the measurement of self-management in 
ESRD based on these lessons. 
8.7.2 General suggestions 
 
1. Any empirical study of self-management should begin by reporting an operational definition 
of the concept.  
2. Phrases such as, “increasing self-management” should be avoided unless adequate context 
and definition is provided. For example, “The goal of the study was to increase self-
management” is too vague to be helpful. More specific language such as, “The goal of the 
study was to improve adherence to fluid restrictions” or “to increase the seeking of social 
support” would be preferable. 
3. It is valid to study one aspect of self-management behaviour, but it is important to be clear 
about whether behaviour or psychological status are being measured. For example, high 
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levels of psychological distress, such as used in this dissertation, are an example of a 
psychological status. What a person does when confronted with low mood is a behaviour. 
4. The concept of ‘balance’ between medical, social, and emotional needs should receive 
further study. The concept came up repeatedly in the qualitative work presented here, and 
elsewhere in the self-management literature, but is rarely investigated quantitatively. 
Further investigating how the decision making process works when weighing up choices 
could potentially prove to be highly informative. 
5. Self-efficacy should not be conflated with self-management behaviour. 
 
 
8.7.3 Alterations specific to the BHDS 
 
 Based on the findings in these cognitive interviews, there are some specific 
recommendations that may improve the quality of this scale: 
Issue 1: Frequency or duration 
The time period of six months resulted in some infrequent behaviours, such as searching for 
kidney diet information, to be recalled from the initiation of the dialysis process, which for most 
participants took place years prior to the interview 
Suggestion:  Separate items into several groups of questions, with varying time periods 
depending on the type of behaviour. Keeping the questionnaire simple would be paramount, so two 
or three different sections at most. These sections could include how often a participant has 
performed an action over time periods such as: “Ever”, “The last 6 months” and “The last week”. It 
may be helpful to distinguish between the two time periods. Alternatively, the question could ask for 
frequency for both “Ever” and “The last 6 months”. This may also produce interesting data about 
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behaviours that are performed more over the course of an individual’s life on dialysis, and which are 
performed less.  
Issue 2: Limited applicability 
Some questions were not applicable for all participants, leading to confusion about whether 
to leave a question blank, or provide an inappropriate answer. 
Suggestion: Include a ‘Not applicable’ option. This could be for all questions, or limited to 
those that are conceivably not applicable to everyone. For example, it does not make sense to give a 
lower self-management score to a patient for not adjusting their phosphate binder dose to the size 
of their meal when they are not prescribed phosphate binders. 
Suggestion: Have two different versions of the scale, one for people on in-centre 
haemodialysis, and another for people on home haemodialysis. Exclude the ‘Self-care haemodialysis’ 
subsection to avoid ceiling effects, and to protect future participants from unnecessary item burden. 
 
Issue 3: Unclear reference, wording, or misunderstanding 
Some specific items were unclear in their meaning or wording, resulting in participants being 
unsure of how to answer, or giving an answer to a different question than the one intended. 
Suggestions: 
 In SM21, the term, “caregiver” should be clarified. It is not clear whether it was intended to 
be restricted to professional caregivers in the original scale, but as self-management 
involves the patient’s informal caregivers, a definition including these should be used. For 
example, “Spoke up to a caregiver (for example, a nurse, or a family member who cares for 
you) because you thought they were doing something wrong?” 
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 SM24, “Tried to get staff or your doctor to think well of you in order to get better care?” 
could be split into two questions, “Have you tried to get staff or you doctor to think well of 
you?” “Have you tried to get better care?” 
 SM26, “Acted more cheerful than you felt so staff would give you good care?” This item 
could be broken down into multiple parts, as for SM24. Alternatively, one question could be 
retained (as two questions) and the other dropped to avoid inflating the total item count. 
 SM34, “Took responsibility for parts of your care or treatment?” could be rephrased to make 
the intended meaning of the question clearer. For example, “Taken responsibility for parts of 
your care or treatment that might otherwise be performed by staff or your doctor?” 
 
Issue 4: Difficulty producing an example 
Being unable to produce a specific example was anticipated as being a problem, but this was so rare 
as to not be problematic. 
Issue 5: Conflicting clauses 
Participants answered the first part of the question regardless of the whole question. A potential 
solution may be to use a two part question: 
“17a: Do you handle problems or symptoms by yourself?” 
“17b: If yes, do you do this to avoid having to talk about the problem or symptom?” 
Conditional question can cause difficulty at the analysis stage, particularly if there is missing data. 
They can also be more confusing for participants. It therefore may be preferable to have two 
separate questions, each with a ‘Not applicable’ option (as above). 
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These conflicts usually resulted in misunderstandings, and as such have been covered under 
issue 3 (unclear reference, wording, or misunderstanding). 
The questionnaire should be expanded to include social and emotional issues. The work in 
chapter 5 and the current chapter identified social and emotionally focused behaviours that may be 
important in self-management. Chapter 5 in particular that the question of ‘who self-management is 
for’ is important when considering what it entails. If we are interested in self-management from a 
healthcare professional perspective, only socially and emotionally focused behaviours that relate to 
clinical outcomes would be of interest. For example, an item might cover, “Turning down a drink 
when in a social situation, such as at the pub or coffee shop”. If we consider self-management to be 
about the overall wellbeing of the individual, then we will be interested in behaviours that improve 
emotional and social wellbeing, undertaken while living with ESRD, regardless of whether they 
improve clinical outcomes. In this case, we might be more interested in the “balancing acts” that 
participants discussed in chapter 5. These might include items that look more like, “I sometimes eat 
something that makes me happy, even if I know it is recommended against”. This is not just a 
question of content, but also of how questions are framed. 
 Indeed, perhaps a more concerted effort to measure both ‘viewpoints’ of self-management, 
to allow further investigation into how each approach relates to not just clinical, but also emotional 
and social outcomes (such as IDWG, psychological distress, and perceived social support) is 
desirable.  
 The next step in creating a revised scale will be to conduct another set of cognitive 
interviews based on the BHDS and generate a new specific set of items. In combination with the 
work presented in the present chapter, this will allow for the generation of both in-centre and home 
scales. It will also allow a qualitative comparison of the responses of home and in-centre patients to 
specific questions about self-management behaviour. The second set of interviews and creation of a 
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specific set of items goes beyond this dissertation, but is a logical next step in improved 
measurement of self-management behaviour in people on haemodialysis. 
 
8.8 Conclusion 
 
 This chapter looked at how the BHDS, a scale measuring behaviours for people on 
haemodialysis, could be improved. Cognitive interviews provided insight into participants’ thought 
processes when responding to each question, and found that certain questions may provide 
inaccurate answers to due to problems with frequency or duration, limited applicability, unclear 
reference, and conflicting clauses. A number of suggestions were made as to how these problems 
could be overcome in a revised questionnaire. 
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9.1 Introduction 
 
This dissertation has presented empirical investigations that support the thesis: 
Certain self-management behaviours in End Stage Renal Disease are predicted by self-efficacy, 
patient activation, and psychological distress, and in turn predict clinical status. However, self-
management is often oversimplified and poorly operationalised, in both the literature and in clinical 
practice, to adherence and ‘good/bad’ distinctions that may impede future investigations and 
interventions. 
The core findings from these investigations include: 
1. Educational materials on self-management exist, for both patients and staff involved in their 
care, but these rarely go beyond adherence 
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2. Renal staff tend to view self-management as being about adherence at all costs, while 
patients tend to view it as a series of complex balancing acts between their health, 
emotional wellbeing, and social functioning 
3. The dialysis unit is viewed as a ‘family’, one that can either support self-management 
behaviour, or undermine it 
4. ‘Defensive’ and ‘cooperative’ self-management styles have distinct relationships to patient 
activation, self-efficacy, and psychological distress 
5. Self-management behaviours are positively associated with interdialytic weight gain (IDWG), 
and this relationship remains stable over time 
6. Self-efficacy predicts survival among in-centre haemodialysis patients over 36 months 
7. Existing tools for measuring self-management can be difficult to understand, and require 
reworking 
 
 
9.2 Conceptualising self-management in ESRD 
 
“… self-management is often oversimplified, in both the literature and in clinical practice, to 
adherence and ‘good/bad’ distinctions that may impede future investigations.” 
 The first set of investigations explored the views of patients and staff involved in their care 
on self-management, using focus groups, interviews, and thematic analysis. One of the core findings 
to come out of these was the fact that while there was much overlap between staff and patients in 
identifying important elements of self-management, they had a very different focus. Staff tended to 
focus on adherence, whereas patients identified complex medical, social and emotional balancing 
acts. Further, the staff focus on adherence to medical recommendations such as fluid restrictions, 
tended to be characterised by dividing patients into ‘good’ and ‘bad’, with a specific set of attributes 
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that distinguished them. The distinction between good and bad patients has been observed 
elsewhere. In a study involving focus groups and interviews with patients and staff discussing the 
UK’s Expert Patient Programme, staff appeared to have a very negative response to patients who 
displayed signs of distress during consultations (Wilson, Kendall, & Brooks, 2006).  
 This good/bad distinction seems salient to the psychological and health literature on self-
management in two ways. Firstly, as noted, the self-management goals of clinicians and patients 
may be very different, with one group focusing on clinical issues such as survival, symptom control, 
and slowing disease progression, and the other balancing quality of life and role functioning with 
survival and low symptom burden. Indeed, what emerged in the course of the quantitative 
investigations in chapters 6 and 7, and was explored further in chapter 8, is that some self-
management behaviours may be associated with poorer psychological health. These seem to be 
behaviours where the individual attempts to ‘do it all themselves’. 
 This ‘do it all yourself’ is something that can be seen in the investigations in chapter 5. Junior 
staff in particular often believed that ‘self-management’ was a drive to get patients to do it all 
themselves, to reduce staffing and cut costs.  Senior nursing staff were more concerned about the 
risk of litigation. This fear of litigation from self-managing patients who ‘go off and make mistakes’ 
has been observed elsewhere (Martin, 2004). However, this fear appears to be largely unfounded, 
and theoretically at least, it should be unlikely that any provider who provides good information 
should be liable for the actions of a self-managing patient (Wilson et al., 2006). 
 An interesting additional finding is that some among both staff and patients perceived the 
dialysis unit as being like a ‘family’, and that this was almost universally regarded as a positive thing. 
The properties ascribed to this family were social, supportive and cooperative, which in the context 
of the findings elsewhere in this thesis suggest that this is likely to be a positive quality worth 
nurturing. However, further exploration of this, and how such a dynamic could be captured to 
improve future self-management interventions, is required. 
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 It is notable that emotional, social, and role functioning all came out as important factors to 
patients when discussing self-management. The importance of an individual adjusting to the 
challenges that life on dialysis presents is important, as it is in any chronic disease (Charmaz, 1983). 
However, perhaps because of the way the interviews and focus groups were structured, or because 
the focus was not on long term survivors, there was little discussion of transformational experiences. 
These have frequently been found in both dialysis populations (Curtin et al., 2002) and other chronic 
illnesses (Carpenter, Brockopp, & Andrykowski, 1999). 
 The fact that empirical studies often conflate self-management with adherence 
oversimplifies the matter, and misses the broad range of self-management behaviours that ESRD 
requires. Similarly, this same focus on adherence, along with the dichotomous good/bad distinction 
that staff hold raises the question of which aims ‘good’ self-management is trying to achieve, and 
who self-management is for. 
 
9.3 Predicting performance of self-management behaviours 
 
“Self-management behaviours in End Stage Renal Disease are predicted by self-efficacy, patient 
activation, and psychological distress…” 
 Self-efficacy and patient activation each predicted self-management behaviours cross-
sectionally in different models. The association is what we would expect from evidence supporting 
Social Cognitive Theory and emerging Patient Activation Theory in other conditions (Bandura, 2004; 
Hibbard, Mahoney, Stock, & Tusler, 2007). What was more surprising was that total self-
management behaviour score was associated with higher levels of psychological distress. That is, the 
more frequently self-management behaviours were performed, the more distressed an individual 
was. Investigating the self-management subscales revealed this to be due to the ‘defensive’ self-
management behaviours, as opposed to the ‘cooperative’ behaviours. Defensive self-management 
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behaviour was associated with higher levels of psychological distress, while cooperative behaviours 
were not. This may make intuitive sense when considered in terms of isolation; a tendency to pull 
away and manage situations alone when they could be managed cooperatively. This could be either 
an indicator or cause of social isolation and depressive symptoms.  
 In the context of the qualitative work presented here, some of these results are not 
surprising. During the cognitive interviews in chapter 8, there were examples of individuals 
displaying a high sense of self-efficacy and ‘do it all oneself’ attitude, accompanied by high levels of 
psychological distress. Conversely, individuals who appeared to be coping better emotionally 
identified cooperative relationships with their healthcare teams. The idea that depression may be 
the mediating variable between self-efficacy and defensive self-management is interesting. High 
levels of psychological distress may be responsible for the performance of more defensive self-
management behaviours in those with low self-efficacy, as indicated by the findings of the mediation 
analysis. 
 One limitation of the work presented here is that perceived social support was not 
measured at the start of the study, when participant numbers were highest. This limits the ability to 
test the hypothesis that perceived isolation was the mediator of the relationship between high 
performance of defensive self-management behaviours and high levels of psychological distress. 
 Disease related knowledge was not measured in the studies presented here, but may be 
related to self-management, with self-efficacy as a mediating variable (Rimal, 2001). However, 
Bandura notes that many studies have demonstrated that increasing participant knowledge alone 
rarely changes behaviour, and maintains that self-efficacy is the critical variable (Bandura, 2004). He 
also contends that changing levels of perceived social support does not change behaviour unless it 
enhances self-efficacy (Bandura, 2002). If social support fosters dependence, then it may in fact 
reduce self-efficacy and thus self-management capacity. 
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 In prior longitudinal studies in other chronic conditions, self-efficacy was found to predict 
unaided smoking cessation in heavy smokers (Carey, Kalra, Carey, Halperin, & Steven, 1993). The use 
of latent growth models identified those with high patient activation as being more likely to engage 
in more frequent self-management behaviours over a 6 month period  (Hibbard et al., 2007). 
 The finding of a relationship between psychological distress and certain ‘defensive’ self-
management behaviours is a replication of the findings obtained as part of the validation process for 
the BHDS (Curtin et al., 2004). The finding that self-efficacy is related to fewer ‘defensive’ self-
management behaviours, measured by the BHDS, is novel. Furthermore, the finding that depression 
mediates the relationship between self-efficacy and defensive self-management is novel and 
potentially important. Defensive self-management behaviour was related to higher serum 
phosphate levels in chapter 7 at 9 and 18 month follow-up, although this did not hold true in 
multivariate analyses. 
 
9.4 Self-management behaviours as predictors of clinical status 
 
 “… and in turn predict clinical status” 
Self-management behaviours were associated with clinical status at baseline. The original 
work on the BHDS did not include measures of clinical status such as IDWG and phosphate, so the 
potential direction of a relationship was unknown. However, it was hypothesised that cooperative 
self-management would be associated with lower IDWG and phosphate. The results described in 
chapter 7 showed a very different story, with cooperative subscales being correlated with higher 
IDWG at baseline, and remaining associated with IDWG in a multivariate longitudinal model. As 
discussed in chapter 7, the longitudinal model may suffer from the attrition rate of respondents, but 
the fact that IDWG and cooperative self-management behaviours were positively correlated cross 
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sectionally may indicate that this relationship warrants further investigation, as there is currently a 
drive for more patients to be responsible for more of their own dialysis (Dainton & Wilkie, 2013). 
Patient activation increased from the start to the end of the 18 month study period. Over 
this period, the SELFMADE facilitator was introducing some new services aimed at providing peer 
support, encouraging exercise, helping participants to organise holidays, and providing some one-to-
one goal setting. Additionally, there were other research studies going on at the same time in the 
units trialling a brief self-affirmation intervention (Wileman et al., 2014). It may be that these 
activities, partly focused on improving self-efficacy and patient activation, were responsible for this 
change, although it is unclear why patient activation increased while self-efficacy did not. An 
alternative explanation is that those with lower patient activation were lost to follow-up, although 
baseline patient activation was not associated with whether follow-up observations were missing or 
not. 
 The relationship between self-efficacy and survival has not previously been demonstrated 
among people on in-centre haemodialysis. In chapter 7, self-efficacy predicted survival, while self-
management behaviour did not. One of the most theoretically likely causal mechanisms by which we 
may expect self-efficacy to predict survival would be via increased performance of self-management 
behaviours, and thus greater adherence to IDWG. However, IDWG and phosphate were not 
associated with mortality in this sample. However, this is not entirely surprising, as previous research 
has found that the relationship between IDWG and mortality is small, and only evident for very large 
weight gains (Hecking et al., 2013). 
There is some evidence from studies in other chronic illnesses that self-efficacy is linked to 
survival, for example in chronic obstructive pulmonary disorder and coronary heart disease (Kaplan, 
Ries, Prewitt, & Eakin, 1994; Sarkar, Ali, & Whooley, 2009) This is the first time that self-efficacy has 
been shown to predict survival among people on dialysis for ESRD. Other previous studies have 
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suggested that such a link should exist by logical extension of relationships between self-
management behaviour and survival (Zrinyi et al., 2003), but none have demonstrated this. 
 
9.5 Measuring self-management 
 
“… poorly operationalised… that may impede future investigations” 
 Indications that the HDBS may contain some weaknesses became apparent during the 
quantitative empirical investigations described in chapter 6 and 7. The investigation described in 
chapter 8 was aimed at ensuring that the thought processes used when responding to questions 
matched up with how they would be interpreted in the analysis stage. A number of areas of 
potential weakness and areas for improvement were identified. Lessons on measuring self-
management were collated from throughout this dissertation and presented as a series of 
suggestions for future measurement. 
 A secondary aim of exploring respondents’ answers in greater depth was to obtain more 
information about the character of their responses when answering defensive questions, and when 
answering cooperative questions. This potential distinction has not received enough attention in the 
literature to date, and further understanding of these clusters of behaviours could be vital in 
encouraging self-management that is beneficial to patients. 
 This is the first study that has used and reported cognitive interviewing techniques to try and 
better understand the cognitive processes of people on haemodialysis when answering questions 
about their self-management behaviours. These interviews have produced some novel insights into 
both structural elements of the BHDS, as well as the broader issues around self-management 
behaviours. Understanding the cognitive processes of responding to questions about self-
management behaviour can help improve the design of future scales to better capture subtleties 
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that are currently being missed.  With such a broad interest in the implementation of self-
management interventions in the NHS, and indeed worldwide, understanding the validity of 
measures used, is vital. With an absence of ‘gold standard’ self-management measures, particularly 
in ESRD, using qualitative methods to explore both the validity and structural robustness of 
measures is vital. Evaluating self-management interventions in the future will require the creation 
and selection of appropriate outcome measures, along with an understanding of what they are 
measuring. 
 The development of a new scale goes beyond the scope of this dissertation. However, the 
next stage in the process of developing the BHDS into a more useful tool for measuring self-
management behaviour would be to conduct further cognitive interviews with people on in-centre 
haemodialysis. Social and emotional elements of self-management behaviour could be more 
explicitly included. Appropriate items could be modified, new items selected, and piloting could 
begin. 
 
9.6 General remarks 
 
 This dissertation has sought to investigate self-management behaviour, both as a concept, 
and in terms of how it relates to variables that it is frequently associated with in theory, academic 
literature, and increasingly, clinical practice. 
 One of the most important messages to have emerged throughout is “Who is self-
management for?”. This question should be asked whenever a new study, initiative, or intervention 
is being undertaken. Chapter 5 demonstrated that patients and healthcare professionals (HCPs) had 
overlapping ideas about what self-management entails, but a very different focus in their ideas 
about what was important – balance or adherence. Similarly, the motivations that patients reported 
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for engaging in predominantly medically-focused self-management behaviours were generally driven 
by a desire to maintain their social and emotional wellbeing. 
 In the interviews conducted 18 months after the focus groups, there were a mix of views 
from participants on whether they’d like to be more involved in their own haemodialysis or not 
(shared haemodialysis care), usually only being interested if it would cut down on waiting time. 
Understanding motivations such as this are important as new initiatives emerge to promote self-care 
haemodialysis (Dainton & Wilkie, 2013; Glidewell et al., 2013). As survival results from chapter 7 
suggest, self-efficacy may be an important factor to improve, but understanding why patients would 
or would not want to engage in their own care is key to securing that engagement. Furthermore, the 
intervention should be aimed at helping patients to work towards the goals that are important to 
them, and ‘time’ came up repeatedly in chapters 5 and 8 as one of the most precious things to 
people on dialysis. 
 When designing future self-management interventions, particularly those using online 
support, it is useful to note that there are resources available online, as documented in chapter 3. 
However, these materials frequently only touch on the emotional and social aspects of living with 
ESRD. Given the fact that psychological distress may mediate the relationship between self-efficacy 
and self-management behaviour, it may be important to include these elements in designing future 
online resources, and when deciding which resources to direct patients towards in clinical practice. 
 Results from chapter 7 suggesting that greater engagement in cooperative self-management 
behaviours may be associated with higher IDWG may call into question whether greater 
engagement will even necessarily produce improved clinical outcomes. Replication of the data 
obtained in that chapter would lend strength to those findings. However, to evaluate the impact that 
haemodialysis self-care behaviours have on clinical status, a prospective, randomised controlled trial 
would be required. Observational data presented in chapter 7 may be confounded by unmeasured 
variables not controlled for. 
251 
 
 At the time of writing, there is a building drive in the United Kingdom to promote self-
management, and to find ways to measure the success of interventions. Currently the method 
favoured by NHS England is by introducing the PAM-13 into routine clinical care (NHS England, 
2013). Patient activation was related to self-management behaviour in chapter 6, but it will be 
important to distinguish ‘activation’ from self-management behaviour.  
Additionally, ‘shared haemodialysis care’ is now a ‘CQUIN’. A CQUIN is a guideline set by the 
Commissioning for Quality and Innovation Scheme in the NHS. These guidelines state this goal as, 
“To offer the choice to in-centre haemodialysis patients to become involved in tasks relating to their 
dialysis.  Patients are to be supported to do as little or as much of their treatment as they feel able 
or wish to do”. The focus of this goal is stated to be improving patient experience; however, it only 
concerns the practical delivery of dialysis, and not the wider social and emotional aspects of self-
management. This may be an appropriate goal for increased participation in haemodialysis in light of 
the work in this dissertation. Interviews and focus groups identified services users who wanted to be 
more involved in their care, and those who wanted to be treated by others; in both cases, there 
were a variety of reasons. Chapter 7 indicates that this participation may not necessarily result in 
improved clinical status, albeit when shared haemodialysis care was not officially supported. 
However, if we ask, “Who is self-management for?”, it may be that participation enables patients to 
work towards their non-medical self-management goals, such as saving time through more flexible 
treatment times or seeing more of their family, or feeling more in control of their care. It remains 
important to integrate support for other elements of self-management into in-centre haemodialysis 
care. 
 
9.7 Limitations 
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While the work set out here has produced novel findings, guided by theory and 
methodological rigour, there are nonetheless limitations to be addressed. 
 The focus groups carried out here were rigorously coded by a team of four researchers in 
such a way that agreement and accuracy were paramount. However, all members of the coding 
team were involved with the project, and therefore will have had some pre-conceived ideas about 
what they might find in the results. The integrity of the results could have been improved by adding 
an external coder completely blind to the aims and goals of the project. 
 The quantitative investigations reported here were conducted while patients dialysed. For 
depression and illness perceptions, intra versus inter dialytic questionnaire completion has shown to 
yield almost identical results (Chilcot, Wellsted, & Farrington, 2008). The on-versus-off dialysis 
properties of questionnaires such as that for self-management behaviours are unknown, and 
participants may therefore have produced different answers if completing the questionnaires while 
not on dialysis. However, given the similar performance in each condition of other instruments, this 
was deemed acceptable for the purposes of these studies. Investigating these properties may be an 
important part of further developing the self-management questionnaire. 
 The attrition rate for completion of questionnaires was high, if commensurate with similar 
studies conducted in the same population (NHS Kidney Care, 2013). This resulted in a loss of power 
for longitudinal analyses where repeated questionnaire results were used. This may have 
implications for the validity of the findings where analyses use questionnaire data as repeated 
measures, namely the multilevel models described in chapter 7 and the finding that patient 
activation increased over time. Despite attempts to statistically investigate patterns of missing data, 
and account for missingness using multiple imputation, mitigating statistical processes are not a 
perfect substitute for a more complete set of data. 
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 The data reported throughout this dissertation, both qualitative and quantitative, was 
collected at sites that were running multiple research projects, and that were implementing multiple 
interventions oriented towards themes around self-management (peer support and self-affirmation, 
for example). This can complicate interpretation of longitudinal qualitative results, and may have 
influenced participants’ responses in the 18-month interviews described in chapter 5. However, to 
an extent this represents ‘business as usual’ for both the sites studied, and sites in the wider NHS 
and other healthcare systems worldwide. Service developments, complex interventions, and 
research projects are constantly going on, and so observing participants in this setting may in fact be 
more representative of a ‘real world’ population than one in which no such activity is taking place. 
 The quantitative data reported here are all observational, and therefore caution is 
warranted when interpreting causal relationships, even where data were longitudinal. Additionally, 
observed relationships may be due to unobserved variables that were not, or could not, be included 
in multivariate models. Where possible, randomized controlled trials (RCTs) would offer the best 
evidence for causality. This may be possible in future investigations of self-care haemodialysis 
behaviours and IDWG, for example. This example is particularly salient due to the findings in chapter 
7. Participants interested in undertaking more of their own dialysis in-centre may be randomized to 
receive training and use self-care bays, or to a control group that would continue receiving dialysis as 
normal. Self-reported self-management behaviours could be recorded, as well as direct observation 
or record keeping of which parts of dialysis patients are performing – and the two could be 
compared to validate the self-report measure. By following up IDWG over time, an assessment of 
the contribution of self-care haemodialysis to IDWG could be more reliably made.  
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9.8 Practical implications and directions for future research 
 
From the investigations presented here, there appear to be salient, practical reasons for 
better conceptualising and communicating what self-management is. 
Taking into account the gap between HCP and patient views on what self-management 
means will be vital for making interventions successful. A self-management intervention 
implemented by, for example, a specialist nurse or a health psychologist would stand a much lower 
chance of success if the clinical staff that surround the patient day-to-day were giving different 
messages about what self-management entails. Further, service level changes will increase the 
likelihood of the success of interventions 
As a more sophisticated and specific language surrounding self-management evolves, there 
is a need for good quality research into interventions or service level improvements that may help 
foster it. The results presented here suggest that these interventions should be based on an 
awareness that beneficial self-management may not always refer to the patient doing more by 
themselves. It may be important to find ways to address the question of defensive self-management 
with patients, and discourage strongly defensive self-management behaviours. Perhaps the notion 
of ‘self-management’ itself would be better reconceptualised as ‘cooperative management’ (Von 
Korff, Gruman, Schaefer, Curry, & Wagner, 1997). 
 Further research should seek to investigate the reasons why certain defensive behaviours 
appear to be linked to higher levels of psychological distress. For example, what might it be about 
patients attempting to carefully managing the impressions they give staff, or about withholding 
symptom information, that may cause the association with psychological distress? 
 A more complete investigation of Social Cognitive Theory in people on dialysis could include 
a test of knowledge, as well as more specific tests of both self-efficacy and outcome expectancies. 
The work presented here was conducted with the aim of capturing a broad range of self-
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management behaviours, but it may be instructive to focus on predicting a very specific set of 
behaviours using Social Cognitive Theory. 
 ‘Self-management’ needs to be broken down and operationalised by its component 
behaviours if it is be of empirical value in conceptually guiding research and clinical practice. 
Ultimately, behaviours aimed at maximising psychosocial wellbeing and optimal medical outcomes 
may not always be entirely mutually reinforcing – but it is for the individual living with the condition 
to set their priorities and decide where their balance lies, and how to spend the precious time that 
they have. 
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Appendix G: Focus group schedules 
FOCUS GROUP – CLINICIANS 
 
ARRIVAL 
 Greet everyone as they arrive, offer refreshments and encourage them to take a seat 
 Explain that you will be the person who helps to keep the discussion going and that the 
other person will not be talking but will take notes and record the discussion to help you 
remember how the group went. 
 Go through the Information Sheet and remind them they can still say withdraw at any time, 
remind them that although we will write about what was said in the group that their names 
will not be used. 
 Take signed informed consent. 
 Agree with the group the ground rules for the focus group: that anything said in the 
discussion will not be repeated elsewhere, there are no right or wrong answers, that people 
will speak one at a time, that every person’s views are valuable and should be listened to. 
 Assure the group that the discussion will last no longer than 45 minutes. 
 
END OF FOCUS GROUP 
 After 30 minutes begin to bring the focus group to a close. Summarise what you think 
people have said and the main issues that people talked about. Ask the group if that sounds 
right or if you have forgotten to mention anything. Ask if there is anything that people would 
like to add.   
 Thank people for taking part in the focus group and answer any final questions about what 
happens next in the study.  
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DISCUSSION PROMPTS 
 
Remind the group what they have been invited to talk about i.e what they think is important in 
helping people on haemodialysis to self-manage  
 
Prioritising needs in haemodialysis self-management 
 
 In your experience what are the important things for self-management in patients on 
dialysis? 
 
 If not raised in discussion ask for their opinions on how important the following are: 
 
o Fluid intake 
o Diet 
o Medications 
o Exercise 
o Mental well being 
 
 If you had to rank all the things you have talked about, what would be the top 2 in terms of 
importance? 
 
What are the challenges in trying to look after themselves? 
 
 Thinking about some of the things you think are important in self-management, what are 
some of the difficulties patients face in keeping to these? 
 
 If you had to rank the difficulties you have spoken of, what are the 2 most difficult? 
 
 
What helps to self-manage? 
  
 Currently what kind of things do you find patients do to help theselves self-manage? 
 
303 
 
 Do you think that there are any things you could be doing that you are not already to help 
your patients self-manage? 
 
 Is there anything else that could help patients look after themselves better? 
 
Finally 
 Is there anything else you would like to say about self-management when on dialysis? 
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FOCUS GROUP – PATIENTS 
 
ARRIVAL 
 Greet everyone as they arrive, offer refreshments and encourage them to take a seat 
 When everyone has arrived or within 10 minutes of the stated start time, welcome 
everyone, introduce everyone and ask if people are happy to have a badge with their first 
name on it.   
 Explain that you will be the person who helps to keep the discussion going and that the 
other person will not be talking but will take notes and record the discussion to help you 
remember how the group went. 
 Go through the Information Sheet and remind them they can still say withdraw at any time, 
remind them that although we will write about what was said in the group that their names 
will not be used. 
 Take signed informed consent. 
 Agree with the group the ground rules for the focus group: that anything said in the 
discussion will not be repeated elsewhere, there are no right or wrong answers, that people 
will speak one at a time, that every person’s views are valuable and should be listened to. 
 Assure the group that the discussion will last no longer than 60 minutes. 
 
END OF FOCUS GROUP 
 After 45 minutes begin to bring the focus group to a close. Summarise what you think 
people have said and the main issues that people talked about. Ask the group if that sounds 
right or if you have forgotten to mention anything. Ask if there is anything that people would 
like to add.   
 Thank people for taking part in the focus group and answer any final questions about what 
happens next in the study.  
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DISCUSSION PROMPTS 
 
Remind the group what they have been invited to talk about i.e what they think is important in 
helping people on haemodialysis to take good care of themselves.  
 
Prioritising needs in haemodialysis self-management 
 
 In your experience what are the important things to remember in looking after yourself when 
on dialysis? 
 
 If not raised in discussion ask for their opinions on how important the following are: 
 
o Fluid intake 
o Diet 
o Medications 
o Exercise 
o Mental well being 
 
 If you had to rank all the things you have talked about, what would be the top 2 in terms of 
importance? 
 
What are the challenges in trying to look after themselves? 
 
 Thinking about some of the things you think are important when looking after yourself, what 
are some of the difficulties you face day to day? 
 
 If you had to rank the difficulties you have spoken of, what are the 2 most difficult? 
 
 
What helps to self-manage? 
  
 Currently what kind of things do you find help you to look after yourself? 
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 Do you think that there is anything your health staff could do to help you that they are not 
already doing? 
 
 Is there anything else that could help you look after yourself better? 
 
Finally 
 Is there anything else you would like to say about taking care of yourself when on dialysis? 
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Appendix H: Interview schedules 
INTERVIEW SCHEDULE 
CLINICIAN 
 
BACKGROUND 
 Can you tell me a little about yourself  
o What is your role on the renal unit? 
o How long have you worked on the unit? 
SELF MANAGEMENT – GENERAL 
 In your opinion, what are the key things a patient has to do for themselves to maintain 
optimum health whilst on dialysis? 
 What kind of difficulties do you find they experience in self-managing? 
 What kind of things have you found helps a patient to self-care when on dialysis? 
 
EVALUATING THE SELF MANAGEMENT FACILITATOR ROLE 
 How closely have you worked with INSERT FACILITATOR’S NAME on the renal unit? 
 How has she helped your patients? Can you describe this in more detail for me? 
 Do you think the unit has changed at all since INSERT FACILITATOR’S NAME started working 
there? If so, how? 
 What else do you think staff in the unit could do to promote self-management? 
 Is there anything else you think INSERT FACILITATOR’S NAME  could do to help  
o Patients self-manage more effectively 
o Staff promote self-management more effectively 
 
CONCLUSION 
 Is there anything else you would like to say about helping patients to look after themselves 
more effectively? 
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INTERVIEW SCHEDULE 
PATIENTS  
 
BACKGROUND 
 Can you tell me a little about yourself  
o How long have you been on dialysis? 
o How often do you come to the Unit? 
o Apart from the problems with your kidneys, do you have any other health issues? 
o Do you live on your own or are there other people at home? 
o Do you work? 
SELF MANAGEMENT – GENERAL 
 What kinds of things do you have to do to look after yourself because you are on dialysis? 
 On a day to day basis, how difficult is it to look after yourself? 
 What kinds of things do you find helps in taking care of yourself? 
 
EVALUATING THE SELF MANAGEMENT FACILITATOR ROLE 
 Are you aware of or have you met INSERT FACILITATOR’S NAME on the renal unit? 
 What do you think her job is on the unit? 
 How has she helped you? Can you describe this in more detail for me? 
 Do you think the unit has changed at all since INSERT FACILITATOR’S NAME started working 
there? If so, how? 
 Has the way any of the other staff works with you changed since INSERT FACILITATOR’S 
NAME started? If so, how? 
 What else could the unit do to help you look after yourself? 
 
CONCLUSION 
 Is there anything else you would like to say about how the unit helps you look after yourself? 
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